{
    "questions": [
        {
            "body": "What is the alternative lengthening of telomeres?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26428317",
                "http://www.ncbi.nlm.nih.gov/pubmed/28969871",
                "http://www.ncbi.nlm.nih.gov/pubmed/24531712",
                "http://www.ncbi.nlm.nih.gov/pubmed/25471051",
                "http://www.ncbi.nlm.nih.gov/pubmed/25593184",
                "http://www.ncbi.nlm.nih.gov/pubmed/19154407",
                "http://www.ncbi.nlm.nih.gov/pubmed/21037079",
                "http://www.ncbi.nlm.nih.gov/pubmed/11196173",
                "http://www.ncbi.nlm.nih.gov/pubmed/24792489",
                "http://www.ncbi.nlm.nih.gov/pubmed/23482750"
            ],
            "id": "5ab908d4fcf456587200001a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1993,
                    "offsetInEndSection": 2128,
                    "text": "We conclude that alternative lengthening of telomeres is a frequent telomere-maintenance mechanism in cytogenetically complex sarcomas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28969871",
                    "endSection": "abstract",
                    "offsetInBeginSection": 461,
                    "offsetInEndSection": 597,
                    "text": "The alternative lengthening of telomeres (ALT) pathway is a TMM frequently activated in tumors of mesenchymal or neuroepithelial origin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 105,
                    "offsetInEndSection": 197,
                    "text": "Alternative lengthening of telomeres is a telomere-maintenance mechanism common in sarcomas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24531712",
                    "endSection": "abstract",
                    "offsetInBeginSection": 167,
                    "offsetInEndSection": 256,
                    "text": "Telomeres are also maintained by the recombination-based alternative lengthening pathway."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 371,
                    "offsetInEndSection": 567,
                    "text": "We previously reported that alternative lengthening of telomeres and loss of ATRX expression were common in leiomyosarcoma, angiosarcoma, pleomorphic liposarcoma, and dedifferentiated liposarcoma."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25471051",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "A model of a patient-derived IDH1 mutant anaplastic astrocytoma with alternative lengthening of telomeres."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1413,
                    "offsetInEndSection": 1541,
                    "text": "By contrast, none of the 71 gene fusion-associated sarcomas was ATRX deficient or alternative lengthening of telomeres positive."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24531712",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1252,
                    "offsetInEndSection": 1371,
                    "text": "We concluded that alternative lengthening of telomeres is important in epidermal homeostasis and tumorigenesis in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25471051",
                    "endSection": "abstract",
                    "offsetInBeginSection": 389,
                    "offsetInEndSection": 514,
                    "text": "The astrocytic subgroup was found to have frequent mutations in ATRX, TP53 and displays alternative lengthening of telomeres."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1231,
                    "offsetInEndSection": 1412,
                    "text": "Alternative lengthening of telomeres and/or loss of ATRX were uncommon in malignant peripheral nerve sheath tumors, gastrointestinal stromal tumors, and embryonal rhabdomyosarcomas."
                }
            ]
        },
        {
            "body": "Which organ express and secretes the hormone FGF21?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25495872",
                "http://www.ncbi.nlm.nih.gov/pubmed/24424044",
                "http://www.ncbi.nlm.nih.gov/pubmed/28039838",
                "http://www.ncbi.nlm.nih.gov/pubmed/28844867",
                "http://www.ncbi.nlm.nih.gov/pubmed/27911795",
                "http://www.ncbi.nlm.nih.gov/pubmed/20851878",
                "http://www.ncbi.nlm.nih.gov/pubmed/24432989",
                "http://www.ncbi.nlm.nih.gov/pubmed/17623664",
                "http://www.ncbi.nlm.nih.gov/pubmed/18045786",
                "http://www.ncbi.nlm.nih.gov/pubmed/26330054"
            ],
            "id": "5ad3aa47133db5eb78000004",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25495872",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 76,
                    "text": "Glucocorticoids regulate the metabolic hormone FGF21 in a feed-forward loop."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24424044",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 138,
                    "text": "Liver-enriched transcription factor CREBH interacts with peroxisome proliferator-activated receptor \u03b1 to regulate metabolic hormone FGF21."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28039838",
                    "endSection": "abstract",
                    "offsetInBeginSection": 697,
                    "offsetInEndSection": 759,
                    "text": "FGF21 is now considered a stress-responsive hormone in humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28844867",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 118,
                    "text": "FGF21 is a multifunctional metabolic and stress hormone which is normally expressed in liver but cellular stress, e.g."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24424044",
                    "endSection": "abstract",
                    "offsetInBeginSection": 105,
                    "offsetInEndSection": 496,
                    "text": "In this study, we demonstrated that the liver-enriched transcription factor CREBH (cAMP-responsive element binding protein, hepatocyte specific) and peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1) function as binary transcriptional activators to regulate lipid metabolism by activating fibroblast growth factor 21 (FGF21), a hepatic hormone that regulates whole-body energy homeostasis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27911795",
                    "endSection": "abstract",
                    "offsetInBeginSection": 433,
                    "offsetInEndSection": 577,
                    "text": "\u03b2-Klotho is an obligate coreceptor for the hormone FGF21, which is secreted from the liver and implicated in macronutrient preference in humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20851878",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 156,
                    "text": "Fibroblast growth factor 21 (FGF21) is a potent antidiabetic and triglyceride-lowering hormone whose hepatic expression is highly responsive to food intake."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24432989",
                    "endSection": "abstract",
                    "offsetInBeginSection": 90,
                    "offsetInEndSection": 198,
                    "text": "The placenta actively synthesizes and secretes many hormones, but it is unknown whether this includes FGF21."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17623664",
                    "endSection": "abstract",
                    "offsetInBeginSection": 737,
                    "offsetInEndSection": 938,
                    "text": "Accordingly, FGF19, but not FGF21, activates FGF signaling in hepatocytes that primarily express FGFR4 and reduces transcription of CYP7A1 that encodes the rate-limiting enzyme for bile acid synthesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18045786",
                    "endSection": "abstract",
                    "offsetInBeginSection": 347,
                    "offsetInEndSection": 543,
                    "text": "An elementary communication is displayed as a causal link from a cell that secretes a particular hormone to those cells which express the corresponding hormone receptor and respond to the hormone."
                }
            ]
        },
        {
            "body": "What is the biological role of Neddylation?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26260793",
                "http://www.ncbi.nlm.nih.gov/pubmed/23148618",
                "http://www.ncbi.nlm.nih.gov/pubmed/27245101",
                "http://www.ncbi.nlm.nih.gov/pubmed/22836579",
                "http://www.ncbi.nlm.nih.gov/pubmed/24124476",
                "http://www.ncbi.nlm.nih.gov/pubmed/25531226",
                "http://www.ncbi.nlm.nih.gov/pubmed/24821572",
                "http://www.ncbi.nlm.nih.gov/pubmed/28891468",
                "http://www.ncbi.nlm.nih.gov/pubmed/22805479",
                "http://www.ncbi.nlm.nih.gov/pubmed/26860454"
            ],
            "id": "5ace3e3f0340b9f058000012",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26260793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 170,
                    "text": "Neddylation is a posttranslational modification that controls diverse biological processes by covalently conjugating the ubiquitin-like protein NEDD8 to specific targets."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23148618",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "The neddylation conjugation pathway has a pivotal role in mediating ubiquitination of proteins and regulation of numerous biological processes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26260793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 171,
                    "offsetInEndSection": 312,
                    "text": "Neddylation is commonly mediated by NEDD8-specific enzymes (typical neddylation) and, sometimes, by ubiquitin enzymes (atypical neddylation)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26260793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 313,
                    "offsetInEndSection": 497,
                    "text": "Although typical neddylation is known to regulate protein function in many ways, the regulatory mechanisms and biological consequence of atypical neddylation remain largely unexplored."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27245101",
                    "endSection": "abstract",
                    "offsetInBeginSection": 177,
                    "offsetInEndSection": 265,
                    "text": "Unlike RING-type neddylation ligases, HECT-type neddylation ligase remains less defined."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22836579",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 52,
                    "text": "NEDDylation regulates E2F-1-dependent transcription."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24124476",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 144,
                    "text": "While neddylation is known to activate cullin (CUL)-RING ubiquitin ligases (CRLs), its role in regulating T cell signaling is poorly understood."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26260793",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 140,
                    "text": "NEDD8 Ultimate Buster 1 Long (NUB1L) Protein Suppresses Atypical Neddylation and Promotes the Proteasomal Degradation of Misfolded Proteins."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25531226",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 48,
                    "text": "Protein neddylation: beyond cullin-RING ligases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27245101",
                    "endSection": "abstract",
                    "offsetInBeginSection": 400,
                    "offsetInEndSection": 457,
                    "text": "JunB neddylation attenuates its transcriptional activity."
                }
            ]
        },
        {
            "body": "What is break induced replication?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25329304",
                "http://www.ncbi.nlm.nih.gov/pubmed/28427283",
                "http://www.ncbi.nlm.nih.gov/pubmed/16888651",
                "http://www.ncbi.nlm.nih.gov/pubmed/11377793",
                "http://www.ncbi.nlm.nih.gov/pubmed/18562643",
                "http://www.ncbi.nlm.nih.gov/pubmed/26920759",
                "http://www.ncbi.nlm.nih.gov/pubmed/8631700",
                "http://www.ncbi.nlm.nih.gov/pubmed/26055704",
                "http://www.ncbi.nlm.nih.gov/pubmed/17671506",
                "http://www.ncbi.nlm.nih.gov/pubmed/20516198"
            ],
            "id": "5ab9050bfcf4565872000019",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25329304",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "Broken replication forks result in DNA breaks that are normally repaired via homologous recombination or break induced replication (BIR)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28427283",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "Break induced replication in eukaryotes: mechanisms, functions, and consequences."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28427283",
                    "endSection": "abstract",
                    "offsetInBeginSection": 125,
                    "offsetInEndSection": 219,
                    "text": "This type of DSB break typically arises at collapsed replication forks or at eroded telomeres."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16888651",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 232,
                    "text": "Molecular studies on double-strand break (DSB) repair in mitosis are usually performed with enzymatically induced DSBs, but spontaneous DSBs might arise because of replication failures, for example when replication encounters nicks."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11377793",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 83,
                    "text": "Double-strand break repair: are Rad51/RecA--DNA joints barriers to DNA replication?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18562643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 999,
                    "offsetInEndSection": 1140,
                    "text": "Tn7 transposition is not dependent on any known specific pathway of replication fork reactivation as a means of recognizing DNA break repair."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26920759",
                    "endSection": "abstract",
                    "offsetInBeginSection": 852,
                    "offsetInEndSection": 979,
                    "text": "MTE1 is important for resolution of Rad52 foci during double-strand break repair and for suppressing break-induced replication."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8631700",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "The DNA replication priming protein, PriA, is required for homologous recombination and double-strand break repair."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26055704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 878,
                    "offsetInEndSection": 1034,
                    "text": "Collectively, our data point to the existence of a functional interplay between hMSH5 and FANCJ in double-strand break repair induced by replication stress."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8631700",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1049,
                    "offsetInEndSection": 1277,
                    "text": "These results suggest that PriA-dependent primosome assembly is crucial for both homologous recombination and double-strand break repair and support the proposal that these processes in E. coli involve extensive DNA replication."
                }
            ]
        },
        {
            "body": "What is a fibrocyte?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22043022",
                "http://www.ncbi.nlm.nih.gov/pubmed/16543402",
                "http://www.ncbi.nlm.nih.gov/pubmed/21872912",
                "http://www.ncbi.nlm.nih.gov/pubmed/26351669",
                "http://www.ncbi.nlm.nih.gov/pubmed/18025235",
                "http://www.ncbi.nlm.nih.gov/pubmed/21106092",
                "http://www.ncbi.nlm.nih.gov/pubmed/23951012",
                "http://www.ncbi.nlm.nih.gov/pubmed/22325070",
                "http://www.ncbi.nlm.nih.gov/pubmed/22022512",
                "http://www.ncbi.nlm.nih.gov/pubmed/25429068"
            ],
            "id": "5ad247720340b9f058000017",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22043022",
                    "endSection": "abstract",
                    "offsetInBeginSection": 288,
                    "offsetInEndSection": 462,
                    "text": "Fibrocyte cultures offer one source of transplantable cells, but determining what fibrocyte types they contain and what phenotype transplanted cells may adopt is problematic."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16543402",
                    "endSection": "abstract",
                    "offsetInBeginSection": 438,
                    "offsetInEndSection": 586,
                    "text": "As SAP binds to Fc receptors for immunoglobulin G (IgG; Fc gammaRs), Fc gammaR activation may be an inhibitory signal for fibrocyte differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16543402",
                    "endSection": "abstract",
                    "offsetInBeginSection": 724,
                    "offsetInEndSection": 838,
                    "text": "Monoclonal antibodies that bind to Fc gammaRI (CD64) or Fc gammaRII (CD32) also inhibit fibrocyte differentiation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21872912",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 73,
                    "text": "Functional KCa3.1 K+ channels are required for human fibrocyte migration."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26351669",
                    "endSection": "abstract",
                    "offsetInBeginSection": 881,
                    "offsetInEndSection": 969,
                    "text": "\u03b12\u03b21, \u03b1M\u03b22, and \u03b1X\u03b22 integrins are needed for lumican-induced fibrocyte differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16543402",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1034,
                    "offsetInEndSection": 1188,
                    "text": "Using inhibitors of protein kinase enzymes, we show that Syk- and Src-related tyrosine kinases participate in the inhibition of fibrocyte differentiation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18025235",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "Cysteinyl leukotrienes are autocrine and paracrine regulators of fibrocyte function."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21106092",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 70,
                    "text": "Toll-like receptor 2 agonists inhibit human fibrocyte differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23951012",
                    "endSection": "abstract",
                    "offsetInBeginSection": 658,
                    "offsetInEndSection": 794,
                    "text": "Proteases with other site specificities such as pepsin, endoprotease GluC, and chymotrypsin do not potentiate fibrocyte differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22043022",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 196,
                    "text": "Spiral ligament fibrocytes function in cochlear homeostasis, maintaining the endocochlear potential by participating in potassium recycling, and fibrocyte degeneration contributes to hearing loss."
                }
            ]
        },
        {
            "body": "Which cellular functions are affected by lncRNA H19 in the heart?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27027436",
                "http://www.ncbi.nlm.nih.gov/pubmed/26089099",
                "http://www.ncbi.nlm.nih.gov/pubmed/27059301",
                "http://www.ncbi.nlm.nih.gov/pubmed/28881833",
                "http://www.ncbi.nlm.nih.gov/pubmed/26722426",
                "http://www.ncbi.nlm.nih.gov/pubmed/27813675",
                "http://www.ncbi.nlm.nih.gov/pubmed/24920070",
                "http://www.ncbi.nlm.nih.gov/pubmed/28765931",
                "http://www.ncbi.nlm.nih.gov/pubmed/28203482",
                "http://www.ncbi.nlm.nih.gov/pubmed/27693036"
            ],
            "id": "5ac7185f0340b9f058000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27027436",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 173,
                    "text": "OBJECTIVE\nThe long non-coding RNA (lncRNA) gene, H19, has been involving in multiple biological functions, which also plays a vital role in colorectal cancer carcinogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26089099",
                    "endSection": "abstract",
                    "offsetInBeginSection": 225,
                    "offsetInEndSection": 388,
                    "text": "The developmentally regulated, imprinted H19 long noncoding RNA (lncRNA) functions to reduce the bioavailability of microRNA let-7 by acting as a molecular sponge."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27059301",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 125,
                    "text": "LncRNA H19 functions as a competing endogenous RNA to regulate AQP3 expression by sponging miR-874 in the intestinal barrier."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28881833",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1350,
                    "offsetInEndSection": 1495,
                    "text": "Thus, these results indicate that lncRNA H19 functions as an important mediator of BMP9 signaling by modulating Notch signaling-targeting miRNAs."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28881833",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "lncRNA H19 mediates BMP9-induced osteogenic differentiation of mesenchymal stem cells (MSCs) through Notch signaling."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27027436",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 101,
                    "text": "Association of genetic variants in lncRNA H19 with risk of colorectal cancer in a Chinese population."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26722426",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1507,
                    "offsetInEndSection": 1599,
                    "text": "Our study demonstrates that lncRNA H19, which is induced by c-Myc, is up-regulated in NSCLC."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26089099",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 103,
                    "text": "H19 lncRNA alters stromal cell growth via IGF signaling in the endometrium of women with endometriosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27813675",
                    "endSection": "abstract",
                    "offsetInBeginSection": 459,
                    "offsetInEndSection": 595,
                    "text": "Here we demonstrate that StAR is a novel target of the microRNA let-7, which itself is regulated by the long noncoding RNA (lncRNA) H19."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27059301",
                    "endSection": "abstract",
                    "offsetInBeginSection": 430,
                    "offsetInEndSection": 685,
                    "text": "Here, we show that the human long noncoding RNA (lncRNA) H19 may function as a competing endogenous RNA (ceRNA) to regulate the expression of AQP3 through competition for miR-874, thus playing a significant role in maintaining intestinal barrier function."
                }
            ]
        },
        {
            "body": "Dinutuximab is used for treatment of which disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26912916",
                "http://www.ncbi.nlm.nih.gov/pubmed/26917818",
                "http://www.ncbi.nlm.nih.gov/pubmed/29238760",
                "http://www.ncbi.nlm.nih.gov/pubmed/26891967",
                "http://www.ncbi.nlm.nih.gov/pubmed/27756784",
                "http://www.ncbi.nlm.nih.gov/pubmed/27872101",
                "http://www.ncbi.nlm.nih.gov/pubmed/27485082",
                "http://www.ncbi.nlm.nih.gov/pubmed/25940913",
                "http://www.ncbi.nlm.nih.gov/pubmed/25851859",
                "http://www.ncbi.nlm.nih.gov/pubmed/26791869"
            ],
            "id": "589a247078275d0c4a000035",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26912916",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 29,
                    "text": "Dinutuximab and Panobinostat."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 73,
                    "text": "Dinutuximab: An Anti-GD2 Monoclonal Antibody for High-Risk Neuroblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818",
                    "endSection": "abstract",
                    "offsetInBeginSection": 939,
                    "offsetInEndSection": 1343,
                    "text": "Dinutuximab is a chimeric, human-murine, anti-GD2 monoclonal antibody approved in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), aldesleukin (interleukin-2 [IL-2]), and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to first-line multiagent, multimodality therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1596,
                    "offsetInEndSection": 1877,
                    "text": "CONCLUSIONS\nDinutuximab is the first anti-GD2 monoclonal antibody approved in combination with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to first-line multiagent, multimodality therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1878,
                    "offsetInEndSection": 2054,
                    "text": "Ongoing research will determine if dinutuximab could be used earlier in treatment, in nonresponders to initial therapies, in combination with chemotherapy, or in other cancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29238760",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "Dinutuximab is a monoclonal antibody targeted at disialoganglioside (GD2), a tumor-associated antigen widely expressed in human neuroblastoma cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26891967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 200,
                    "text": "Dinutuximab (ch14.18; Unituxin\u2122) is a chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma cells."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27756784",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 156,
                    "text": "TGF\u03b2R1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27872101",
                    "endSection": "abstract",
                    "offsetInBeginSection": 155,
                    "offsetInEndSection": 355,
                    "text": "Consequently, blockade of TGF\u03b2 signaling with galunisertib in combination with the anti-GD2 mAb dinutuximab plus adoptively transferred NK cells is a promising tool for the treatment of neuroblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27485082",
                    "endSection": "abstract",
                    "offsetInBeginSection": 293,
                    "offsetInEndSection": 483,
                    "text": "In 2015, dinutuximab (an anti-GD2 mAb) was approved by the US FDA and is currently used in a combination immunotherapeutic regimen for the treatment of children with high-risk neuroblastoma."
                }
            ]
        },
        {
            "body": "What is the ChIP-exo method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                "http://www.ncbi.nlm.nih.gov/pubmed/26005864",
                "http://www.ncbi.nlm.nih.gov/pubmed/23026909",
                "http://www.ncbi.nlm.nih.gov/pubmed/25612620",
                "http://www.ncbi.nlm.nih.gov/pubmed/24373287",
                "http://www.ncbi.nlm.nih.gov/pubmed/26404150",
                "http://www.ncbi.nlm.nih.gov/pubmed/24475069",
                "http://www.ncbi.nlm.nih.gov/pubmed/26503782",
                "http://www.ncbi.nlm.nih.gov/pubmed/26518661",
                "http://www.ncbi.nlm.nih.gov/pubmed/25720775"
            ],
            "id": "5ac24c9495d0062724000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 986,
                    "offsetInEndSection": 1138,
                    "text": "Here, we describe the ChIP-exo method that we have optimized and streamlined for mammalian systems and next-generation sequencing-by-synthesis platform."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 432,
                    "offsetInEndSection": 544,
                    "text": "The ChIP-exo method is a refined version of ChIP-seq that substantially improves upon both resolution and noise."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "The ChIP-exo Method: Identifying Protein-DNA Interactions with Near Base Pair Precision."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26005864",
                    "endSection": "abstract",
                    "offsetInBeginSection": 585,
                    "offsetInEndSection": 717,
                    "text": "Chromatin immunoprecipitation with exonuclease treatment (ChIP-exo) indicates that multiple DNA binding modes also are used in vivo."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23026909",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "ChIP-exo method for identifying genomic location of DNA-binding proteins with near-single-nucleotide accuracy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25612620",
                    "endSection": "abstract",
                    "offsetInBeginSection": 471,
                    "offsetInEndSection": 600,
                    "text": "Using the ChIP-exo method, high-resolution genomic binding sites of ATF4 and CEBPB responsive to YW3-56 treatment were generated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 776,
                    "offsetInEndSection": 848,
                    "text": "The ChIP-exo libraries are then subjected to high throughput sequencing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23026909",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 171,
                    "text": "This unit describes the ChIP-exo methodology, which combines chromatin immunoprecipitation (ChIP) with lambda exonuclease digestion followed by high-throughput sequencing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24373287",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 122,
                    "text": "ChIP-exonuclease (ChIP-exo) is a modified ChIP-seq approach for high resolution mapping of transcription factor DNA sites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24373287",
                    "endSection": "abstract",
                    "offsetInBeginSection": 123,
                    "offsetInEndSection": 324,
                    "text": "We describe an Illumina-based ChIP-exo method which provides a global improvement of the data quality of estrogen receptor (ER) ChIP and insights into the motif structure for key ER-associated factors."
                }
            ]
        },
        {
            "body": "Where do mitochondrial DNA deletion breakpoints tend to occur?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/9344670",
                "http://www.ncbi.nlm.nih.gov/pubmed/25193669",
                "http://www.ncbi.nlm.nih.gov/pubmed/9876894",
                "http://www.ncbi.nlm.nih.gov/pubmed/22661583",
                "http://www.ncbi.nlm.nih.gov/pubmed/22424738",
                "http://www.ncbi.nlm.nih.gov/pubmed/2456798",
                "http://www.ncbi.nlm.nih.gov/pubmed/26530670",
                "http://www.ncbi.nlm.nih.gov/pubmed/27084947",
                "http://www.ncbi.nlm.nih.gov/pubmed/8619128",
                "http://www.ncbi.nlm.nih.gov/pubmed/1551433"
            ],
            "id": "5abc9ecffcf4565872000021",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9344670",
                    "endSection": "abstract",
                    "offsetInBeginSection": 624,
                    "offsetInEndSection": 811,
                    "text": "On the other hand, in the proximal part of the gene, deletion breakpoints do not preferentially occur in a few introns, but are spread over a large DNA segment containing introns 2 to 42."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25193669",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 217,
                    "text": "DNA sequences proximal to human mitochondrial DNA deletion breakpoints prevalent in human disease form G-quadruplexes, a class of DNA structures inefficiently unwound by the mitochondrial replicative Twinkle helicase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25193669",
                    "endSection": "abstract",
                    "offsetInBeginSection": 823,
                    "offsetInEndSection": 1002,
                    "text": "Circular dichroism and UV spectral analysis demonstrated that mitochondrial G-rich sequences near deletion breakpoints prevalent in human disease form G-quadruplex DNA structures."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25193669",
                    "endSection": "abstract",
                    "offsetInBeginSection": 348,
                    "offsetInEndSection": 635,
                    "text": "In this work, we performed a computational analysis of the human mitochondrial genome using the \"Pattern Finder\" G-quadruplex (G4) predictor algorithm to assess whether G4-forming sequences reside in close proximity (within 20 base pairs) to known mitochondrial DNA deletion breakpoints."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9876894",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 216,
                    "text": "OBJECTIVES\nTo develop a protocol capable of identifying deletions in mitochondrial DNA and use it to identify the breakpoints of a mtDNA deletion in a patient with chronic progressive external ophthalmoplegia (CPEO)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22661583",
                    "endSection": "abstract",
                    "offsetInBeginSection": 653,
                    "offsetInEndSection": 848,
                    "text": "Furthermore, we discover that the most frequent deletion breakpoints occur within or near predicted structures, a result that is supported by data from transgenic mice with mitochondrial disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9344670",
                    "endSection": "abstract",
                    "offsetInBeginSection": 394,
                    "offsetInEndSection": 623,
                    "text": "Within the central high-frequency deletion region, the small, 6.6-kb, intron 49 shows a much higher density of deletion breakpoints than intron 44, which was previously believed to coincide with the most mutable zone of the gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22424738",
                    "endSection": "abstract",
                    "offsetInBeginSection": 630,
                    "offsetInEndSection": 770,
                    "text": "Confirmatory testing included: mitochondrial DNA deletion testing and sequencing of the breakpoints, muscle biopsy, and bone marrow studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25193669",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1003,
                    "offsetInEndSection": 1403,
                    "text": "A biochemical analysis of purified recombinant human Twinkle protein (gene product of c10orf2) showed that the mitochondrial replicative helicase inefficiently unwinds well characterized intermolecular and intramolecular G-quadruplex DNA substrates, as well as a unimolecular G4 substrate derived from a mitochondrial sequence that nests a deletion breakpoint described in human renal cell carcinoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2456798",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1030,
                    "offsetInEndSection": 1241,
                    "text": "Analysis of the breakpoints of this deletion together with the breakpoints of two other small deletions involving the beta-globin gene suggests that the breakpoints may occur at DNA polymerase alpha pause sites."
                }
            ]
        },
        {
            "body": "Name 4 circular RNA molecules associated with carcinogenesis.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28253710",
                "http://www.ncbi.nlm.nih.gov/pubmed/1069269",
                "http://www.ncbi.nlm.nih.gov/pubmed/7678559",
                "http://www.ncbi.nlm.nih.gov/pubmed/28185365",
                "http://www.ncbi.nlm.nih.gov/pubmed/28342987",
                "http://www.ncbi.nlm.nih.gov/pubmed/2607342",
                "http://www.ncbi.nlm.nih.gov/pubmed/2538748",
                "http://www.ncbi.nlm.nih.gov/pubmed/26485708",
                "http://www.ncbi.nlm.nih.gov/pubmed/8692851",
                "http://www.ncbi.nlm.nih.gov/pubmed/16452114"
            ],
            "id": "5ac721230340b9f058000005",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28253710",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 82,
                    "text": "Circular RNAs (circRNAs) are a class of newly-identified non-coding RNA molecules."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1069269",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 120,
                    "text": "Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7678559",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 43,
                    "text": "Mis-splicing yields circular RNA molecules."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1069269",
                    "endSection": "abstract",
                    "offsetInBeginSection": 668,
                    "offsetInEndSection": 726,
                    "text": "(iv) Viroids are covalently closed circular RNA molecules."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28185365",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "Circular RNAs (circRNAs) are a class of new-found RNA molecules that have a special covalent loop structure without a 5' cap and 3' tail."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28342987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 120,
                    "text": "Circular RNAs (circRNAs) are a type of non-coding RNA molecules that lack a 5'-terminal cap and 3'-terminal poly A tail."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7678559",
                    "endSection": "abstract",
                    "offsetInBeginSection": 276,
                    "offsetInEndSection": 430,
                    "text": "Here we determine the structure of these novel transcripts, showing that they correspond to circular RNA molecules containing only exons in genomic order."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1069269",
                    "endSection": "abstract",
                    "offsetInBeginSection": 497,
                    "offsetInEndSection": 540,
                    "text": "(ii) Viroids are single-stranded molecules."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2607342",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 172,
                    "text": "We have confirmed that two closely related circular RNA molecules previously named grapevine yellow speckel viroid (GYSV) and grapevine viroid 1B (GV1B) are indeed viroids."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2538748",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "Entamoeba histolytica ribosomal RNA genes are carried on palindromic circular DNA molecules."
                }
            ]
        },
        {
            "body": "Which is the enzymatic activity of nardilysin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/15544571",
                "http://www.ncbi.nlm.nih.gov/pubmed/21151101",
                "http://www.ncbi.nlm.nih.gov/pubmed/12095415",
                "http://www.ncbi.nlm.nih.gov/pubmed/28207963",
                "http://www.ncbi.nlm.nih.gov/pubmed/22653443",
                "http://www.ncbi.nlm.nih.gov/pubmed/23604405",
                "http://www.ncbi.nlm.nih.gov/pubmed/15629122",
                "http://www.ncbi.nlm.nih.gov/pubmed/14759602",
                "http://www.ncbi.nlm.nih.gov/pubmed/27051521",
                "http://www.ncbi.nlm.nih.gov/pubmed/12590613"
            ],
            "id": "5ac138aa95d0062724000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15544571",
                    "endSection": "abstract",
                    "offsetInBeginSection": 353,
                    "offsetInEndSection": 499,
                    "text": "Since for those processes its enzymatic activity is not required, it is now evident that nardilysin fulfills at least two distinct functions, i.e."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15544571",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 102,
                    "text": "Nardilysin, a basic residues specific metallopeptidase that mediates cell migration and proliferation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15544571",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "Nardilysin (NRDc), a metallopeptidase of the M16 family, presents, in vitro, cleavage specificity for basic residues."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21151101",
                    "endSection": "abstract",
                    "offsetInBeginSection": 191,
                    "offsetInEndSection": 321,
                    "text": "Here we demonstrate that the cytosolic endopeptidases nardilysin and thimet oligopeptidase (TOP) complemented proteasome activity."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12095415",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 136,
                    "text": "The metalloendopeptidase nardilysin (NRDc) is potently inhibited by heparin-binding epidermal growth factor-like growth factor (HB-EGF)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28207963",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 62,
                    "text": "Nardilysin (NRDC) is a metalloendopeptidase of the M16 family."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12095415",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 178,
                    "text": "Nardilysin (N-arginine dibasic convertase, or NRDc) is a cytosolic and cell-surface metalloendopeptidase that, in vitro, cleaves substrates upstream of Arg or Lys in basic pairs."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22653443",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "Mutant p53 interactome identifies nardilysin as a p53R273H-specific binding partner that promotes invasion."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21151101",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 95,
                    "text": "Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21151101",
                    "endSection": "abstract",
                    "offsetInBeginSection": 322,
                    "offsetInEndSection": 583,
                    "text": "Nardilysin and TOP were required, either together or alone, for the generation of a tumor-specific CTL epitope from PRAME, an immunodominant CTL epitope from Epstein-Barr virus protein EBNA3C, and a clinically important epitope from the melanoma protein MART-1."
                }
            ]
        },
        {
            "body": "The Mantoux test detects what latent infection/disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16307510",
                "http://www.ncbi.nlm.nih.gov/pubmed/20843417",
                "http://www.ncbi.nlm.nih.gov/pubmed/21987138",
                "http://www.ncbi.nlm.nih.gov/pubmed/20381206",
                "http://www.ncbi.nlm.nih.gov/pubmed/23405647",
                "http://www.ncbi.nlm.nih.gov/pubmed/21822042",
                "http://www.ncbi.nlm.nih.gov/pubmed/23128409",
                "http://www.ncbi.nlm.nih.gov/pubmed/19297045",
                "http://www.ncbi.nlm.nih.gov/pubmed/17501976",
                "http://www.ncbi.nlm.nih.gov/pubmed/12238571"
            ],
            "id": "5ab147edfcf4565872000013",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16307510",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 101,
                    "text": "Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16307510",
                    "endSection": "abstract",
                    "offsetInBeginSection": 474,
                    "offsetInEndSection": 657,
                    "text": "Until recently, the 100-year-old tuberculin skin test (Mantoux) has been the only available diagnostic test for latent tuberculosis infection, despite its many well-known limitations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20843417",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 126,
                    "text": "BACKGROUND\nThe Mantoux tuberculin skin test (TST) is widely used to diagnose latent infection with Mycobacterium tuberculosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21987138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 555,
                    "offsetInEndSection": 821,
                    "text": "Assays based on the detection of synthesis of gamma interferon in vitro by peripheral monoclonal cells, stimulated by specific antigens (ESAT-6 and CFP-10), seem to offer better accuracy when compared to the Mantoux test in identifying latent tuberculosis infection."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20381206",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "[Mantoux versus immunoferon-gamma test for diagnosis of latent tuberculosis infection in TB patient contacts]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23405647",
                    "endSection": "abstract",
                    "offsetInBeginSection": 156,
                    "offsetInEndSection": 326,
                    "text": "Although Mantoux test is the most used, IGRA (Interferon-gamma Release Assays) tests seem to give good results for presumptive diagnosis of active or latent tuberculosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16307510",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1036,
                    "offsetInEndSection": 1305,
                    "text": "They are more sensitive than the tuberculin skin test in detecting people with active tuberculosis, and their results correlate more closely with M. tuberculosis exposure risk factors than the tuberculin skin test in people likely to have latent tuberculosis infection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16307510",
                    "endSection": "abstract",
                    "offsetInBeginSection": 323,
                    "offsetInEndSection": 473,
                    "text": "However, in developed countries, large efforts are also expended to identify and give prophylactic drugs to people with latent tuberculosis infection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21822042",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1031,
                    "offsetInEndSection": 1236,
                    "text": "If Ghon's complex or untreated posttuberculous lesions are present, or if the results the Mantoux test or interferon-gamma release assay are positive, the patient should be treated for latent tuberculosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16307510",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 142,
                    "text": "Tuberculosis is responsible for more then 2 million deaths worldwide each year and vies with HIV as the world's most fatal infectious disease."
                }
            ]
        },
        {
            "body": "What is measured with the Proseek panels?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                "http://www.ncbi.nlm.nih.gov/pubmed/28930774",
                "http://www.ncbi.nlm.nih.gov/pubmed/28586402",
                "http://www.ncbi.nlm.nih.gov/pubmed/28948068",
                "http://www.ncbi.nlm.nih.gov/pubmed/28734077",
                "http://www.ncbi.nlm.nih.gov/pubmed/28694499",
                "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                "http://www.ncbi.nlm.nih.gov/pubmed/28083617",
                "http://www.ncbi.nlm.nih.gov/pubmed/29392211",
                "http://www.ncbi.nlm.nih.gov/pubmed/29050213"
            ],
            "id": "5a9d99ac4e03427e73000002",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 44,
                    "text": "ProSeeK: a web server for MLPA probe design."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1548,
                    "offsetInEndSection": 1676,
                    "text": "ProSeeK will become a useful tool for all laboratories that are currently using MLPA in their research projects for CNV studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28930774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 738,
                    "offsetInEndSection": 948,
                    "text": "The samples were analyzed with a multiplex proximity extension assay in which 92 inflammation-related proteins were measured simultaneously (Proseek Multiplex Inflammation I; Olink Bioscience, Uppsala, Sweden)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28586402",
                    "endSection": "abstract",
                    "offsetInBeginSection": 216,
                    "offsetInEndSection": 362,
                    "text": "A total of 92 biomarkers were measured before a standardized meal as well as 30 and 120 minutes afterwards with the Proseek Multiplex CVD III kit."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28948068",
                    "endSection": "abstract",
                    "offsetInBeginSection": 304,
                    "offsetInEndSection": 449,
                    "text": "A total of 92 biomarkers were measured before a standardized meal as well as 30 and 120\u00a0min afterward with the Proseek Multiplex Neurology\u00a0I kit."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28734077",
                    "endSection": "abstract",
                    "offsetInBeginSection": 524,
                    "offsetInEndSection": 702,
                    "text": "METHODS AND RESULTS\nPlasma concentrations of MMP12 were measured at baseline in 3394 subjects with high-risk for cardiovascular disease (CVD) using the Olink ProSeek CVD I array."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28694499",
                    "endSection": "abstract",
                    "offsetInBeginSection": 503,
                    "offsetInEndSection": 814,
                    "text": "Using the Proseek Multiplex Inflammation assay, we measured in patients that had suffered mild TBI (n\u2009=\u200910) or severe TBI (n\u2009=\u200910) with extra-cranial injury or extracranial injury only (EC) (n\u2009=\u200910), 92 inflammation-associated proteins in serum obtained: <1\u2009hr (within 1-hour), 4-12\u2009hr and 48-72\u2009hr post injury."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1490,
                    "offsetInEndSection": 1618,
                    "text": "Proseek found that expression of Carcinoembryonic Antigen (CEA), IL-8 and prolactin are significantly correlated with CRC stage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28083617",
                    "endSection": "abstract",
                    "offsetInBeginSection": 543,
                    "offsetInEndSection": 828,
                    "text": "Serum concentrations of 92 inflammation-associated proteins were measured in samples obtained from 80 aHSCT patients 14\u00a0days after transplantation and from 23 healthy control subjects by a novel sensitive proximity extension assay technology using Proseek Multiplex Inflammation I kit."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1281,
                    "offsetInEndSection": 1489,
                    "text": "RESULTS\nSimilar quantitative expression patterns for 13 plasma antigens common to both platforms endorsed the potential efficacy of Proseek as an immune-based multiplex assay for proteomic biomarker research."
                }
            ]
        },
        {
            "body": "Is Enlimomab effective for stroke treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                "http://www.ncbi.nlm.nih.gov/pubmed/12365824",
                "http://www.ncbi.nlm.nih.gov/pubmed/19849665",
                "http://www.ncbi.nlm.nih.gov/pubmed/9693236",
                "http://www.ncbi.nlm.nih.gov/pubmed/9744839",
                "http://www.ncbi.nlm.nih.gov/pubmed/11692032",
                "http://www.ncbi.nlm.nih.gov/pubmed/12038658",
                "http://www.ncbi.nlm.nih.gov/pubmed/23804334",
                "http://www.ncbi.nlm.nih.gov/pubmed/9973515",
                "http://www.ncbi.nlm.nih.gov/pubmed/12777909"
            ],
            "id": "58ec6eb5eda5a5767200000c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1440,
                    "offsetInEndSection": 1635,
                    "text": "CONCLUSIONS\nThe authors conclude that anti-ICAM therapy with enlimomab is not an effective treatment for ischemic stroke in the model studied and, indeed, may significantly worsen stroke outcome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 134,
                    "offsetInEndSection": 282,
                    "text": "Enlimomab, a murine intercellular adhesion molecule-1 (ICAM-1) antibody, reduces leukocyte adhesion and infarct size in experimental stroke studies."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 91,
                    "text": "Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 283,
                    "offsetInEndSection": 384,
                    "text": "The purpose of the current clinical trial was to evaluate the use of enlimomab after ischemic stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 387,
                    "offsetInEndSection": 546,
                    "text": "METHODS\nA total of 625 patients with ischemic stroke were randomized to receive either enlimomab (n = 317) or placebo (n = 308) within 6 hours of stroke onset."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12365824",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "Anti-leukocyte antibodies: LeukArrest (Hu23F2G) and Enlimomab (R6.5) in acute stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19849665",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1772,
                    "offsetInEndSection": 1933,
                    "text": "Treatment with a murine anti-ICAM-1 antibody (enlimomab) has been investigated in patients with acute ischemic stroke in the Enlimomab Acute Stroke Trial (EAST)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1246,
                    "offsetInEndSection": 1361,
                    "text": "There were significantly more adverse events with enlimomab treatment than placebo, primarily infections and fever."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9693236",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 165,
                    "text": "Safety, pharmacokinetics and biological activity of enlimomab (anti-ICAM-1 antibody): an open-label, dose escalation study in patients hospitalized for acute stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9744839",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1441,
                    "offsetInEndSection": 1524,
                    "text": "However, this treatment failed to show benefit in the Enlimomab Acute Stroke Trial."
                }
            ]
        },
        {
            "body": "Are AAV vectors considered for the treatment of retinal dystrophies?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21818300",
                "http://www.ncbi.nlm.nih.gov/pubmed/26609316",
                "http://www.ncbi.nlm.nih.gov/pubmed/23150381",
                "http://www.ncbi.nlm.nih.gov/pubmed/27229628",
                "http://www.ncbi.nlm.nih.gov/pubmed/18414684",
                "http://www.ncbi.nlm.nih.gov/pubmed/23593201",
                "http://www.ncbi.nlm.nih.gov/pubmed/24150896",
                "http://www.ncbi.nlm.nih.gov/pubmed/27416076",
                "http://www.ncbi.nlm.nih.gov/pubmed/15960597",
                "http://www.ncbi.nlm.nih.gov/pubmed/25105153"
            ],
            "id": "5a74acd80384be9551000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21818300",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 163,
                    "text": "BACKGROUND\nGene transfer using adeno-associated viral (AAV) vectors has been successfully applied in the retina for the treatment of inherited retinal dystrophies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26609316",
                    "endSection": "abstract",
                    "offsetInBeginSection": 285,
                    "offsetInEndSection": 530,
                    "text": "These novel gene vectors aim to more safely and efficiently transduce retinal cells, expand the gene packaging capacity of AAV, and utilize new strategies to correct the varying mechanisms of dysfunction found with inherited retinal dystrophies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23150381",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 126,
                    "text": "Adeno-associated virus (AAV) vectors are in wide use for in vivo gene transfer for the treatment of inherited retinal disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27229628",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 178,
                    "text": "Recombinant adeno-associated virus (AAV) has emerged as a promising vector for retinal gene delivery to restore visual function in certain forms of inherited retinal dystrophies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18414684",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 130,
                    "text": "Vectors derived from adeno-associated virus (AAV) are promising for human gene therapy, including treatment for retinal blindness."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23593201",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 125,
                    "text": "Adeno-associated viral vectors (AAV) have been shown to be safe in the treatment of retinal degenerations in clinical trials."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24150896",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1008,
                    "offsetInEndSection": 1157,
                    "text": "Thus, dual AAV trans-splicing or hybrid vectors are an attractive strategy for gene therapy of retinal diseases that require delivery of large genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27416076",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "Gene therapy using adeno-associated viral (AAV) vectors for the treatment of retinal degenerations has shown safety and efficacy in clinical trials."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15960597",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 202,
                    "text": "Recombinant adeno-associated viral (AAV) vectors have become powerful gene delivery tools for the treatment of retinal degeneration in a variety of animal models that mimic corresponding human diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25105153",
                    "endSection": "abstract",
                    "offsetInBeginSection": 196,
                    "offsetInEndSection": 311,
                    "text": "Tyrosine mutant adeno-associated virus (AAV) has been considered as a class of highly potent gene transfer vectors."
                }
            ]
        },
        {
            "body": "Does International Citicoline Trial on acUte Stroke trial supports efficacy of citicoline for stroke treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22691567",
                "http://www.ncbi.nlm.nih.gov/pubmed/23600725",
                "http://www.ncbi.nlm.nih.gov/pubmed/18637642",
                "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                "http://www.ncbi.nlm.nih.gov/pubmed/11706098",
                "http://www.ncbi.nlm.nih.gov/pubmed/22581817",
                "http://www.ncbi.nlm.nih.gov/pubmed/27234918",
                "http://www.ncbi.nlm.nih.gov/pubmed/10582983",
                "http://www.ncbi.nlm.nih.gov/pubmed/12865605",
                "http://www.ncbi.nlm.nih.gov/pubmed/27072975"
            ],
            "id": "58ec709aeda5a5767200000e",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22691567",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23600725",
                    "endSection": "abstract",
                    "offsetInBeginSection": 68,
                    "offsetInEndSection": 455,
                    "text": "In humans, although a recent trial International Citicoline Trial on Acute Stroke (ICTUS) has shown that global recovery is similar in CDP-choline and placebo groups, CDP-choline was shown to be more beneficial in some patients, such as those with moderate stroke severity and not treated with t-PA. Several mechanisms have been proposed to explain the beneficial actions of CDP-choline."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18637642",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 213,
                    "text": "The International Citicoline Trial in acUte Stroke is a sequential phase III study of the use of the drug citicoline in the treatment of acute ischaemic stroke, which was initiated in 2006 in 56 treatment centres."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22691567",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1908,
                    "offsetInEndSection": 2059,
                    "text": "INTERPRETATION\nUnder the circumstances of the ICTUS trial, citicoline is not efficacious in the treatment of moderate-to-severe acute ischaemic stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22691567",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 96,
                    "text": "BACKGROUND\nCiticoline is approved in some countries for the treatment of acute ischaemic stroke."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 52,
                    "text": "Efficacy of citicoline as an acute stroke treatment."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11706098",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 94,
                    "text": "A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22581817",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 239,
                    "text": "BACKGROUND AND PURPOSE\nThe neuroprotective potential of citicoline in acute ischemic stroke has been shown in many experimental studies and, although the exact mechanisms are still unknown, a clinical Phase III trial is currently underway."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18637642",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 121,
                    "text": "Evaluation of a sequential global test of improved recovery following stroke as applied to the ICTUS trial of citicoline."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11706098",
                    "endSection": "abstract",
                    "offsetInBeginSection": 282,
                    "offsetInEndSection": 378,
                    "text": "OBJECTIVE\nTo determine the safety and efficacy of citicoline treatment in acute stroke patients."
                }
            ]
        },
        {
            "body": "Is human lysyl oxidase-like 2 a glycoprotein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20306300",
                "http://www.ncbi.nlm.nih.gov/pubmed/21954900",
                "http://www.ncbi.nlm.nih.gov/pubmed/23319596",
                "http://www.ncbi.nlm.nih.gov/pubmed/27063404",
                "http://www.ncbi.nlm.nih.gov/pubmed/25146937",
                "http://www.ncbi.nlm.nih.gov/pubmed/28112368",
                "http://www.ncbi.nlm.nih.gov/pubmed/11691588",
                "http://www.ncbi.nlm.nih.gov/pubmed/21732535",
                "http://www.ncbi.nlm.nih.gov/pubmed/28670509",
                "http://www.ncbi.nlm.nih.gov/pubmed/27735137"
            ],
            "id": "5ad240f70340b9f058000015",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20306300",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 194,
                    "text": "The lysyl oxidase-like 2 (LOXL2) protein is a human paralogue of lysyl oxidase (LOX) that functions as an amine oxidase for formation of lysine-derived cross-links found in collagen and elastin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20306300",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 97,
                    "text": "The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21954900",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1382,
                    "offsetInEndSection": 1478,
                    "text": "This method was successfully applied to a novel recombinant protein, human lysyl oxidase-like 2."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23319596",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 119,
                    "text": "Post-translational modifications of recombinant human lysyl oxidase-like 2 (rhLOXL2) secreted from Drosophila S2 cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23319596",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 193,
                    "text": "Human lysyl oxidase-like 2 (hLOXL2) is highly up-regulated in metastatic breast cancer cells and tissues and induces epithelial-to-mesenchymal transition, the first step of metastasis/invasion."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21954900",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 233,
                    "text": "A general protease digestion procedure for optimal protein sequence coverage and post-translational modifications analysis of recombinant glycoproteins: application to the characterization of human lysyl oxidase-like 2 glycosylation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27063404",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 127,
                    "text": "A truncated splice variant of human lysyl oxidase-like 2 promotes migration and invasion in esophageal squamous cell carcinoma."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25146937",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 27,
                    "text": "Human lysyl oxidase-like 2."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28112368",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 96,
                    "text": "LOXL3-sv2, a novel variant of human lysyl oxidase-like 3 (LOXL3), functions as an amine oxidase."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11691588",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 121,
                    "text": "A novel human lysyl oxidase-like gene (LOXL4) on chromosome 10q24 has an altered scavenger receptor cysteine rich domain."
                }
            ]
        },
        {
            "body": "Can GDF15 be a biomarker for metformin treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                "http://www.ncbi.nlm.nih.gov/pubmed/25541611",
                "http://www.ncbi.nlm.nih.gov/pubmed/24669014",
                "http://www.ncbi.nlm.nih.gov/pubmed/28880265",
                "http://www.ncbi.nlm.nih.gov/pubmed/25446397",
                "http://www.ncbi.nlm.nih.gov/pubmed/28787735",
                "http://www.ncbi.nlm.nih.gov/pubmed/27926473",
                "http://www.ncbi.nlm.nih.gov/pubmed/28801589",
                "http://www.ncbi.nlm.nih.gov/pubmed/26990020",
                "http://www.ncbi.nlm.nih.gov/pubmed/24179558"
            ],
            "id": "5ad3013d0340b9f058000019",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 863,
                    "offsetInEndSection": 1010,
                    "text": "CONCLUSIONS\nGDF15 levels are a biomarker for the use of metformin in people with dysglycemia, and its concentration reflects the dose of metformin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 68,
                    "text": "Growth Differentiation Factor 15 as a Novel Biomarker for Metformin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25541611",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 56,
                    "text": "GDF15 Is a Novel Biomarker for Impaired Fasting Glucose."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25541611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1610,
                    "offsetInEndSection": 1683,
                    "text": "GDF15 may be a novel biomarker for detecting IFG in nondiabetic patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24669014",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1886,
                    "offsetInEndSection": 2041,
                    "text": "CONCLUSIONS\nGDF15 expression can be used as a prognostic biomarker for OSCC, and as a predictive biomarker for benefitting from TPF induction chemotherapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 774,
                    "offsetInEndSection": 860,
                    "text": "A 1.64 ng/mL higher GDF15 level predicted a 188-mg higher metformin dose (P < 0.0001)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24669014",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 447,
                    "offsetInEndSection": 698,
                    "text": "RESULTS\nGrowth differentiation factor 15 (GDF15) was strongly linked to metformin, such that the odds of metformin use per SD increase in level varied from 3.73 (95% CI 3.40, 4.09) to 3.94 (95% CI 3.59, 4.33) depending on the other included variables."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28880265",
                    "endSection": "abstract",
                    "offsetInBeginSection": 801,
                    "offsetInEndSection": 1075,
                    "text": "Together, our findings demonstrate that CDP138 positively modulates the TGF-\u03b2/Smad signaling pathway via GDF15 to promote radioresistance and metastasis, suggesting CDP138 as a potential oncogenic biomarker and a promising therapeutic target in the treatment of lung cancer."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25446397",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 95,
                    "text": "GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases."
                }
            ]
        },
        {
            "body": "Has rituximab been considered as a treatment for chronic fatigues syndrome? (November 2017)",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21918268",
                "http://www.ncbi.nlm.nih.gov/pubmed/20068404",
                "http://www.ncbi.nlm.nih.gov/pubmed/20392977",
                "http://www.ncbi.nlm.nih.gov/pubmed/14567524",
                "http://www.ncbi.nlm.nih.gov/pubmed/22007328",
                "http://www.ncbi.nlm.nih.gov/pubmed/24853856",
                "http://www.ncbi.nlm.nih.gov/pubmed/28164324",
                "http://www.ncbi.nlm.nih.gov/pubmed/20462915",
                "http://www.ncbi.nlm.nih.gov/pubmed/18469554",
                "http://www.ncbi.nlm.nih.gov/pubmed/29204098"
            ],
            "id": "5aa395fcd6d6b54f79000007",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21918268",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 10,
                    "text": "Rituximab."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20068404",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 11,
                    "text": "Ofatumumab."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21918268",
                    "endSection": "abstract",
                    "offsetInBeginSection": 961,
                    "offsetInEndSection": 1139,
                    "text": "In solid organ transplantation, rituximab is useful in the prevention and treatment of acute and chronic rejection as well as in post transplantation lymphoproliferative disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20392977",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1128,
                    "offsetInEndSection": 1343,
                    "text": "As a selective, B cell targeted therapy, rituximab should be considered as a treatment option for patients with either myasthenia gravis or LEMS for whom standard immunosuppressive treatments have been unsuccessful."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21918268",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "Rituximab is a chimeric mouse-human monoclonal antibody against the CD 20 antigen on the surface of B lymphocytes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21918268",
                    "endSection": "abstract",
                    "offsetInBeginSection": 858,
                    "offsetInEndSection": 960,
                    "text": "Nephrotic syndrome and opsoclonus-myoclonus syndrome are among the emerging indications for rituximab."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14567524",
                    "endSection": "abstract",
                    "offsetInBeginSection": 237,
                    "offsetInEndSection": 372,
                    "text": "Recently, the chimeric anti-CD20 monoclonal antibody rituximab was considered as an alternative treatment option in this patient group."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22007328",
                    "endSection": "abstract",
                    "offsetInBeginSection": 561,
                    "offsetInEndSection": 772,
                    "text": "Participants cited a range of etiologies and overlapping conditions including asthma, Reactive Airway Dysfunction Syndrome (RADS), Sick Building Syndrome (SBS), Chronic Fatigues Syndrome (CFS), and Fibromyalgia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24853856",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 318,
                    "text": "This is the case of a 79-year-old man with chronic lymphocytic leukemia who presented with Guillain-Barr\u00e9 syndrome with features overlapping with the Miller Fisher syndrome and Bickerstaff brainstem encephalitis and positive antiganglioside GQ1b antibody about 6 months after treatment with bendamustine and rituximab."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21918268",
                    "endSection": "abstract",
                    "offsetInBeginSection": 494,
                    "offsetInEndSection": 736,
                    "text": "It has proved useful as salvage therapy in relapsed refractory non-Hodgkins lymphoma and leukemia, and in hematological conditions including chronic immune thrombocytopenic purpura, hemophilia with inhibitors, and autoimmune hemolytic anemia."
                }
            ]
        },
        {
            "body": "Does oncogene-induced DNA replication stress inhibit genomic instability?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20177397",
                "http://www.ncbi.nlm.nih.gov/pubmed/23204322",
                "http://www.ncbi.nlm.nih.gov/pubmed/22410776",
                "http://www.ncbi.nlm.nih.gov/pubmed/25959964",
                "http://www.ncbi.nlm.nih.gov/pubmed/21311564",
                "http://www.ncbi.nlm.nih.gov/pubmed/22465609",
                "http://www.ncbi.nlm.nih.gov/pubmed/28166452",
                "http://www.ncbi.nlm.nih.gov/pubmed/27911848",
                "http://www.ncbi.nlm.nih.gov/pubmed/26616915",
                "http://www.ncbi.nlm.nih.gov/pubmed/28931330"
            ],
            "id": "5ab9032afcf4565872000018",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20177397",
                    "endSection": "abstract",
                    "offsetInBeginSection": 489,
                    "offsetInEndSection": 846,
                    "text": "Instead, the mutation patterns of the tumour suppressor TP53 (which encodes p53), ataxia telangiectasia mutated (ATM) and cyclin-dependent kinase inhibitor 2A (CDKN2A; which encodes p16INK4A and p14ARF) support the oncogene-induced DNA replication stress model, which attributes genomic instability and TP53 and ATM mutations to oncogene-induced DNA damage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23204322",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "Oncogene-induced DNA replication stress is thought to drive genomic instability in cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22410776",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "Oncogene-induced replication stress is recognized as the primary cause of accumulation of DNA damage and genome instability in precancerous cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959964",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1641,
                    "offsetInEndSection": 1756,
                    "text": "Our results demonstrate how oncogene-induced replication stress contributes to genomic instability in human cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23204322",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1063,
                    "offsetInEndSection": 1278,
                    "text": "We propose that single-stranded DNA generated in response to oncogene-induced replication stress compromises the repair of deaminated cytosines and other damaged bases, leading to the observed SNS mutator phenotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22410776",
                    "endSection": "abstract",
                    "offsetInBeginSection": 552,
                    "offsetInEndSection": 754,
                    "text": "Loss of WRN affects cell cycle progression and results in enhanced accumulation of double-strand breaks and instability at common fragile sites in cells experiencing oncogene-induced replication stress."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20177397",
                    "endSection": "abstract",
                    "offsetInBeginSection": 214,
                    "offsetInEndSection": 488,
                    "text": "In sporadic (non-hereditary) cancers the molecular basis of genomic instability remains unclear, but recent high-throughput sequencing studies suggest that mutations in DNA repair genes are infrequent before therapy, arguing against the mutator hypothesis for these cancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21311564",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1007,
                    "offsetInEndSection": 1228,
                    "text": "Comparative genomic hybridization analysis of stem cells derived by these protocols revealed the presence of genomic deletions and amplifications, whose signature was suggestive of oncogene-induced DNA replication stress."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22410776",
                    "endSection": "abstract",
                    "offsetInBeginSection": 963,
                    "offsetInEndSection": 1218,
                    "text": "Overall, our findings give insights into the mechanisms protecting replication forks in cells experiencing oncogene-induced replication stress, and identify factors that, when mutated or dysfunctional, may enhance genome instability in precancerous cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20177397",
                    "endSection": "abstract",
                    "offsetInBeginSection": 57,
                    "offsetInEndSection": 213,
                    "text": "In hereditary cancers, genomic instability results from mutations in DNA repair genes and drives cancer development, as predicted by the mutator hypothesis."
                }
            ]
        },
        {
            "body": "Is the petrous bone used in ancient DNA sampling?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                "http://www.ncbi.nlm.nih.gov/pubmed/28526291",
                "http://www.ncbi.nlm.nih.gov/pubmed/26086078",
                "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                "http://www.ncbi.nlm.nih.gov/pubmed/28502003",
                "http://www.ncbi.nlm.nih.gov/pubmed/21855309",
                "http://www.ncbi.nlm.nih.gov/pubmed/19493899",
                "http://www.ncbi.nlm.nih.gov/pubmed/22183740",
                "http://www.ncbi.nlm.nih.gov/pubmed/27907810",
                "http://www.ncbi.nlm.nih.gov/pubmed/21318033"
            ],
            "id": "5abd3707fcf456587200002d",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "A minimally-invasive method for sampling human petrous bones from the cranial base for ancient DNA analysis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28526291",
                    "endSection": "abstract",
                    "offsetInBeginSection": 605,
                    "offsetInEndSection": 708,
                    "text": "The petrous part yielded more endogenous ancient DNA molecules than the squamous part of the same bone."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 77,
                    "text": "Optimal Ancient DNA Yields from the Inner Ear Part of the Human Petrous Bone."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 70,
                    "text": "Comparing Ancient DNA Preservation in Petrous Bone and Tooth Cementum."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078",
                    "endSection": "abstract",
                    "offsetInBeginSection": 517,
                    "offsetInEndSection": 890,
                    "text": "In this study we investigate whether (a) different parts of the petrous bone of archaeological human specimens give different percentages of endogenous DNA yields, (b) there are significant differences in average DNA read lengths, damage patterns and total DNA concentration, and (c) it is possible to obtain endogenous ancient DNA from petrous bones from hot environments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1341,
                    "offsetInEndSection": 1462,
                    "text": "Lastly, we show that petrous bones from ancient cremated individuals contain no measurable levels of authentic human DNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                    "endSection": "abstract",
                    "offsetInBeginSection": 209,
                    "offsetInEndSection": 495,
                    "text": "The osseous labyrinth inside the petrous bone has been shown to yield higher amounts of endogenous DNA than any other skeletal element; however, accessing this labyrinth in cases of a complete or reconstructed skull involves causing major structural damage to the cranial vault or base."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                    "endSection": "abstract",
                    "offsetInBeginSection": 731,
                    "offsetInEndSection": 943,
                    "text": "We assessed this method by comparing the aDNA results from one petrous bone processed using our novel method to its pair, which was processed using established protocols for sampling disarticulated petrous bones."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 208,
                    "text": "Ancient DNA (aDNA) research involves invasive and destructive sampling procedures that are often incompatible with anthropological, anatomical, and bioarcheological analyses requiring intact skeletal remains."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078",
                    "endSection": "abstract",
                    "offsetInBeginSection": 341,
                    "offsetInEndSection": 516,
                    "text": "The only skeletal element for which a systematically higher endogenous DNA content compared to other skeletal elements has been shown is the petrous part of the temporal bone."
                }
            ]
        },
        {
            "body": "Is recursive splicing more common in short introns?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                "http://www.ncbi.nlm.nih.gov/pubmed/27965595",
                "http://www.ncbi.nlm.nih.gov/pubmed/25970246",
                "http://www.ncbi.nlm.nih.gov/pubmed/19924226",
                "http://www.ncbi.nlm.nih.gov/pubmed/28520720",
                "http://www.ncbi.nlm.nih.gov/pubmed/2725514",
                "http://www.ncbi.nlm.nih.gov/pubmed/21974994",
                "http://www.ncbi.nlm.nih.gov/pubmed/23097425",
                "http://www.ncbi.nlm.nih.gov/pubmed/12034457"
            ],
            "id": "5abc974bfcf456587200001f",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 87,
                    "text": "Subdivision of large introns in Drosophila by recursive splicing at nonexonic elements."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                    "endSection": "abstract",
                    "offsetInBeginSection": 167,
                    "offsetInEndSection": 364,
                    "text": "We present bioinformatic, phylogenetic, and experimental evidence in Drosophila for a mechanism that subdivides many large introns by recursive splicing at nonexonic elements and alternative exons."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                    "endSection": "abstract",
                    "offsetInBeginSection": 971,
                    "offsetInEndSection": 1253,
                    "text": "Experimental analyses of in vivo processing intermediates and lariat products from four large introns in the unrelated genes kuzbanian, outspread, and Ultrabithorax confirmed that these introns are removed by a series of recursive splicing steps using the predicted nonexonic sites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 160,
                    "text": "Recursive splicing is a process in which large introns are removed in multiple steps by re-splicing at ratchet points--5' splice sites recreated after splicing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1038,
                    "offsetInEndSection": 1226,
                    "text": "Together, these results indicate that recursive splicing is commonly used in Drosophila, occurs in humans, and provides insight into the mechanisms by which some large introns are removed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                    "endSection": "abstract",
                    "offsetInBeginSection": 839,
                    "offsetInEndSection": 970,
                    "text": "These patterns of enrichment and conservation indicate that recursive splice sites are advantageous in the context of long introns."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                    "endSection": "abstract",
                    "offsetInBeginSection": 562,
                    "offsetInEndSection": 709,
                    "text": "The sequential nature of recursive splicing was confirmed by identification of lariat introns generated by splicing to and from the ratchet points."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1254,
                    "offsetInEndSection": 1427,
                    "text": "Mutation of nonexonic site RP3 within Ultrabithorax also confirmed that recursive splicing is the predominant processing pathway even with a shortened version of the intron."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1428,
                    "offsetInEndSection": 1498,
                    "text": "We discuss currently known and potential roles for recursive splicing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27965595",
                    "endSection": "abstract",
                    "offsetInBeginSection": 844,
                    "offsetInEndSection": 1029,
                    "text": "This process, called \"recursive splicing,\" often involves non-canonical splicing elements positioned deep within introns, and different mechanisms for its deployment have been proposed."
                }
            ]
        },
        {
            "body": "Is Lysyl oxidase crosslinking collagen?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/2577359",
                "http://www.ncbi.nlm.nih.gov/pubmed/28800626",
                "http://www.ncbi.nlm.nih.gov/pubmed/25238333",
                "http://www.ncbi.nlm.nih.gov/pubmed/8096378",
                "http://www.ncbi.nlm.nih.gov/pubmed/8785587",
                "http://www.ncbi.nlm.nih.gov/pubmed/2870873",
                "http://www.ncbi.nlm.nih.gov/pubmed/9260463",
                "http://www.ncbi.nlm.nih.gov/pubmed/4377875",
                "http://www.ncbi.nlm.nih.gov/pubmed/2890532",
                "http://www.ncbi.nlm.nih.gov/pubmed/20460108"
            ],
            "id": "5ac07b67dd95b2cd42000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2577359",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1169,
                    "offsetInEndSection": 1392,
                    "text": "The fact that lysyl oxidase activity was diminished in old rats does not corroborate the observation by several authors that increased collagen insolubility is a consequence of higher intra- and intermolecular crosslinking."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28800626",
                    "endSection": "abstract",
                    "offsetInBeginSection": 270,
                    "offsetInEndSection": 462,
                    "text": "Lysyl oxidase (Lox) is a key enzyme required for crosslinking and deposition of insoluble collagen, so we investigated whether targeting Lox might be an approach to reduce abdominal adhesions."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25238333",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 230,
                    "text": "P2Y2R activation by nucleotides released from the highly metastatic breast cancer cell MDA-MB-231 contributes to pre-metastatic niche formation by mediating lysyl oxidase secretion, collagen crosslinking, and monocyte recruitment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8096378",
                    "endSection": "abstract",
                    "offsetInBeginSection": 185,
                    "offsetInEndSection": 348,
                    "text": "A decrease in the functional activity of lysyl oxidase, a cuproenzyme, is thought in part to be responsible for the decreased crosslinking of collagen and elastin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8785587",
                    "endSection": "abstract",
                    "offsetInBeginSection": 748,
                    "offsetInEndSection": 945,
                    "text": "These results raise the possibility that extracellular lysyl oxidase may have important roles to play in biology in addition to its established function in the crosslinking of elastin and collagen."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2870873",
                    "endSection": "abstract",
                    "offsetInBeginSection": 556,
                    "offsetInEndSection": 777,
                    "text": "These data indicate that although skin lysyl oxidase activity is decreased by glucocorticoid treatment, the crosslinking of acid extracted collagen as measured by the alpha/beta ratio and collagen solubility is increased."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9260463",
                    "endSection": "abstract",
                    "offsetInBeginSection": 363,
                    "offsetInEndSection": 605,
                    "text": "Lysyl oxidase, which catalyzes the corresponding aldehyde formation from certain lysyl and hydroxylysyl residues in collagen and elastin in the first step of the linking reaction, is the only known enzyme required in the crosslinking process."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/4377875",
                    "endSection": "abstract",
                    "offsetInBeginSection": 250,
                    "offsetInEndSection": 442,
                    "text": "The most promising method seems to be the blocking of crosslinks formation among collagen molecules by beta-aminopropionitrile, a competitive inhibitor of a crosslinking enzyme, lysyl oxidase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2890532",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "Lysyl oxidase, the only enzyme involved in collagen crosslinking, is shown to be present in embryos of the sea urchin Strongylocentrotus purpuratus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20460108",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 132,
                    "text": "LOX, the principal enzyme involved in crosslinking of collagen, was the first of several lysyl oxidase isotypes to be characterized."
                }
            ]
        },
        {
            "body": "Is sternotomy closure done using either a sternal ZipFix\u2122 implant  or conventional steel wire following cardiac surgery?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26290838",
                "http://www.ncbi.nlm.nih.gov/pubmed/19592548",
                "http://www.ncbi.nlm.nih.gov/pubmed/11251261",
                "http://www.ncbi.nlm.nih.gov/pubmed/15215921",
                "http://www.ncbi.nlm.nih.gov/pubmed/28846532",
                "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                "http://www.ncbi.nlm.nih.gov/pubmed/21929741",
                "http://www.ncbi.nlm.nih.gov/pubmed/15658909",
                "http://www.ncbi.nlm.nih.gov/pubmed/16967378",
                "http://www.ncbi.nlm.nih.gov/pubmed/17073957"
            ],
            "id": "5ab2cdc5fcf4565872000016",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26290838",
                    "endSection": "abstract",
                    "offsetInBeginSection": 454,
                    "offsetInEndSection": 692,
                    "text": "METHODS\nData were collected retrospectively on 1,354 patients who underwent sternal closure after major cardiac surgery, using either the multifilament cable wiring system or conventional steel wires between January 2009 and October 2010."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19592548",
                    "endSection": "abstract",
                    "offsetInBeginSection": 298,
                    "offsetInEndSection": 694,
                    "text": "Between 2000 and 2007, 200 patients undergoing median sternotomy for cardiac surgery, with one or more risk factors including New York Heart Association functional class III/IV, chronic obstructive pulmonary disease, osteoporosis, obesity, and off-midline sternotomy, were randomly assigned to group A (sternal weave closure, 100 patients) or group B (routine sternal wire closure, 100 patients)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26290838",
                    "endSection": "abstract",
                    "offsetInBeginSection": 308,
                    "offsetInEndSection": 451,
                    "text": "We aimed to compare conventional steel wiring to multifilament cable fixation for sternal closure in patients undergoing major cardiac surgery."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26290838",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "Multifilament Cable Wire versus Conventional Wire for Sternal Closure in Patients Undergoing Major Cardiac Surgery."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11251261",
                    "endSection": "abstract",
                    "offsetInBeginSection": 75,
                    "offsetInEndSection": 285,
                    "text": "With a biological model, we measured the rate of cutting through bone, of standard steel wire closure, peristernal steel wire, figure-of-eight closure, polyester and sternal bands sternotomy closure techniques."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15215921",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 139,
                    "text": "Sternal closure after median sternotomy in the pediatric age group may be accomplished with non-resorbable sutures or stainless steel wire."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26290838",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1473,
                    "offsetInEndSection": 1631,
                    "text": "CONCLUSION\nThe surgical outcomes of sternal closure using multifilament cable wires were comparable to those observed when conventional steel wires were used."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28846532",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1372,
                    "offsetInEndSection": 1601,
                    "text": "Conclusion: This randomized study of cardiac surgery patients showed no significant benefits of rigid fixation over conventional sternal wire closure with regard to intubation time, postoperative pain, or length of hospital stay."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 219,
                    "text": "OBJECTIVES\nTo determine the difference in sternal infection and other infectious events between conventional wire and cable-tie-based closure techniques post-sternotomy in a collective of patients after cardiac surgery."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21929741",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 136,
                    "text": "Nickel allergy can raise clinical problems in patients undergoing cardiac surgery who require sternal closure with stainless steel wire."
                }
            ]
        },
        {
            "body": "Is transcription of eRNA bidirectional?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25934506",
                "http://www.ncbi.nlm.nih.gov/pubmed/21572438",
                "http://www.ncbi.nlm.nih.gov/pubmed/27932455",
                "http://www.ncbi.nlm.nih.gov/pubmed/23273978",
                "http://www.ncbi.nlm.nih.gov/pubmed/27068475",
                "http://www.ncbi.nlm.nih.gov/pubmed/25588787",
                "http://www.ncbi.nlm.nih.gov/pubmed/24953189",
                "http://www.ncbi.nlm.nih.gov/pubmed/26166704",
                "http://www.ncbi.nlm.nih.gov/pubmed/28765524",
                "http://www.ncbi.nlm.nih.gov/pubmed/25404134"
            ],
            "id": "5ac24f7595d0062724000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25934506",
                    "endSection": "abstract",
                    "offsetInBeginSection": 918,
                    "offsetInEndSection": 1066,
                    "text": "XR-seq maps capture transcription-coupled repair at sites of divergent gene promoters and bidirectional enhancer RNA (eRNA) production at enhancers."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21572438",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27932455",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 121,
                    "text": "Single-cell profiling reveals that eRNA accumulation at enhancer-promoter loops is not required to sustain transcription."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23273978",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1029,
                    "offsetInEndSection": 1124,
                    "text": "Moreover, eRNA production from p53BERs is required for efficient p53 transcription enhancement."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27068475",
                    "endSection": "abstract",
                    "offsetInBeginSection": 342,
                    "offsetInEndSection": 517,
                    "text": "PSA eRNA binds to CYCLIN T1, activates P-TEFb, and promotes cis and trans target gene transcription by increasing serine-2 phosphorylation of RNA polymerase II (Pol II-Ser2p)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25588787",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "Chromatin looping and eRNA transcription precede the transcriptional activation of gene in the \u03b2-globin locus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27932455",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1131,
                    "offsetInEndSection": 1362,
                    "text": "Lastly, basal eRNA transcription at enhancers, but not E2-induced transcription, is maintained upon depletion of MLL1 and ER\u03b1, suggesting some degree of chromatin accessibility prior to signal-dependent activation of transcription."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24953189",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 129,
                    "text": "A TEAD1/p65 complex regulates the eutherian-conserved MnSOD intronic enhancer, eRNA transcription and the innate immune response."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27932455",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1363,
                    "offsetInEndSection": 1497,
                    "text": "Together, our findings suggest that eRNA accumulation at enhancer-promoter loops is not required to sustain target gene transcription."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26166704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 651,
                    "offsetInEndSection": 1000,
                    "text": "Condensins positively regulate ligand-dependent enhancer activation at least in part by recruiting an E3 ubiquitin ligase, HECTD1, to modulate the binding of enhancer-associated coactivators/corepressors, including p300 and RIP140, permitting full eRNA transcription, formation of enhancer:promoter looping, and the resultant coding gene activation."
                }
            ]
        },
        {
            "body": "Is the protein pelota a ribosomal rescue factor?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28213379",
                "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                "http://www.ncbi.nlm.nih.gov/pubmed/1742359",
                "http://www.ncbi.nlm.nih.gov/pubmed/3884000",
                "http://www.ncbi.nlm.nih.gov/pubmed/8900058",
                "http://www.ncbi.nlm.nih.gov/pubmed/20876129",
                "http://www.ncbi.nlm.nih.gov/pubmed/17889667",
                "http://www.ncbi.nlm.nih.gov/pubmed/22909071",
                "http://www.ncbi.nlm.nih.gov/pubmed/16280348",
                "http://www.ncbi.nlm.nih.gov/pubmed/7588080"
            ],
            "id": "5ad35933133db5eb78000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28213379",
                    "endSection": "abstract",
                    "offsetInBeginSection": 813,
                    "offsetInEndSection": 952,
                    "text": "Our data suggest that the decay of platelet mRNAs is slowed by the natural loss of the mRNA surveillance and ribosome rescue factor Pelota."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                    "endSection": "abstract",
                    "offsetInBeginSection": 271,
                    "offsetInEndSection": 398,
                    "text": "In eukaryotes, Pelota (Dom34 in yeast) and Hbs1 are responsible for solving general problems of ribosomal stall in translation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1742359",
                    "endSection": "abstract",
                    "offsetInBeginSection": 228,
                    "offsetInEndSection": 438,
                    "text": "We show here that these suppressors also rescue temperature-sensitive sporulation phenotypes (Spots) caused by mutations in RNA polymerase, ribosomal protein, and protein synthesis elongation factor EF-G genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3884000",
                    "endSection": "abstract",
                    "offsetInBeginSection": 342,
                    "offsetInEndSection": 483,
                    "text": "These are EF-P and the rescue protein as well as a previously undescribed factor we call W, which is found in the high-salt ribosomal eluate."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8900058",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "An archaebacterial homolog of pelota, a meiotic cell division protein in eukaryotes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876129",
                    "endSection": "abstract",
                    "offsetInBeginSection": 183,
                    "offsetInEndSection": 334,
                    "text": "In eukaryotes, the protein complex of Pelota (yeast Dom34) and Hbs1 translational GTPase recognizes the stalled ribosome containing the defective mRNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17889667",
                    "endSection": "abstract",
                    "offsetInBeginSection": 217,
                    "offsetInEndSection": 299,
                    "text": "Homologs of Dom34, called Pelota, are broadly conserved in eukaryotes and archaea."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                    "endSection": "abstract",
                    "offsetInBeginSection": 399,
                    "offsetInEndSection": 521,
                    "text": "In archaea, aPelota and aEF1\u03b1, homologous to Pelota and Hbs1, respectively, are considered to be involved in that process."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8900058",
                    "endSection": "abstract",
                    "offsetInBeginSection": 278,
                    "offsetInEndSection": 414,
                    "text": "The S. solfataricus PelA protein is about 20% identical with pelota, DOM34 and the hypothetical protein R74.6 of Caenorhabditis elegans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22909071",
                    "endSection": "abstract",
                    "offsetInBeginSection": 297,
                    "offsetInEndSection": 534,
                    "text": "A small protein, ArfA of 55 amino acids (formerly called YdhL), mediates binding of release factor 2 to the ribosomal A site lacking a complete mRNA codon and thereby triggers translational termination and rescue of the stalled ribosome."
                }
            ]
        },
        {
            "body": "Is CXCL7 a chemokine?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/29038657",
                "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                "http://www.ncbi.nlm.nih.gov/pubmed/26404753",
                "http://www.ncbi.nlm.nih.gov/pubmed/20652010",
                "http://www.ncbi.nlm.nih.gov/pubmed/20652876",
                "http://www.ncbi.nlm.nih.gov/pubmed/16401476",
                "http://www.ncbi.nlm.nih.gov/pubmed/27959418",
                "http://www.ncbi.nlm.nih.gov/pubmed/12193731",
                "http://www.ncbi.nlm.nih.gov/pubmed/23136963",
                "http://www.ncbi.nlm.nih.gov/pubmed/26233476"
            ],
            "id": "5a9db99ffd02ddc336000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29038657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 148,
                    "offsetInEndSection": 313,
                    "text": "CXCL7 exerts its function by activating the CXC chemokine receptor 2 (CXCR2) receptor and binding sulfated glycosaminoglycans (GAGs) that regulate receptor activity."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29038657",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 145,
                    "text": "Platelet-Derived Chemokine CXCL7 Dimer Preferentially Exists in the Glycosaminoglycan-Bound Form: Implications for Neutrophil-Platelet Crosstalk."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 111,
                    "text": "Chemokine CXCL7 Heterodimers: Structural Insights, CXCR2 Receptor Function, and Glycosaminoglycan Interactions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29038657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 147,
                    "text": "Platelet-derived chemokine CXCL7 (also known as NAP-2) plays a crucial role in orchestrating neutrophil recruitment in response to vascular injury."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26404753",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1642,
                    "offsetInEndSection": 1748,
                    "text": "We identified novel molecular networks including CXCL7 chemokine as a promising target for future studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20652010",
                    "endSection": "abstract",
                    "offsetInBeginSection": 243,
                    "offsetInEndSection": 317,
                    "text": "The chemokine CXCL7 binds heparin and the G-protein-linked receptor CXCR2."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20652876",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 126,
                    "text": "Chondrogenic differentiation of human mesenchymal stem cells in micro-masses is impaired by high doses of the chemokine CXCL7."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                    "endSection": "abstract",
                    "offsetInBeginSection": 461,
                    "offsetInEndSection": 802,
                    "text": "Solution nuclear magnetic resonance (NMR) and molecular dynamics characterization of platelet-derived chemokine CXCL7 heterodimerization with chemokines CXCL1, CXCL4, and CXCL8 indicated that packing interactions promote CXCL7-CXCL1 and CXCL7-CXCL4 heterodimers, and electrostatic repulsive interactions disfavor the CXCL7-CXCL8 heterodimer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16401476",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1049,
                    "offsetInEndSection": 1326,
                    "text": "The principal mediator of these protease-related effects was identified as the potent neutrophil chemokine CXCL7 (neutrophil activating peptide 2), a proteolytic cleavage product of chemotactically inert platelet basic protein (PBP), not previously identified in the intestine."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27959418",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 100,
                    "text": "CXCL7 is an important chemoattractant cytokine, which signals through binding to its receptor CXCR2."
                }
            ]
        },
        {
            "body": "The TRPM2 gene is associated with development of spontaneous thromboembolism?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16205735",
                "http://www.ncbi.nlm.nih.gov/pubmed/26311765",
                "http://www.ncbi.nlm.nih.gov/pubmed/21140288",
                "http://www.ncbi.nlm.nih.gov/pubmed/27919223",
                "http://www.ncbi.nlm.nih.gov/pubmed/21135052",
                "http://www.ncbi.nlm.nih.gov/pubmed/28199210",
                "http://www.ncbi.nlm.nih.gov/pubmed/12529379",
                "http://www.ncbi.nlm.nih.gov/pubmed/24584019",
                "http://www.ncbi.nlm.nih.gov/pubmed/27792045",
                "http://www.ncbi.nlm.nih.gov/pubmed/16352308"
            ],
            "id": "5ab144fefcf4565872000012",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16205735",
                    "endSection": "abstract",
                    "offsetInBeginSection": 851,
                    "offsetInEndSection": 972,
                    "text": "TRPM2 encodes a calcium channel receptor and TSPEAR encodes a peptide with repeats associated with epilepsy in the mouse."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26311765",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1578,
                    "offsetInEndSection": 1678,
                    "text": "TRPM2 is highly associated with BD; however, its involvement in the etiology of BD is still unknown."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21140288",
                    "endSection": "abstract",
                    "offsetInBeginSection": 868,
                    "offsetInEndSection": 1032,
                    "text": "Genetic variants of the TRPM2 gene confer a risk of developing Western Pacific amyotropic lateral sclerosis and parkinsonism-dementia complex and bipolar disorders."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27919223",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1131,
                    "offsetInEndSection": 1356,
                    "text": "CONCLUSIONS\nThis work demonstrates that SNPs in TRPM2 are associated with differences in gene expression, suggesting that modulation of expression of this innate immune gene contributes to susceptibility to R. equi pneumonia."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27919223",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 177,
                    "text": "TRPM2 SNP genotype previously associated with susceptibility to Rhodococcus equi pneumonia in Quarter Horse foals displays differential gene expression identified using RNA-Seq."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26311765",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "TRPM2, a Susceptibility Gene for Bipolar Disorder, Regulates Glycogen Synthase Kinase-3 Activity in the Brain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21135052",
                    "endSection": "abstract",
                    "offsetInBeginSection": 449,
                    "offsetInEndSection": 601,
                    "text": "TRPM2 is a non-selective, calcium (Ca(2+))-permeable cation channel of the melastatin-related transient receptor potential (TRPM) ion channel subfamily."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28199210",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 238,
                    "text": "The Transient Receptor Potential Melastatin 2 (TRPM2) is a member of G protein coupled receptor superfamily and a novel dual-function protein that possesses both ion channel and Adenosine 5'-DiphosPhatase Ribose (ADPR) hydrolase function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12529379",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 89,
                    "text": "TRPM2 is a member of the melastatin-related TRP (transient receptor potential) subfamily."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24584019",
                    "endSection": "abstract",
                    "offsetInBeginSection": 660,
                    "offsetInEndSection": 869,
                    "text": "TRPM2 deficiency attenuated pain behaviors (mechanical allodynia, thermal hyperalgesia and spontaneous pain behaviors) in various kinds of inflammatory and neuropathic pain, but not in nociceptive pain models."
                }
            ]
        },
        {
            "body": "Is a mutation of the  ZIKV's membrane protein prM responsible for the microcephaly in new-born infants?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                "http://www.ncbi.nlm.nih.gov/pubmed/28049830",
                "http://www.ncbi.nlm.nih.gov/pubmed/27366760",
                "http://www.ncbi.nlm.nih.gov/pubmed/25076193",
                "http://www.ncbi.nlm.nih.gov/pubmed/28931684",
                "http://www.ncbi.nlm.nih.gov/pubmed/27876396",
                "http://www.ncbi.nlm.nih.gov/pubmed/27795432",
                "http://www.ncbi.nlm.nih.gov/pubmed/29284702",
                "http://www.ncbi.nlm.nih.gov/pubmed/28932235",
                "http://www.ncbi.nlm.nih.gov/pubmed/28878777"
            ],
            "id": "5ac0aee419833b0d7b000004",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "A single mutation in the prM protein of Zika virus contributes to fetal microcephaly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28049830",
                    "endSection": "abstract",
                    "offsetInBeginSection": 971,
                    "offsetInEndSection": 1212,
                    "text": "The expression of premembrane protein (prM) resulted in cell-cycle G1 accumulation, whereas membrane-anchored capsid (anaC), membrane protein (M), envelope protein (E), and nonstructural protein 4A (NS4A) caused cell-cycle G2/M accumulation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27366760",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 157,
                    "text": "Zika virus (ZIKV) infection is a new emerging threat around the globe which might be responsible for microcephaly and Guillain-Barre syndrome in the infants."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25076193",
                    "endSection": "abstract",
                    "offsetInBeginSection": 274,
                    "offsetInEndSection": 465,
                    "text": "Although the prM protein is an essential component of the DENV viral cycle, little is known about its biological functions and what regions of this protein are responsible for said functions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 743,
                    "offsetInEndSection": 894,
                    "text": "This functional adaption makes ZIKV more virulent to human NPCs, thus contributing to the increased incidence of microcephaly in recent ZIKV epidemics."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 245,
                    "offsetInEndSection": 558,
                    "text": "Here we show that a single serine-to-asparagine substitution [Ser139\u2192Asn139 (S139N)] in the viral polyprotein substantially increased ZIKV infectivity in both human and mouse neural progenitor cells (NPCs) and led to more severe microcephaly in the mouse fetus, as well as higher mortality rates in neonatal mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "Zika virus (ZIKV) has evolved into a global health threat because of its unexpected causal link to microcephaly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25076193",
                    "endSection": "abstract",
                    "offsetInBeginSection": 466,
                    "offsetInEndSection": 832,
                    "text": "By performing an exhaustive study of membrane rupture induced by a prM peptide library on simple and complex model membranes as well as their ability to modulate the phospholipid phase transitions of 1,2-dimyristoyl-sn-glycero-3-phosphatidylcholine and 1,2-dimyristoyl-sn-glycero-3-[phospho-rac-glycerol], we identified six membranotropic regions on the prM protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28931684",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2235,
                    "offsetInEndSection": 2416,
                    "text": "To elucidate the functional significance of glycosylation in ZIKV pathogenicity, recombinant ZIKVs from infectious clones with or without the glycan on the E protein were generated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25076193",
                    "endSection": "abstract",
                    "offsetInBeginSection": 84,
                    "offsetInEndSection": 273,
                    "text": "Apart from preventing the premature fusion activity of the DENV E protein, prM has several other unknown biological roles, displaying both protein-protein and membrane-protein interactions."
                }
            ]
        },
        {
            "body": "What is the aim of the PhenCode database?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17326095",
                "http://www.ncbi.nlm.nih.gov/pubmed/25385275",
                "http://www.ncbi.nlm.nih.gov/pubmed/10786290",
                "http://www.ncbi.nlm.nih.gov/pubmed/10592257",
                "http://www.ncbi.nlm.nih.gov/pubmed/9016504",
                "http://www.ncbi.nlm.nih.gov/pubmed/15608195",
                "http://www.ncbi.nlm.nih.gov/pubmed/25480687",
                "http://www.ncbi.nlm.nih.gov/pubmed/25541585",
                "http://www.ncbi.nlm.nih.gov/pubmed/17377989",
                "http://www.ncbi.nlm.nih.gov/pubmed/11752251"
            ],
            "id": "5ad4f4f5133db5eb7800000a",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17326095",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 62,
                    "text": "PhenCode: connecting ENCODE data with mutations and phenotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17326095",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 222,
                    "text": "PhenCode (Phenotypes for ENCODE; http://www.bx.psu.edu/phencode) is a collaborative, exploratory project to help understand phenotypes of human mutations in the context of sequence and functional data from genome projects."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275",
                    "endSection": "abstract",
                    "offsetInBeginSection": 307,
                    "offsetInEndSection": 473,
                    "text": "These subsets were filtered against disease-related variants in the ClinVar, UniProtKB/Swiss-Prot, and PhenCode databases, to identify neutral or nonpathogenic cases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17326095",
                    "endSection": "abstract",
                    "offsetInBeginSection": 462,
                    "offsetInEndSection": 844,
                    "text": "Initially, we focused on a few selected LSDBs covering genes encoding alpha- and beta-globins (HBA, HBB), phenylalanine hydroxylase (PAH), blood group antigens (various genes), androgen receptor (AR), cystic fibrosis transmembrane conductance regulator (CFTR), and Bruton's tyrosine kinase (BTK), but we plan to include additional loci of clinical importance, ultimately genomewide."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10786290",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 66,
                    "text": "INTERACT: an object oriented protein-protein interaction database."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17326095",
                    "endSection": "abstract",
                    "offsetInBeginSection": 923,
                    "offsetInEndSection": 1084,
                    "text": "Users can find interesting mutations in the UCSC Genome Browser (in a new Locus Variants track) and follow links back to the LSDBs for more detailed information."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17326095",
                    "endSection": "abstract",
                    "offsetInBeginSection": 845,
                    "offsetInEndSection": 922,
                    "text": "We have also imported variant data and associated OMIM links from Swiss-Prot."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17326095",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1085,
                    "offsetInEndSection": 1438,
                    "text": "Alternatively, they can start with queries on mutations or phenotypes at an LSDB and then display the results at the Genome Browser to view complementary information such as functional data (e.g., chromatin modifications and protein binding from the ENCODE consortium), evolutionary constraint, regulatory potential, and/or any other tracks they choose."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10592257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 94,
                    "text": "ooTFD (object-oriented Transcription Factors Database) is an object-oriented successor to TFD."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17326095",
                    "endSection": "abstract",
                    "offsetInBeginSection": 223,
                    "offsetInEndSection": 461,
                    "text": "Currently, it connects human phenotype and clinical data in various locus-specific databases (LSDBs) with data on genome sequences, evolutionary history, and function from the ENCODE project and other resources in the UCSC Genome Browser."
                }
            ]
        },
        {
            "body": "What is the basis of the Sp3 procedure used in proteomics?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25358341",
                "http://www.ncbi.nlm.nih.gov/pubmed/16024108",
                "http://www.ncbi.nlm.nih.gov/pubmed/16275928",
                "http://www.ncbi.nlm.nih.gov/pubmed/27668303",
                "http://www.ncbi.nlm.nih.gov/pubmed/12954773",
                "http://www.ncbi.nlm.nih.gov/pubmed/12837748",
                "http://www.ncbi.nlm.nih.gov/pubmed/11432740",
                "http://www.ncbi.nlm.nih.gov/pubmed/15474306",
                "http://www.ncbi.nlm.nih.gov/pubmed/12356736",
                "http://www.ncbi.nlm.nih.gov/pubmed/8070411"
            ],
            "id": "5ac28c0c95d006272400000a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25358341",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1125,
                    "offsetInEndSection": 1330,
                    "text": "Together, the findings of this work position SP3 as a superior protocol that facilitates exciting new directions in multiple areas of proteomics ranging from developmental biology to clinical applications."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16024108",
                    "endSection": "abstract",
                    "offsetInBeginSection": 104,
                    "offsetInEndSection": 230,
                    "text": "The Sp3 promoter is a GC-rich region that contains putative binding sites for Elk-1, c-Myb, NF-1, Ap1, Sp1, NF-Y, Ap2 and USF."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16275928",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Molecular basis for keratoconus: lack of TrkA expression and its transcriptional repression by Sp3."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27668303",
                    "endSection": "abstract",
                    "offsetInBeginSection": 197,
                    "offsetInEndSection": 511,
                    "text": "In this study, we examined the effect of TFF2 on gastric cancer cell lines in\u00a0vitro and characterized the interaction between TFF2 and Sp3, including the mechanisms that mediate this interaction, using genomics and proteomics approaches, as well as genetics techniques, such as RNA interference and gene knockdown."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25358341",
                    "endSection": "abstract",
                    "offsetInBeginSection": 699,
                    "offsetInEndSection": 927,
                    "text": "To illustrate these benefits, characterization of 1,000 HeLa cells and single Drosophila embryos is used to establish that SP3 provides an enhanced platform for profiling proteomes derived from sub-microgram amounts of material."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16275928",
                    "endSection": "abstract",
                    "offsetInBeginSection": 758,
                    "offsetInEndSection": 884,
                    "text": "Sp3 is a bifunctional transcription factor that has been reported to stimulate or repress the transcription of numerous genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12954773",
                    "endSection": "abstract",
                    "offsetInBeginSection": 253,
                    "offsetInEndSection": 417,
                    "text": "While Sp1 functions strictly as a transcriptional activator, Sp3 has been shown to be transcriptionally inactive for promoters containing multiple Sp-binding sites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12837748",
                    "endSection": "abstract",
                    "offsetInBeginSection": 386,
                    "offsetInEndSection": 600,
                    "text": "We now report that histone deacetylase inhibitor trichostatin A (TSA) induces acetylation of Sp3, which acts as a transcriptional activator of transforming growth factor-beta receptor type II (RII) in MCF-7L cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16024108",
                    "endSection": "abstract",
                    "offsetInBeginSection": 556,
                    "offsetInEndSection": 717,
                    "text": "Transient transfections and luciferase assays revealed activation of the Sp3 proximal promoter upon overexpression of either Sp1 or Sp3, alone or in combination."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12837748",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 46,
                    "text": "Acetylated sp3 is a transcriptional activator."
                }
            ]
        },
        {
            "body": "What is \"enhancer hijacking\"?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27490482",
                "http://www.ncbi.nlm.nih.gov/pubmed/25043047",
                "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                "http://www.ncbi.nlm.nih.gov/pubmed/26229090",
                "http://www.ncbi.nlm.nih.gov/pubmed/26065614",
                "http://www.ncbi.nlm.nih.gov/pubmed/21917792",
                "http://www.ncbi.nlm.nih.gov/pubmed/14998483",
                "http://www.ncbi.nlm.nih.gov/pubmed/26253026",
                "http://www.ncbi.nlm.nih.gov/pubmed/15492932",
                "http://www.ncbi.nlm.nih.gov/pubmed/25414315"
            ],
            "id": "5abc9157fcf456587200001e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27490482",
                    "endSection": "abstract",
                    "offsetInBeginSection": 895,
                    "offsetInEndSection": 1003,
                    "text": "EBV therefore drives lymphomagenesis by hijacking long-range enhancer hubs and specific cellular co-factors."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25043047",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 70,
                    "text": "Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25043047",
                    "endSection": "abstract",
                    "offsetInBeginSection": 903,
                    "offsetInEndSection": 1131,
                    "text": "Our results, supported by evidence from mouse models, identify GFI1 and GFI1B as prominent medulloblastoma oncogenes and implicate 'enhancer hijacking' as an efficient mechanism driving oncogene activation in a childhood cancer."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 102,
                    "text": "Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "abstract",
                    "offsetInBeginSection": 751,
                    "offsetInEndSection": 880,
                    "text": "We additionally pursued cancer-type-specific analyses and uncovered IGF2 as a target for enhancer hijacking in colorectal cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "abstract",
                    "offsetInBeginSection": 235,
                    "offsetInEndSection": 476,
                    "text": "Here we present a framework for inferring cancer-related gene overexpression resulting from CRE reorganization (e.g., enhancer hijacking) by integrating SCNAs, gene expression data and information on topologically associating domains (TADs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26229090",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1313,
                    "offsetInEndSection": 1504,
                    "text": "We identify novel mechanisms of enhancer-driven regulation of the oncogenes MYC and BCL6, and show that the BCL6 locus can serve as an enhancer donor in an \"enhancer hijacking\" translocation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26065614",
                    "endSection": "abstract",
                    "offsetInBeginSection": 209,
                    "offsetInEndSection": 526,
                    "text": "The so-called omics revolution, enabled by high-throughput sequencing, has empowered large consortia and independent groups alike to make major genetic discoveries, from dominant-negative histone mutations and hijacking of distal enhancer elements, to new oncogenic gene fusions and aberrantly active gene expression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25043047",
                    "endSection": "abstract",
                    "offsetInBeginSection": 737,
                    "offsetInEndSection": 902,
                    "text": "Somatic structural variants juxtapose GFI1 or GFI1B coding sequences proximal to active enhancer elements, including super-enhancers, instigating oncogenic activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27490482",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1004,
                    "offsetInEndSection": 1156,
                    "text": "EBV-driven MYC enhancer activation may contribute to the genesis and localisation of MYC-Immunoglobulin translocation breakpoints in Burkitt's lymphoma."
                }
            ]
        },
        {
            "body": "What disease is tinea ?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/8821157",
                "http://www.ncbi.nlm.nih.gov/pubmed/12748593",
                "http://www.ncbi.nlm.nih.gov/pubmed/24134312",
                "http://www.ncbi.nlm.nih.gov/pubmed/10948816",
                "http://www.ncbi.nlm.nih.gov/pubmed/12894115",
                "http://www.ncbi.nlm.nih.gov/pubmed/25396139",
                "http://www.ncbi.nlm.nih.gov/pubmed/12040364",
                "http://www.ncbi.nlm.nih.gov/pubmed/14996619",
                "http://www.ncbi.nlm.nih.gov/pubmed/26885800",
                "http://www.ncbi.nlm.nih.gov/pubmed/19942789"
            ],
            "id": "5aa67b4fd6d6b54f7900000f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8821157",
                    "endSection": "abstract",
                    "offsetInBeginSection": 195,
                    "offsetInEndSection": 262,
                    "text": "Iatrogenic disease (tinea incognito) is a new and more subtle form."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12748593",
                    "endSection": "abstract",
                    "offsetInBeginSection": 544,
                    "offsetInEndSection": 665,
                    "text": "Among superficial mycoses, tinea pedis is viewed as the pivotal disease because it is intractable and is the most common."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24134312",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 103,
                    "text": "Tinea capitis is a common disease of childhood that typically follows one of several clinical patterns."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10948816",
                    "endSection": "abstract",
                    "offsetInBeginSection": 535,
                    "offsetInEndSection": 687,
                    "text": "Tinea pedis may be a risk factor for streptococcal infections such as erysipelas, mainly in tropical countries, where tinea pedis is a frequent disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12894115",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "Tinea capitis is generally thought to be a common disease in children but not in adults."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25396139",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "Tinea capitis is generally thought to be a common disease in children but not in adults."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12040364",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 105,
                    "text": "Tinea pedis responds well to topical antifungal therapy, however, relapse of the disease is not uncommon."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14996619",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 64,
                    "text": "Tinea capitis is primarily a disease of pre-adolescent children."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24134312",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 46,
                    "text": "Tinea capitis mimicking dissecting cellulitis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26885800",
                    "endSection": "abstract",
                    "offsetInBeginSection": 194,
                    "offsetInEndSection": 355,
                    "text": "Moccasin tinea pedis has not been recognized by governing bodies as a definable and treatable disease entity separate from interdigital tinea pedis at this time."
                }
            ]
        },
        {
            "body": "How are deletion breakpoints defined?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22445104",
                "http://www.ncbi.nlm.nih.gov/pubmed/8314578",
                "http://www.ncbi.nlm.nih.gov/pubmed/1741389",
                "http://www.ncbi.nlm.nih.gov/pubmed/21103668",
                "http://www.ncbi.nlm.nih.gov/pubmed/16293123",
                "http://www.ncbi.nlm.nih.gov/pubmed/8619128",
                "http://www.ncbi.nlm.nih.gov/pubmed/8875237",
                "http://www.ncbi.nlm.nih.gov/pubmed/11336982",
                "http://www.ncbi.nlm.nih.gov/pubmed/15732063",
                "http://www.ncbi.nlm.nih.gov/pubmed/8307327"
            ],
            "id": "5abc9c1efcf4565872000020",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22445104",
                    "endSection": "abstract",
                    "offsetInBeginSection": 178,
                    "offsetInEndSection": 332,
                    "text": "Effective and efficient deletion mapping requires both extensive genomic coverage and a high density of molecularly defined breakpoints across the genome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8314578",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1059,
                    "offsetInEndSection": 1256,
                    "text": "One YAC in the centromeric contig contains an insert encompassing the minimum interval for GK deficiency defined by patient deletion breakpoints, and this clone includes all or part of the GK gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1741389",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1225,
                    "offsetInEndSection": 1465,
                    "text": "Therefore, the Fah gene maps within or proximal to the hsdr-1 locus, as defined by deletion breakpoints, and disruption of this gene may be partially or completely responsible for the phenotypes associated with the hsdr-1 deletion syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21103668",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 162,
                    "text": "Large deletions are found in approximately 5% of patients with severe haemophilia A, but only a few deletion breakpoints have been characterised precisely so far."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16293123",
                    "endSection": "abstract",
                    "offsetInBeginSection": 282,
                    "offsetInEndSection": 499,
                    "text": "Subsequently, the deletion of exon 2 of the copper metabolism domain containing 1 (COMMD1) gene (formerly MURR1) was shown to be the major cause of copper toxicosis, although the deletion breakpoints were not defined."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8619128",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 100,
                    "text": "DNA sequences of the deletion breakpoints of 24 human T-lymphocyte hprt gene mutations are reported."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8875237",
                    "endSection": "abstract",
                    "offsetInBeginSection": 872,
                    "offsetInEndSection": 1135,
                    "text": "A degree of breakpoint clustering was found, but the identification of a number of deletion types, based on the position of proximal and distal breakpoints as defined by microsatellite analysis, strongly supports a leukaemogenic mechanism involving gene deletion."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8314578",
                    "endSection": "abstract",
                    "offsetInBeginSection": 605,
                    "offsetInEndSection": 770,
                    "text": "Patient deletion breakpoints in the region of the two YAC contigs define at least eight intervals, and seven deletion breakpoints are contained within these contigs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11336982",
                    "endSection": "abstract",
                    "offsetInBeginSection": 788,
                    "offsetInEndSection": 939,
                    "text": "The deletion breakpoints were defined by a combination of long polymerase chain reaction (PCR) amplifications, and conventional PCR and DNA sequencing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15732063",
                    "endSection": "abstract",
                    "offsetInBeginSection": 293,
                    "offsetInEndSection": 621,
                    "text": "Fluorescence in situ hybridization (FISH) and molecular studies defined the breakpoints at 7q21.11 and 7q21.3 on the paternal chromosome 7, with the proximal deletion breakpoint between the elastin gene (localized at 7q11.23) and D7S2517, and the distal breakpoint between D7S652 and the COL1A2 gene (localized at 7q21.3-q22.1)."
                }
            ]
        },
        {
            "body": "How is the nuclear localization of lncRNA mediated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27198227",
                "http://www.ncbi.nlm.nih.gov/pubmed/26578588",
                "http://www.ncbi.nlm.nih.gov/pubmed/28404604",
                "http://www.ncbi.nlm.nih.gov/pubmed/26709446",
                "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                "http://www.ncbi.nlm.nih.gov/pubmed/25690653",
                "http://www.ncbi.nlm.nih.gov/pubmed/27250657",
                "http://www.ncbi.nlm.nih.gov/pubmed/25849144",
                "http://www.ncbi.nlm.nih.gov/pubmed/23828888",
                "http://www.ncbi.nlm.nih.gov/pubmed/28652379"
            ],
            "id": "5ab8fb5bfcf4565872000017",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27198227",
                    "endSection": "abstract",
                    "offsetInBeginSection": 850,
                    "offsetInEndSection": 1040,
                    "text": "Our findings indicate that RBPs HuR and GRSF1 govern the cytoplasmic and mitochondrial localization of the lncRNA RMRP, which is encoded by nuclear DNA but has key functions in mitochondria."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27198227",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "HuR and GRSF1 modulate the nuclear export and mitochondrial localization of the lncRNA RMRP."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26578588",
                    "endSection": "abstract",
                    "offsetInBeginSection": 788,
                    "offsetInEndSection": 1067,
                    "text": "To address whether localization of the lncRNA influences susceptibility to degradation by either ASOs or RNAi, nuclear lncRNAs (MALAT1 and NEAT1), cytoplasmic lncRNAs (DANCR and OIP5-AS1) and dual-localized lncRNAs (TUG1, CasC7 and HOTAIR) were compared for knockdown efficiency."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28404604",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "NEAT1_2 long noncoding RNA (lncRNA) is the molecular scaffold of paraspeckle nuclear bodies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26709446",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 130,
                    "text": "Paraspeckles are subnuclear structures that assemble on nuclear paraspeckle assembly transcript 1 (NEAT1) long noncoding (lnc)RNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                    "endSection": "abstract",
                    "offsetInBeginSection": 150,
                    "offsetInEndSection": 427,
                    "text": "As many lncRNAs regulate nuclear events and thus must localize to nuclei, we analyzed the sequence requirements for nuclear localization in an intergenic lncRNA named BORG (BMP2-OP1-responsive gene), which is both spliced and polyadenylated but is strictly localized in nuclei."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25690653",
                    "endSection": "abstract",
                    "offsetInBeginSection": 570,
                    "offsetInEndSection": 789,
                    "text": "Subcellular localization analysis revealed that compared to mRNAs, lncRNAs more often have a specific subcellular localization with a markedly higher percentage of nuclear enrichment within the Myc-repressed lncRNA set."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27198227",
                    "endSection": "abstract",
                    "offsetInBeginSection": 167,
                    "offsetInEndSection": 440,
                    "text": "Using affinity RNA pull-down followed by mass spectrometry analysis, we found two RNA-binding proteins (RBPs), HuR (human antigen R) and GRSF1 (G-rich RNA sequence-binding factor 1), that associated with the nuclear DNA-encoded lncRNA RMRP and mobilized it to mitochondria."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27250657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 906,
                    "offsetInEndSection": 1204,
                    "text": "Further, lncRNA SPRY4-IT1 can directly increase the transcription, expression, and nuclear localization of Snail, one key transcription factor during the EMT processes of cancer cells, while siRNA-mediated specific knockdown of Snail can significantly attenuate SPRY4-IT1-induced EMT of ESCC cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25849144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 481,
                    "offsetInEndSection": 663,
                    "text": "We have identified an evolutionarily conserved nuclear antisense lncRNA, generated from within the human FGFR2 locus, that promotes epithelial-specific alternative splicing of FGFR2."
                }
            ]
        },
        {
            "body": "What is ATAC-seq?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28550296",
                "http://www.ncbi.nlm.nih.gov/pubmed/27903897",
                "http://www.ncbi.nlm.nih.gov/pubmed/29155775",
                "http://www.ncbi.nlm.nih.gov/pubmed/27832532",
                "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                "http://www.ncbi.nlm.nih.gov/pubmed/27008018",
                "http://www.ncbi.nlm.nih.gov/pubmed/26977395",
                "http://www.ncbi.nlm.nih.gov/pubmed/25679813",
                "http://www.ncbi.nlm.nih.gov/pubmed/28505247",
                "http://www.ncbi.nlm.nih.gov/pubmed/26294014"
            ],
            "id": "5abd31e0fcf456587200002c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28550296",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 82,
                    "text": "ATAC-seq is a high-throughput sequencing technique that identifies open chromatin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28550296",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 59,
                    "text": "Reducing mitochondrial reads in ATAC-seq using CRISPR/Cas9."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28550296",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1159,
                    "offsetInEndSection": 1397,
                    "text": "This strategy reduced the amount of sequencing required to call a high number of peaks, which could lead to cost reduction when performing ATAC-seq on large numbers of samples and in cell types that contain a large amount of mitochondria."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28550296",
                    "endSection": "abstract",
                    "offsetInBeginSection": 83,
                    "offsetInEndSection": 182,
                    "text": "Depending on the cell type, ATAC-seq samples may contain ~20-80% of mitochondrial sequencing reads."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28550296",
                    "endSection": "abstract",
                    "offsetInBeginSection": 334,
                    "offsetInEndSection": 578,
                    "text": "We tested two approaches to decrease wasted sequencing in ATAC-seq libraries generated from lymphoblastoid cell lines: targeted cleavage of mitochondrial DNA fragments using CRISPR technology and removal of detergent from the cell lysis buffer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28550296",
                    "endSection": "abstract",
                    "offsetInBeginSection": 987,
                    "offsetInEndSection": 1158,
                    "text": "The highest number of peaks and highest quality data was obtained by preparing samples with the original ATAC-seq protocol (using detergent) and treating them with CRISPR."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27903897",
                    "endSection": "abstract",
                    "offsetInBeginSection": 405,
                    "offsetInEndSection": 555,
                    "text": "Assay for Transposase Accessible Chromatin sequencing (ATAC-seq) is a recently developed technique used to map open chromatin zones in animal genomes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27903897",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 96,
                    "text": "Combining ATAC-seq with nuclei sorting for discovery of cis-regulatory regions in plant genomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29155775",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 168,
                    "text": "Assay for Transposase-Accessible Chromatin with high-throughput sequencing (ATAC-seq) is a method used for the identification of open (accessible) regions of chromatin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29155775",
                    "endSection": "abstract",
                    "offsetInBeginSection": 631,
                    "offsetInEndSection": 1000,
                    "text": "ATAC-seq is a robust and sensitive alternative to DNase I hypersensitivity analysis coupled with next-generation sequencing (DNase-seq) and formaldehyde-assisted isolation of regulatory elements (FAIRE-seq) for genome-wide analysis of chromatin accessibility and to the sequencing of micrococcal nuclease-sensitive sites (MNase-seq) to determine nucleosome positioning."
                }
            ]
        },
        {
            "body": "What is the TALE-iD method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27940490",
                "http://www.ncbi.nlm.nih.gov/pubmed/24228087",
                "http://www.ncbi.nlm.nih.gov/pubmed/29118409",
                "http://www.ncbi.nlm.nih.gov/pubmed/27526029",
                "http://www.ncbi.nlm.nih.gov/pubmed/28493677",
                "http://www.ncbi.nlm.nih.gov/pubmed/27615025",
                "http://www.ncbi.nlm.nih.gov/pubmed/20345643",
                "http://www.ncbi.nlm.nih.gov/pubmed/24130757",
                "http://www.ncbi.nlm.nih.gov/pubmed/25866970",
                "http://www.ncbi.nlm.nih.gov/pubmed/23019222"
            ],
            "id": "5a8d8f39fcd1d6a10c000024",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27940490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 778,
                    "offsetInEndSection": 1139,
                    "text": "Using different cell types and loci, computational modeling, and a methylation-based orthogonal validation method, \"TALE-iD\", we show that native interactions resemble cross-linked ones, but display improved signal-to-noise ratios and are more focal on regulatory elements and CTCF sites, while strictly abiding to topologically associating domain restrictions."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27940490",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "Exploiting native forces to capture chromosome conformation in mammalian cell nuclei."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27940490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 152,
                    "text": "Mammalian interphase chromosomes fold into a multitude of loops to fit the confines of cell nuclei, and looping is tightly linked to regulated function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27940490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 672,
                    "offsetInEndSection": 777,
                    "text": "We apply i3C to intact nuclei of living cells and exploit native forces that stabilize chromatin folding."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24228087",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 126,
                    "text": "Engineered TAL-effector nucleases (TALENs) and TALE-based constructs have become powerful tools for eukaryotic genome editing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27940490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 290,
                    "offsetInEndSection": 385,
                    "text": "However, all 3C-based methods rely on chemical cross-linking to stabilize spatial interactions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27940490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 539,
                    "offsetInEndSection": 671,
                    "text": "To address these concerns, we developed \"i3C\", a novel approach for capturing spatial interactions without a need for cross-linking."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27940490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 386,
                    "offsetInEndSection": 538,
                    "text": "This step remains a \"black box\" as regards the biases it may introduce, and some discrepancies between microscopy and 3C studies have now been reported."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27940490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 153,
                    "offsetInEndSection": 289,
                    "text": "Chromosome conformation capture (3C) technology has significantly advanced our understanding of this structure-to-function relationship."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29118409",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 118,
                    "text": "Transcription activator-like effectors (TALEs) are DNA major-groove binding proteins widely used for genome targeting."
                }
            ]
        },
        {
            "body": "What is Paget's Disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/15389972",
                "http://www.ncbi.nlm.nih.gov/pubmed/16429324",
                "http://www.ncbi.nlm.nih.gov/pubmed/19181600",
                "http://www.ncbi.nlm.nih.gov/pubmed/18638386",
                "http://www.ncbi.nlm.nih.gov/pubmed/23929251",
                "http://www.ncbi.nlm.nih.gov/pubmed/10560346",
                "http://www.ncbi.nlm.nih.gov/pubmed/15377360",
                "http://www.ncbi.nlm.nih.gov/pubmed/19032921",
                "http://www.ncbi.nlm.nih.gov/pubmed/6254556",
                "http://www.ncbi.nlm.nih.gov/pubmed/15458537"
            ],
            "id": "5aa67b6ad6d6b54f79000010",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15389972",
                    "endSection": "abstract",
                    "offsetInBeginSection": 524,
                    "offsetInEndSection": 598,
                    "text": "Paget's disease is an autosomal dominant trait with genetic heterogeneity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16429324",
                    "endSection": "abstract",
                    "offsetInBeginSection": 195,
                    "offsetInEndSection": 269,
                    "text": "Paget's disease is an autosomal dominant trait with genetic heterogeneity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15389972",
                    "endSection": "abstract",
                    "offsetInBeginSection": 129,
                    "offsetInEndSection": 186,
                    "text": "Paget's disease is primarily a disease of the osteoclast."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16429324",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 123,
                    "text": "Paget's disease of bone is a chronic focal skeletal disorder characterized by increased bone resorption by the osteoclasts."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19181600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 46,
                    "text": "Paget's disease in the Far East is quite rare."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18638386",
                    "endSection": "abstract",
                    "offsetInBeginSection": 85,
                    "offsetInEndSection": 145,
                    "text": "Paget's disease of the skull is a relatively common disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23929251",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 140,
                    "text": "Paget's disease of the breast is a disorder of the nipple-areola complex that, while rare, is often associated with an underlying carcinoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10560346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 33,
                    "text": "Perianal Paget's disease is rare."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15389972",
                    "endSection": "abstract",
                    "offsetInBeginSection": 599,
                    "offsetInEndSection": 739,
                    "text": "Recurrent mutations in the ubiquitin-associated (UBA) domain of sequestosome 1 (SQSTM1/p62) are identified in patients with Paget's disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15389972",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 128,
                    "text": "Paget's disease of bone is a chronic focal skeletal disorder that affects up to 2-3% of the population over the age of 60 years."
                }
            ]
        },
        {
            "body": "What is the function of penicillinase, also known as beta lactamase?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                "http://www.ncbi.nlm.nih.gov/pubmed/5473897",
                "http://www.ncbi.nlm.nih.gov/pubmed/4985545",
                "http://www.ncbi.nlm.nih.gov/pubmed/2073111",
                "http://www.ncbi.nlm.nih.gov/pubmed/5328167",
                "http://www.ncbi.nlm.nih.gov/pubmed/11399858",
                "http://www.ncbi.nlm.nih.gov/pubmed/6803835",
                "http://www.ncbi.nlm.nih.gov/pubmed/1629597",
                "http://www.ncbi.nlm.nih.gov/pubmed/3877980",
                "http://www.ncbi.nlm.nih.gov/pubmed/6448580"
            ],
            "id": "5aae651ffcf456587200000d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                    "endSection": "abstract",
                    "offsetInBeginSection": 212,
                    "offsetInEndSection": 501,
                    "text": "In both cases, we have shown the simultaneous biosynthesis of two enzymes: an inducible and chromosome cephalosporinase frequently found in this germ, and a constitutive beta lactamase, with a penicillinase activity which has been identified with the extrachromosomic beta lactamase R-TEM."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 71,
                    "text": "[Identification of the beta lactamase R-TEM of Pseudomonas aeruginosa]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                    "endSection": "abstract",
                    "offsetInBeginSection": 502,
                    "offsetInEndSection": 766,
                    "text": "These two enzymes have been separated by affinity chromatography, characterized by their kinetic constants given by computerized microacidimetry, and their isoelectric points which are respectively 9.2 for the cephalosporinase and 5.40 for the penicillinase R-TEM."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                    "endSection": "abstract",
                    "offsetInBeginSection": 78,
                    "offsetInEndSection": 160,
                    "text": "aeruginosa resistant to classical beta lactam antibiotics including carbenicillin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                    "endSection": "abstract",
                    "offsetInBeginSection": 161,
                    "offsetInEndSection": 211,
                    "text": "These two strains hydrolyse all these antibiotics."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                    "endSection": "abstract",
                    "offsetInBeginSection": 767,
                    "offsetInEndSection": 836,
                    "text": "Isoelectric focussing also shows the separation of these two enzymes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 77,
                    "text": "This paper is dealing with the enzymatic problem raised by two strains of Ps."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/5473897",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1055,
                    "offsetInEndSection": 1221,
                    "text": "Although CBAP is not a true gratuitous inducer, operationally it approaches gratuity for induction of B. licheniformis penicillinase better than other known inducers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/5473897",
                    "endSection": "abstract",
                    "offsetInBeginSection": 621,
                    "offsetInEndSection": 784,
                    "text": "CBAP is hydrolyzed by the Bacillus penicillinase, but as indicated by its \"physiological efficiency\" (V(max)/K(m)), CBAP is a poor substrate at low concentrations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/4985545",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1169,
                    "offsetInEndSection": 1406,
                    "text": "Such derepression also occurs in a strain of B. cereus very sensitive to penicillin and in which both uninduced as well as \"spore-peptide\"-induced beta-lactamase is a small fraction of that produced by the typical penicillinase producer."
                }
            ]
        },
        {
            "body": "The common house cat, Felis silvestris catus and the domestic dog, Canis familiaris both belong to what taxonomic order?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26239911",
                "http://www.ncbi.nlm.nih.gov/pubmed/17727851",
                "http://www.ncbi.nlm.nih.gov/pubmed/15647367",
                "http://www.ncbi.nlm.nih.gov/pubmed/26969697",
                "http://www.ncbi.nlm.nih.gov/pubmed/19912613",
                "http://www.ncbi.nlm.nih.gov/pubmed/21658128",
                "http://www.ncbi.nlm.nih.gov/pubmed/551363",
                "http://www.ncbi.nlm.nih.gov/pubmed/27195685",
                "http://www.ncbi.nlm.nih.gov/pubmed/28343989",
                "http://www.ncbi.nlm.nih.gov/pubmed/2629770"
            ],
            "id": "5ab1483bfcf4565872000014",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26239911",
                    "endSection": "abstract",
                    "offsetInBeginSection": 346,
                    "offsetInEndSection": 628,
                    "text": "In this study, we show that the SVF is rich in immune cells, with a dominance of adipose tissue macrophages (ATMs) in cattle (Bos primigenius taurus), domestic goat (Capra aegagrus hircus), domestic sheep (Ovis aries), domestic cat (Felis catus) and domestic dog (Canis familiaris)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17727851",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 280,
                    "text": "The present study explored the feasibility of a hair cortisol assay in domestic cats (Felis silvestris catus) and dogs (Canis familiaris) as a valid and reliable alternative to existing non-invasive techniques for monitoring the hypothalamic-pituitary-adrenal (HPA) axis activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15647367",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 241,
                    "text": "The NMR structures of the recombinant cellular form of the prion proteins (PrPC) of the cat (Felis catus), dog (Canis familiaris), and pig (Sus scrofa), and of two polymorphic forms of the prion protein from sheep (Ovis aries) are presented."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26969697",
                    "endSection": "abstract",
                    "offsetInBeginSection": 687,
                    "offsetInEndSection": 1009,
                    "text": "A total of 68 coprosamples were collected from identified specimens from Vulpes vulpes, Canis lupus familiaris, Canis lupus, Felis silvestris catus, Meles meles, Martes foina, and Martes martes With DNA coprosamples, real-time PCR was performed in duplex with a qPCR inhibitor control specifically designed for this study."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19912613",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 136,
                    "text": "Serological survey for influenza type A viruses in domestic dogs (Canis lupus familiaris) and cats (Felis catus) in north-eastern Italy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21658128",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 109,
                    "text": "Domestic dogs (Canis familiaris) and cats (Felis catus) are the most abundant mammalian carnivores worldwide."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/551363",
                    "endSection": "abstract",
                    "offsetInBeginSection": 352,
                    "offsetInEndSection": 630,
                    "text": "The chief disseminators in 2 of these areas were found to be the dog (Canis familiaris) and the black-backed jackal (C. mesomelas); in the third area, the yellow mongoose (Cynictis penicillata), and in the fourth Genetta and Felis spp., including the domestic cat (Felis catis)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27195685",
                    "endSection": "abstract",
                    "offsetInBeginSection": 746,
                    "offsetInEndSection": 854,
                    "text": "Domestic dogs ( Canis familiaris ) and cats ( Felis catus ) may be sources of infection for these pathogens."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28343989",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 300,
                    "text": "Domestic cats (Felis silvestris catus) engage in a variety of relationships with humans and can be conditioned to engage in numerous behaviors using Pavlovian and operant methods Increasingly cat cognition research is providing evidence of their complex socio-cognitive and problem solving abilities."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2629770",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 298,
                    "text": "A serological study utilizing an indirect hemagglutination test (IHAT) for toxoplasmosis was carried out in 222 humans and in 58 domestic animals (31 dogs, Canis familiaris; 27 cats, Felis catus), and in 62 wild mammals distributed into 50 rabbits, Oryctolagus cuniculus and 12 goats, Capra hircus."
                }
            ]
        },
        {
            "body": "What is caused by the ectopic expression of CTCF?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28862757",
                "http://www.ncbi.nlm.nih.gov/pubmed/19369356",
                "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                "http://www.ncbi.nlm.nih.gov/pubmed/14980504",
                "http://www.ncbi.nlm.nih.gov/pubmed/21465478",
                "http://www.ncbi.nlm.nih.gov/pubmed/9591631",
                "http://www.ncbi.nlm.nih.gov/pubmed/28161276",
                "http://www.ncbi.nlm.nih.gov/pubmed/28137913",
                "http://www.ncbi.nlm.nih.gov/pubmed/27613698",
                "http://www.ncbi.nlm.nih.gov/pubmed/26268681"
            ],
            "id": "5abcf6b9fcf4565872000027",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28862757",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1014,
                    "offsetInEndSection": 1228,
                    "text": "Depletion of CTCF resulted in reduced motility and invasiveness in HCC cells that could be reversed by ectopic expression of FOXM1, suggesting that FOXM1 is one of the important downstream effectors of CTCF in HCC."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19369356",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1173,
                    "offsetInEndSection": 1405,
                    "text": "Ectopic expression of Rad21 repressed CTCF-regulated transcription of KSHV lytic genes, and a Rad21-CTCF chimeric protein converted CTCF into an efficient transcriptional repressor of KSHV genes normally activated in the G(2) phase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                    "endSection": "abstract",
                    "offsetInBeginSection": 506,
                    "offsetInEndSection": 655,
                    "text": "Here we show that ectopic expression of CTCF in many cell types inhibits cell clonogenicity by causing profound growth retardation without apoptosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14980504",
                    "endSection": "abstract",
                    "offsetInBeginSection": 213,
                    "offsetInEndSection": 381,
                    "text": "Ectopic expression of CTCF results in severe cell growth inhibition at multiple points within the cell cycle, indicating that CTCF levels must be stringently monitored."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21465478",
                    "endSection": "abstract",
                    "offsetInBeginSection": 120,
                    "offsetInEndSection": 310,
                    "text": "Ectopic expression of CTCF in various normal and tumoral human cell lines inhibits cell division and clonogenicity, with the consequence to consider CTCF a potential tumor-suppressor factor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9591631",
                    "endSection": "abstract",
                    "offsetInBeginSection": 852,
                    "offsetInEndSection": 920,
                    "text": "Enforced ectopic expression of CTCF inhibits cell growth in culture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28161276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 903,
                    "offsetInEndSection": 1056,
                    "text": "The role of GATA-1 in interaction between CTCF sites was revealed by its ectopic expression in 293 cells and by deletion of a GATA-1 site in the LCR HS2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28862757",
                    "endSection": "abstract",
                    "offsetInBeginSection": 547,
                    "offsetInEndSection": 896,
                    "text": "Short hairpin RNA (shRNA)-mediated suppression of CTCF inhibited cell proliferation, motility and invasiveness in HCC cell lines; these effects were correlated with prominent reductions in the expression of telomerase reverse transcriptase (TERT), the shelterin complex member telomerase repeat-binding factor 1, and forkhead box protein M1 (FOXM1)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28137913",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "Chromatin Domain Organization of the TCRb Locus and Its Perturbation by Ectopic CTCF Binding."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                    "endSection": "abstract",
                    "offsetInBeginSection": 832,
                    "offsetInEndSection": 929,
                    "text": "Although conditionally induced CTCF caused the S-phase block, CTCF can also arrest cell division."
                }
            ]
        },
        {
            "body": "What is the dardarin protein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16115731",
                "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                "http://www.ncbi.nlm.nih.gov/pubmed/17394548",
                "http://www.ncbi.nlm.nih.gov/pubmed/16280683",
                "http://www.ncbi.nlm.nih.gov/pubmed/17622782",
                "http://www.ncbi.nlm.nih.gov/pubmed/18213618",
                "http://www.ncbi.nlm.nih.gov/pubmed/16026116",
                "http://www.ncbi.nlm.nih.gov/pubmed/22988875",
                "http://www.ncbi.nlm.nih.gov/pubmed/16102903",
                "http://www.ncbi.nlm.nih.gov/pubmed/16149095"
            ],
            "id": "5ac0fccf19833b0d7b000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16115731",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 166,
                    "text": "Mutations in the leucine-rich repeat kinase 2 (LRRK 2), encoding dardarin protein, have been demonstrated to be linked to autosomal dominant Parkinson's disease (PD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 103,
                    "offsetInEndSection": 204,
                    "text": "Dardarin is a large protein, and mutations are found throughout the gene including the kinase domain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 102,
                    "text": "Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson's disease (PD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17394548",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 178,
                    "text": "Several mutations have been found in the leucine-rich repeat kinase 2 gene (LRRK2), encoding the protein dardarin, which are associated with autosomal dominant Parkinson disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 858,
                    "offsetInEndSection": 1000,
                    "text": "We also show that dardarin protein is expressed within human midbrain neurons and that C-terminal epitopes are also found in some Lewy bodies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16280683",
                    "endSection": "abstract",
                    "offsetInBeginSection": 971,
                    "offsetInEndSection": 1049,
                    "text": "The protein product was named dardarin and contains GTPase and kinase domains."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17622782",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "BACKGROUND\nRecently, mutations in LRRK2 encoding the protein dardarin have been linked to an autosomal dominant form of parkinsonism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18213618",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 105,
                    "text": "Mutation of LRRK2, encoding dardarin, is the most common known genetic cause of Parkinson's disease (PD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 393,
                    "offsetInEndSection": 480,
                    "text": "First, pathogenic mutations increase the tendency of dardarin to form inclusion bodies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17394548",
                    "endSection": "abstract",
                    "offsetInBeginSection": 634,
                    "offsetInEndSection": 784,
                    "text": "We show that mutations in dardarin are more prone to form inclusion bodies in transfected cells and are more toxic than equivalent mutations in LRRK1."
                }
            ]
        },
        {
            "body": "In which syndrome is the RPS19 gene most frequently mutated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21223253",
                "http://www.ncbi.nlm.nih.gov/pubmed/23990987",
                "http://www.ncbi.nlm.nih.gov/pubmed/17053056",
                "http://www.ncbi.nlm.nih.gov/pubmed/21435505",
                "http://www.ncbi.nlm.nih.gov/pubmed/21989989",
                "http://www.ncbi.nlm.nih.gov/pubmed/18515656",
                "http://www.ncbi.nlm.nih.gov/pubmed/24675553",
                "http://www.ncbi.nlm.nih.gov/pubmed/26447946",
                "http://www.ncbi.nlm.nih.gov/pubmed/12586610",
                "http://www.ncbi.nlm.nih.gov/pubmed/22689679"
            ],
            "id": "5a896c26fcd1d6a10c000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21223253",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 231,
                    "text": "The ribosomal protein S19 gene (RPS19) is the most frequently mutated gene in DBA (~25%)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23990987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 163,
                    "offsetInEndSection": 309,
                    "text": "It has been proven that defects of ribosomal proteins can lead to this disease and that RPS19 is the most frequently mutated gene in DBA patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17053056",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 140,
                    "text": "The gene encoding the ribosomal protein S19 (RPS19) is frequently mutated in Diamond-Blackfan anemia (DBA), a congenital erythroblastopenia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21435505",
                    "endSection": "abstract",
                    "offsetInBeginSection": 481,
                    "offsetInEndSection": 649,
                    "text": "Extensive study of the most frequently mutated gene, RPS19, has shown that mutations prevent the assembly of the ribosomal protein into forming pre-ribosomal particles."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21989989",
                    "endSection": "abstract",
                    "offsetInBeginSection": 151,
                    "offsetInEndSection": 227,
                    "text": "Among these genes, ribosomal protein S19 (RPS19) is mutated most frequently."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18515656",
                    "endSection": "abstract",
                    "offsetInBeginSection": 196,
                    "offsetInEndSection": 243,
                    "text": "RPS19 is the most frequently mutated RP in DBA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24675553",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1357,
                    "offsetInEndSection": 1422,
                    "text": "Among these patients, RPS19 was the most frequently mutated gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26447946",
                    "endSection": "abstract",
                    "offsetInBeginSection": 298,
                    "offsetInEndSection": 525,
                    "text": "By applying EMSA and ChIP methodologies in mouse erythroleukemia cells we show that GATA1 and PU.1 bind in vitro and in vivo the proximal promoter region of the RPS19 gene which is frequently mutated in Diamond-Blackfan Anemia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12586610",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 123,
                    "text": "Ribosomal protein S19 (RPS19) is frequently mutated in Diamond-Blackfan anemia (DBA), a rare congenital hypoplastic anemia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21223253",
                    "endSection": "abstract",
                    "offsetInBeginSection": 232,
                    "offsetInEndSection": 471,
                    "text": "TP53-mediated cell cycle arrest and/or apoptosis in erythroid cells have been suggested to be major factors for DBA development, but it is not clear why mutations in the ubiquitously expressed RPS19 gene specifically affect erythropoiesis."
                }
            ]
        },
        {
            "body": "What type of sequences do enhancers evolve from?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21593416",
                "http://www.ncbi.nlm.nih.gov/pubmed/28760812",
                "http://www.ncbi.nlm.nih.gov/pubmed/19913403",
                "http://www.ncbi.nlm.nih.gov/pubmed/2134678",
                "http://www.ncbi.nlm.nih.gov/pubmed/15014138",
                "http://www.ncbi.nlm.nih.gov/pubmed/25956793",
                "http://www.ncbi.nlm.nih.gov/pubmed/20660939",
                "http://www.ncbi.nlm.nih.gov/pubmed/24723612",
                "http://www.ncbi.nlm.nih.gov/pubmed/23805311",
                "http://www.ncbi.nlm.nih.gov/pubmed/16612545"
            ],
            "id": "5ac37afc0340b9f058000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21593416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1283,
                    "offsetInEndSection": 1474,
                    "text": "We suggest that the novel optic lobe enhancer evolved by exploiting the cryptic activity of extant regulatory sequences, and this may reflect a general mechanism whereby new enhancers evolve."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28760812",
                    "endSection": "abstract",
                    "offsetInBeginSection": 93,
                    "offsetInEndSection": 339,
                    "text": "Although many studies have elucidated how individual enhancers can evolve, most of this work has focused on what are called 'minimal' enhancers, the smallest DNA regions that drive expression that approximates an aspect of native gene expression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19913403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 378,
                    "offsetInEndSection": 488,
                    "text": "Many examples show that enhancers can evolve beyond recognizable sequence similarity while retaining function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2134678",
                    "endSection": "abstract",
                    "offsetInBeginSection": 811,
                    "offsetInEndSection": 923,
                    "text": "These findings suggest that new and more efficient enhancers evolve by a combination of basic enhancer elements."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21593416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 90,
                    "offsetInEndSection": 242,
                    "text": "However, the evolutionary origins of novel expression patterns, and the transcriptional control elements (\"enhancers\") that govern them, remain unclear."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28760812",
                    "endSection": "abstract",
                    "offsetInBeginSection": 931,
                    "offsetInEndSection": 1126,
                    "text": "Our results illustrate how sequences outside of minimal enhancer regions can evolve functionally through mechanisms other than changes in transcription factor-binding sites that drive patterning."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21593416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 243,
                    "offsetInEndSection": 332,
                    "text": "Here, we sought to explore the molecular genetic mechanisms by which new enhancers arise."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15014138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 877,
                    "offsetInEndSection": 1010,
                    "text": "The starting sequences considered are either real enhancers from the Drosophila melanogaster genome, or randomized versions of these."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21593416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1169,
                    "offsetInEndSection": 1282,
                    "text": "The Nep1 optic lobe enhancer overlaps with other enhancer activities, from which the novel activity was co-opted."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21593416",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "Evolutionary origin of a novel gene expression pattern through co-option of the latent activities of existing regulatory sequences."
                }
            ]
        },
        {
            "body": "What nerve is involved in carpal tunnel syndrome?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/8077810",
                "http://www.ncbi.nlm.nih.gov/pubmed/15521353",
                "http://www.ncbi.nlm.nih.gov/pubmed/19280893",
                "http://www.ncbi.nlm.nih.gov/pubmed/25630774",
                "http://www.ncbi.nlm.nih.gov/pubmed/29199603",
                "http://www.ncbi.nlm.nih.gov/pubmed/8732402",
                "http://www.ncbi.nlm.nih.gov/pubmed/6642310",
                "http://www.ncbi.nlm.nih.gov/pubmed/9283839",
                "http://www.ncbi.nlm.nih.gov/pubmed/21812236",
                "http://www.ncbi.nlm.nih.gov/pubmed/21845587"
            ],
            "id": "5abcf010fcf4565872000023",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8077810",
                    "endSection": "abstract",
                    "offsetInBeginSection": 121,
                    "offsetInEndSection": 186,
                    "text": "Nerve abscess as a cause of acute carpal tunnel syndrome is rare."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15521353",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 80,
                    "text": "Carpal tunnel syndrome is the most common peripheral nerve compression syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19280893",
                    "endSection": "abstract",
                    "offsetInBeginSection": 162,
                    "offsetInEndSection": 248,
                    "text": "Carpal tunnel syndrome is the most frequently encountered peripheral nerve entrapment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8077810",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 120,
                    "text": "Two cases of acute carpal tunnel syndrome due to median nerve abscess as a consequence of Hansen's disease are reported."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25630774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "Carpal tunnel syndrome (CTS) is the most common median nerve neuropathy, accounting for 90% of all neuropathies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29199603",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 126,
                    "text": "Carpal tunnel syndrome is a neuropathy of the median nerve at the wrist, and represents the most common peripheral neuropathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8732402",
                    "endSection": "abstract",
                    "offsetInBeginSection": 263,
                    "offsetInEndSection": 379,
                    "text": "Steroid injection for carpal tunnel syndrome is generally safe but nerve injury may occur and is difficult to treat."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6642310",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 87,
                    "text": "Carpal tunnel syndrome is a result of median nerve compression within the carpal canal."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9283839",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "Compression neuropathy of the median nerve (carpal tunnel syndrome) is the most common nerve compression syndrome of the extremities."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21812236",
                    "endSection": "abstract",
                    "offsetInBeginSection": 299,
                    "offsetInEndSection": 380,
                    "text": "Carpal tunnel syndrome is caused by compression of the median nerve at the wrist."
                }
            ]
        },
        {
            "body": "What is the function of LOX proteins in the ECM?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                "http://www.ncbi.nlm.nih.gov/pubmed/16085123",
                "http://www.ncbi.nlm.nih.gov/pubmed/25875748",
                "http://www.ncbi.nlm.nih.gov/pubmed/25146937",
                "http://www.ncbi.nlm.nih.gov/pubmed/28273952",
                "http://www.ncbi.nlm.nih.gov/pubmed/11499844",
                "http://www.ncbi.nlm.nih.gov/pubmed/24739883",
                "http://www.ncbi.nlm.nih.gov/pubmed/26055407",
                "http://www.ncbi.nlm.nih.gov/pubmed/28428687",
                "http://www.ncbi.nlm.nih.gov/pubmed/25111273"
            ],
            "id": "5ad243e30340b9f058000016",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 404,
                    "offsetInEndSection": 645,
                    "text": "While the catalytic function of LOX is essential for cross-linking of ECM proteins, we also reported that LOX induced invasive and metastatic properties in breast tumour epithelial cells through hydrogen peroxide-mediated FAK/Src activation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 244,
                    "offsetInEndSection": 403,
                    "text": "We have recently reported the ECM enzyme, lysyl oxidase (LOX), in the central nervous system and observed up-regulation of LOX in anaplastic astrocytoma cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16085123",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 228,
                    "text": "Lysyl oxidase (LOX) is a copper- and lysyl-tyrosyl cofactor containing amine oxidase that has been known to play a critical role in the catalysis of lysine-derived crosslinks in extracellular matrix (ECM) proteins in the dermis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25875748",
                    "endSection": "abstract",
                    "offsetInBeginSection": 153,
                    "offsetInEndSection": 275,
                    "text": "Concurrent with remodeling is the induction of the enzyme lysyl oxidase (LOX) through which ECM proteins are cross-linked."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 951,
                    "offsetInEndSection": 1190,
                    "text": "Immunohistochemistry detected increased LOX within tumour cells and ECM in grade I-IV astrocytic neoplasm compared with normal brain and coincidence of increased LOX with the loss of glial fibrillary acidic protein in higher-grade tumours."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25146937",
                    "endSection": "abstract",
                    "offsetInBeginSection": 154,
                    "offsetInEndSection": 285,
                    "text": "LOXL2 is proposed to function similarly to LOX in the extracellular matrix (ECM) by promoting crosslinking of collagen and elastin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28273952",
                    "endSection": "abstract",
                    "offsetInBeginSection": 136,
                    "offsetInEndSection": 285,
                    "text": "Lysyl oxidase (LOX) and LOX-like (LOXL) proteins play crucial roles in ECM remodeling due to their collagen crosslinking and intracellular functions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11499844",
                    "endSection": "abstract",
                    "offsetInBeginSection": 170,
                    "offsetInEndSection": 377,
                    "text": "Because lysyl oxidase (LOX) is the main collagen cross-linking enzyme that might account for irreversible fibrosis, its expression was studied together with expression of extracellular matrix (ECM) proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24739883",
                    "endSection": "abstract",
                    "offsetInBeginSection": 665,
                    "offsetInEndSection": 805,
                    "text": "LPS induced EC inflammatory activation accompanied by expression of ECM proteins, increase in LOX activity, and activation of Rho signaling."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26055407",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1401,
                    "offsetInEndSection": 1557,
                    "text": "Compared with 2D cell culture, expression of ECM genes and proteins, including COL1A1, LOX, SED1, FN1, and LAMA4, was significantly increased in 3D culture."
                }
            ]
        },
        {
            "body": "Please list 3 diseases treated with Valtrex(valacyclovir)",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/10116128",
                "http://www.ncbi.nlm.nih.gov/pubmed/2398994",
                "http://www.ncbi.nlm.nih.gov/pubmed/7851626",
                "http://www.ncbi.nlm.nih.gov/pubmed/19650351",
                "http://www.ncbi.nlm.nih.gov/pubmed/26922949",
                "http://www.ncbi.nlm.nih.gov/pubmed/20441121",
                "http://www.ncbi.nlm.nih.gov/pubmed/2587453",
                "http://www.ncbi.nlm.nih.gov/pubmed/2488036",
                "http://www.ncbi.nlm.nih.gov/pubmed/28089147",
                "http://www.ncbi.nlm.nih.gov/pubmed/19841603"
            ],
            "id": "5abcf755fcf4565872000028",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10116128",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 30,
                    "text": "Managing diversity--resources."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2398994",
                    "endSection": "abstract",
                    "offsetInBeginSection": 897,
                    "offsetInEndSection": 899,
                    "text": "B."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2398994",
                    "endSection": "abstract",
                    "offsetInBeginSection": 104,
                    "offsetInEndSection": 106,
                    "text": "2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2398994",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 2,
                    "text": "1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7851626",
                    "endSection": "abstract",
                    "offsetInBeginSection": 196,
                    "offsetInEndSection": 198,
                    "text": "2."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19650351",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 62,
                    "text": "Ataxias with autosomal, X-chromosomal or maternal inheritance."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7851626",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 2,
                    "text": "1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10116128",
                    "endSection": "abstract",
                    "offsetInBeginSection": 212,
                    "offsetInEndSection": 400,
                    "text": "If you know of additional resources to help hospitals in managing diversity, please let us know by writing to: Editor, Healthcare Forum Journal, 830 Market Street, San Francisco, CA 94102."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2398994",
                    "endSection": "abstract",
                    "offsetInBeginSection": 255,
                    "offsetInEndSection": 257,
                    "text": "3."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2398994",
                    "endSection": "abstract",
                    "offsetInBeginSection": 377,
                    "offsetInEndSection": 379,
                    "text": "4."
                }
            ]
        },
        {
            "body": "Which olfactory gene senses androsterone?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16533495",
                "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                "http://www.ncbi.nlm.nih.gov/pubmed/1737068",
                "http://www.ncbi.nlm.nih.gov/pubmed/23721465",
                "http://www.ncbi.nlm.nih.gov/pubmed/28443000",
                "http://www.ncbi.nlm.nih.gov/pubmed/18808328",
                "http://www.ncbi.nlm.nih.gov/pubmed/9642779",
                "http://www.ncbi.nlm.nih.gov/pubmed/9462465",
                "http://www.ncbi.nlm.nih.gov/pubmed/11274669",
                "http://www.ncbi.nlm.nih.gov/pubmed/24653035"
            ],
            "id": "5ace17c30340b9f058000009",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16533495",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 177,
                    "text": "Designing products to satisfy customers' emotion requires the information gathered through the human senses, which are visual, auditory, olfactory, gustatory, or tactile senses."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "The nuclear hormone receptor farnesoid X receptor (FXR) is activated by androsterone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                    "endSection": "abstract",
                    "offsetInBeginSection": 166,
                    "offsetInEndSection": 291,
                    "text": "Treatment of castrated male mice with androsterone induced expression of the FXR target gene small heterodimer partner (SHP)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1737068",
                    "endSection": "abstract",
                    "offsetInBeginSection": 623,
                    "offsetInEndSection": 891,
                    "text": "Genomic DNA amplifications with synthetic primers which have nucleotide sequences corresponding to the 5'-region of androsterone UDPGT cDNA, suggested that androsterone UDPGT gene has exon 1 with a length of some 700 bp and that this exon is deleted in LA Wistar rats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23721465",
                    "endSection": "abstract",
                    "offsetInBeginSection": 799,
                    "offsetInEndSection": 1046,
                    "text": "However, the nonsynonymous-to-synonymous substitution rate ratio was relatively higher between orthologous OR genes of L. frontalis and L. colubrina, indicating that L. frontalis and L. colubrina have evolved to possess different olfactory senses."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                    "endSection": "abstract",
                    "offsetInBeginSection": 66,
                    "offsetInEndSection": 165,
                    "text": "Here, we demonstrate that androsterone, a metabolic product of testosterone, is also an FXR ligand."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1737068",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 113,
                    "text": "Large deletion of androsterone UDP-glucuronosyltransferase gene in the inherited deficient strain of Wistar rats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28443000",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 257,
                    "text": "Although the olfactory sense has always been considered with less interest than the visual, auditive or somatic senses, it does plays a major role in our ordinary life, with important implication in dangerous situations or in social and emotional behaviors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18808328",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 175,
                    "text": "The mammalian olfactory system senses an almost unlimited number of chemical stimuli and initiates a process of neural recognition that influences nearly every aspect of life."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                    "endSection": "abstract",
                    "offsetInBeginSection": 516,
                    "offsetInEndSection": 769,
                    "text": "Nuclear magnetic resonance spectroscopy demonstrated the direct binding of androsterone to purified human FXR (hFXR) ligand-binding domain (LBD) protein, resulting in the recruitment of steroid receptor coactivator protein-1 (SRC-1) coactivator peptide."
                }
            ]
        },
        {
            "body": "Where in the body would the navicular bone be found?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27588043",
                "http://www.ncbi.nlm.nih.gov/pubmed/28099198",
                "http://www.ncbi.nlm.nih.gov/pubmed/25787097",
                "http://www.ncbi.nlm.nih.gov/pubmed/13679748",
                "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                "http://www.ncbi.nlm.nih.gov/pubmed/27061802",
                "http://www.ncbi.nlm.nih.gov/pubmed/24705744",
                "http://www.ncbi.nlm.nih.gov/pubmed/25210293",
                "http://www.ncbi.nlm.nih.gov/pubmed/28713611",
                "http://www.ncbi.nlm.nih.gov/pubmed/27299135"
            ],
            "id": "5abd13e1fcf4565872000029",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27588043",
                    "endSection": "abstract",
                    "offsetInBeginSection": 239,
                    "offsetInEndSection": 444,
                    "text": "We hypothesized that a combined pMRI measure incorporating both vertical and medial displacement of the navicular bone induced by loading would be correlated with corresponding stretch sensor measurements."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28099198",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 77,
                    "text": "Osteomyelitis of the accessory and body of the navicular bone: a case report."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25787097",
                    "endSection": "abstract",
                    "offsetInBeginSection": 583,
                    "offsetInEndSection": 762,
                    "text": "We believe that in cases where cerebral palsy patients with paralytic equinus complain of foot pain, the possibility of stress fracture of the navicular bone should be considered."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28099198",
                    "endSection": "abstract",
                    "offsetInBeginSection": 523,
                    "offsetInEndSection": 721,
                    "text": "Both an accessory navicular and the body of the navicular bone may develop osteomyelitis in immunocompromised patients; early diagnosis is important for prescribing effective conservative treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28099198",
                    "endSection": "abstract",
                    "offsetInBeginSection": 155,
                    "offsetInEndSection": 254,
                    "text": "He was admitted to our hospital with osteomyelitis of the accessory and body of the navicular bone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27588043",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1380,
                    "offsetInEndSection": 1745,
                    "text": "Although assessment of total navicular displacement by combining concomitant vertical and medial navicular bone movements would appear advantageous compared to monoplanar measurement the combined measure did not seem to predict dynamic changes of the medial foot arch during walking, which are among several possible factors depending on different walking patterns."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/13679748",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 73,
                    "text": "[Osteoid osteoma of the tarsal navicular bone: an uncommon localization]."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 87,
                    "text": "Fractures of the body of the tarsal navicular bone: case reports and literature review."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27061802",
                    "endSection": "abstract",
                    "offsetInBeginSection": 440,
                    "offsetInEndSection": 631,
                    "text": "This study is furthermore aiming at a clearer and earlier recognition of navicular bone partition, since this condition would finally predispose for a clinical lameness with a poor prognosis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25787097",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 86,
                    "text": "Stress fracture of the navicular bone in a patient with cerebral palsy: a case report."
                }
            ]
        },
        {
            "body": "Name an lncRNA associated with dilated cardiomyopathy.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26141701",
                "http://www.ncbi.nlm.nih.gov/pubmed/28430627",
                "http://www.ncbi.nlm.nih.gov/pubmed/14660611",
                "http://www.ncbi.nlm.nih.gov/pubmed/21709571",
                "http://www.ncbi.nlm.nih.gov/pubmed/8644625",
                "http://www.ncbi.nlm.nih.gov/pubmed/25119045",
                "http://www.ncbi.nlm.nih.gov/pubmed/15991472",
                "http://www.ncbi.nlm.nih.gov/pubmed/25834770",
                "http://www.ncbi.nlm.nih.gov/pubmed/2093724",
                "http://www.ncbi.nlm.nih.gov/pubmed/17010801"
            ],
            "id": "5ac716810340b9f058000003",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26141701",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 97,
                    "text": "Microarray profiling of long non-coding RNA (lncRNA) associated with hypertrophic cardiomyopathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28430627",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 197,
                    "text": "In the previous study, we generated a rat model of dilated cardiomyopathy (DCM) induced by adriamycin and found that the expression of lncRNA H19 was significantly upregulated in myocardial tissue."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28430627",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 87,
                    "text": "The long non-coding RNA H19 promotes cardiomyocyte apoptosis in dilated cardiomyopathy."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14660611",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "A Cypher/ZASP mutation associated with dilated cardiomyopathy alters the binding affinity to protein kinase C."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26141701",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 195,
                    "text": "BACKGROUND\nHypertrophic cardiomyopathy (HCM) is an inherited disorder with around 1400 known mutations; however the molecular pathways leading from genotype to phenotype are not fully understood."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21709571",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 97,
                    "text": "HLA-DRB1 gene polymorphism is associated with idiopathic dilated cardiomyopathy: a meta-analysis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26141701",
                    "endSection": "abstract",
                    "offsetInBeginSection": 521,
                    "offsetInEndSection": 707,
                    "text": "METHODS\nMyocardial tissues were obtained from 7 HCM patients and 5 healthy individuals, and lncRNA and mRNA expression profiles were analyzed using the Arraystar human lncRNA microarray."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26141701",
                    "endSection": "abstract",
                    "offsetInBeginSection": 708,
                    "offsetInEndSection": 790,
                    "text": "Real-time PCR was conducted to validate the expression pattern of lncRNA and mRNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8644625",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 219,
                    "text": "Homozygosity for the deletion allele of the angiotensin-converting enzyme gene (DD) has been associated with a variety of cardiovascular diseases, including ischemic and idiopathic dilated cardiomyopathy, in Caucasians."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25119045",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1662,
                    "offsetInEndSection": 1823,
                    "text": "Human MHRT also originates from MYH7 loci and is repressed in various types of myopathic hearts, suggesting a conserved lncRNA mechanism in human cardiomyopathy."
                }
            ]
        },
        {
            "body": "Which gene is responsible for red hair?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28024137",
                "http://www.ncbi.nlm.nih.gov/pubmed/20046591",
                "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                "http://www.ncbi.nlm.nih.gov/pubmed/16704453",
                "http://www.ncbi.nlm.nih.gov/pubmed/9302268",
                "http://www.ncbi.nlm.nih.gov/pubmed/11689486",
                "http://www.ncbi.nlm.nih.gov/pubmed/10958658",
                "http://www.ncbi.nlm.nih.gov/pubmed/23860522",
                "http://www.ncbi.nlm.nih.gov/pubmed/8354355",
                "http://www.ncbi.nlm.nih.gov/pubmed/19571053"
            ],
            "id": "5ace19420340b9f05800000a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28024137",
                    "endSection": "abstract",
                    "offsetInBeginSection": 115,
                    "offsetInEndSection": 190,
                    "text": "A specific variant of MC1R gene (R allele) is responsible for the red hair."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20046591",
                    "endSection": "abstract",
                    "offsetInBeginSection": 367,
                    "offsetInEndSection": 511,
                    "text": "Recently, mutations in P2RY5 gene, encoding a G-protein coupled receptor, have been shown to be responsible for autosomal recessive woolly hair."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                    "endSection": "abstract",
                    "offsetInBeginSection": 841,
                    "offsetInEndSection": 1114,
                    "text": "Mutations in the P gene were responsible for classic phenotype of oculocutaneous albinism type 2 (OCA2) in all eight, and mutations in the MC1R gene were responsible for the red (rather than yellow/blond) hair in the six of eight who continued to have red hair after birth."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16704453",
                    "endSection": "abstract",
                    "offsetInBeginSection": 156,
                    "offsetInEndSection": 441,
                    "text": "In humans, loss-of-function MC1R mutations cause fair skin, freckling, red hair, and increased predisposition to melanoma; in mice, Mc1r loss-of-function is responsible for the recessive yellow mutation, associated with pheomelanic hair and a decreased number of epidermal melanocytes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9302268",
                    "endSection": "abstract",
                    "offsetInBeginSection": 677,
                    "offsetInEndSection": 987,
                    "text": "However, comparison of the MSHR genotypes in dizygotic twin pairs discordant for red hair colour indicates that the MSHR gene cannot be solely responsible for the red hair phenotype, since five of 13 pairs tested had both haplotypes identical by state (with three of the five having both identical by descent)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11689486",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "Red hair in humans is associated with variant alleles of the alphaMSH receptor gene, MC1R."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10958658",
                    "endSection": "abstract",
                    "offsetInBeginSection": 563,
                    "offsetInEndSection": 869,
                    "text": "In this report, we show that the phenotype of the circler mutant, mariner, is due to mutations in the gene encoding Myosin VIIA, an unconventional myosin which is expressed in sensory hair cells and is responsible for various types of hearing disorder in humans, namely Usher 1B syndrome, DFNB2 and DFNA11."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9302268",
                    "endSection": "abstract",
                    "offsetInBeginSection": 988,
                    "offsetInEndSection": 1141,
                    "text": "Rather, it is likely that additional modifier genes exist, making variance in the MSHR gene necessary but not always sufficient, for red hair production."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23860522",
                    "endSection": "abstract",
                    "offsetInBeginSection": 853,
                    "offsetInEndSection": 1014,
                    "text": "CONCLUSION\nThe red hair phenotype, which results from polymorphisms in the melanocortin-1-receptor (MC1R) gene, is associated with lower risk of prostate cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                    "endSection": "abstract",
                    "offsetInBeginSection": 628,
                    "offsetInEndSection": 775,
                    "text": "Sequence variation in the melanocortin-1 receptor (MC1R) gene is associated with red hair in the normal population, but red hair is unusual in OCA."
                }
            ]
        },
        {
            "body": "Which bacteria was EcoRI, restriction endonuclease isolated from?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/2992974",
                "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                "http://www.ncbi.nlm.nih.gov/pubmed/9653552",
                "http://www.ncbi.nlm.nih.gov/pubmed/8370544",
                "http://www.ncbi.nlm.nih.gov/pubmed/8246264",
                "http://www.ncbi.nlm.nih.gov/pubmed/2695392",
                "http://www.ncbi.nlm.nih.gov/pubmed/3029579",
                "http://www.ncbi.nlm.nih.gov/pubmed/486086",
                "http://www.ncbi.nlm.nih.gov/pubmed/6273907",
                "http://www.ncbi.nlm.nih.gov/pubmed/3025706"
            ],
            "id": "5abd5a62fcf4565872000031",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2992974",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 149,
                    "text": "Purified restriction endonuclease EcoRI isolated from Escherichia coli BS 5 was used for the production of enzyme-specific IgG antibodies in rabbits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                    "endSection": "abstract",
                    "offsetInBeginSection": 95,
                    "offsetInEndSection": 379,
                    "text": "Such bacterial cells fail to express restriction or modification functions in vivo, and phage or plasmid DNA obtained from ColE1-containing cells has unmodified EcoRI sites that are cleaved in vitro by purified EcoRI endonuclease or by enzyme extracted from bacteria that carry ColE1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9653552",
                    "endSection": "abstract",
                    "offsetInBeginSection": 218,
                    "offsetInEndSection": 330,
                    "text": "EcoRI is a homodimeric restriction endonuclease, the dimeric interface of which consists of a four-helix bundle."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9653552",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 89,
                    "text": "Inhibiting the dimeric restriction endonuclease EcoRI using interfacial helical peptides."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 94,
                    "text": "An endonuclease having EcoRI specificity is produced by bacteria containing the ColE1 plasmid."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2992974",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 103,
                    "text": "Immunoelectron microscopic localization of the restriction endonuclease EcoRI in Escherichia coli BS 5."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8370544",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 125,
                    "text": "A new restriction endonuclease, TspEI, from the genus Thermus that generates cohesive termini compatible with those of EcoRI."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8246264",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 407,
                    "text": "High-level mupirocin resistance in coagulase-negative staphylococci isolated from patients undergoing peritoneal dialysis was investigated by transfer of the resistance determinants, usually in the form of a plasmid, to Staphylococcus aureus strains, cleavage of the plasmid by restriction endonuclease and hybridisation with a probe comprising a 4.05 kb EcoRI fragment of a plasmid from a S. aureus strain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2695392",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 138,
                    "text": "The RsrI endonuclease, a type-II restriction endonuclease (ENase) found in Rhodobacter sphaeroides, is an isoschizomer of the EcoRI ENase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3029579",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 237,
                    "text": "The localization of KpnI, SacI, XhoI, AvaI, PstI, BglI, BamHI, EcoRI, PmiI, SalI, BglII, restriction endonuclease cleavage sites in HindIII-F-fragments of DNA from vaccinia strains WR, Copenhagen, LIVP and neurovaccine has been detected."
                }
            ]
        },
        {
            "body": "Which is the main reason for the increase in the incidence of cryptococcal disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16034947",
                "http://www.ncbi.nlm.nih.gov/pubmed/25605772",
                "http://www.ncbi.nlm.nih.gov/pubmed/24052889",
                "http://www.ncbi.nlm.nih.gov/pubmed/14617302",
                "http://www.ncbi.nlm.nih.gov/pubmed/16011530",
                "http://www.ncbi.nlm.nih.gov/pubmed/9827275",
                "http://www.ncbi.nlm.nih.gov/pubmed/27187754",
                "http://www.ncbi.nlm.nih.gov/pubmed/11428412",
                "http://www.ncbi.nlm.nih.gov/pubmed/19245939",
                "http://www.ncbi.nlm.nih.gov/pubmed/2345321"
            ],
            "id": "5ace37d50340b9f058000011",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16034947",
                    "endSection": "abstract",
                    "offsetInBeginSection": 3331,
                    "offsetInEndSection": 3522,
                    "text": "AUTHORS' CONCLUSIONS\nAntifungal primary prophylaxis with either itraconazole or fluconazole is effective in reducing the incidence of cryptococcal disease in adults with advanced HIV disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25605772",
                    "endSection": "abstract",
                    "offsetInBeginSection": 521,
                    "offsetInEndSection": 819,
                    "text": "Phospholipase B1 is a phospholipid-modifying enzyme that has been implicated in multiple stages of cryptococcal pathogenesis, including initiation and persistence of pulmonary infection and dissemination to the central nervous system, but the underlying reason for these phenotypes remains unknown."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16034947",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2975,
                    "offsetInEndSection": 3328,
                    "text": "When the two studies using fluconazole as the intervention were analyzed together (N=518), the incidence of cryptococcal disease was decreased in those taking fluconazole for primary prophylaxis (RR 0.25, 95% CI 0.07, 0.87) compared to those taking placebo; however, there was no significant difference in overall mortality (RR 0.59, 95% CI 0.14, 2.62)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16034947",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2617,
                    "offsetInEndSection": 2974,
                    "text": "When the three studies using itraconazole as the intervention were analyzed together (N=798), the incidence of cryptococcal disease was decreased in those taking itraconazole for primary prophylaxis (RR 0.12, 95% CI 0.03, 0.51) compared to those taking placebo; however, there was no significant difference in overall mortality (RR 1.12, 95% CI 0.70, 1.80)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16034947",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2298,
                    "offsetInEndSection": 2511,
                    "text": "When all five studies are analyzed as a single group (N=1316), the incidence of cryptococcal disease was decreased in those taking primary prophylaxis (RR 0.21, 95% CI 0.09, 0.46) compared to those taking placebo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24052889",
                    "endSection": "abstract",
                    "offsetInBeginSection": 319,
                    "offsetInEndSection": 480,
                    "text": "HIV infection is recognized worldwide as the main underlying disease responsible for the development of cryptococcal meningitis (accounting for 80-90% of cases)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14617302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 255,
                    "offsetInEndSection": 463,
                    "text": "An increase in the incidence of primary pulmonary cryptococcal infections has been reported recently in solid organ recipients; these infections were generally symptomatic with an accelerated clinical course."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16011530",
                    "endSection": "abstract",
                    "offsetInBeginSection": 131,
                    "offsetInEndSection": 334,
                    "text": "A matched, case-control study was performed to examine the impact of highly active antiretroviral therapy (HAART) and azole use on the incidence of invasive cryptococcal disease in HIV-infected patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16034947",
                    "endSection": "abstract",
                    "offsetInBeginSection": 130,
                    "offsetInEndSection": 249,
                    "text": "Primary prophylaxis with antifungal interventions may decrease cryptococcal disease incidence and associated mortality."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9827275",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 144,
                    "text": "The incidence of acute respiratory failure (ARF) associated with cryptococcal disease in patients with AIDS is underestimated in the literature."
                }
            ]
        },
        {
            "body": "Which genes are responsible for the high-altitude adaptation of Tibetans?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25501874",
                "http://www.ncbi.nlm.nih.gov/pubmed/22503288",
                "http://www.ncbi.nlm.nih.gov/pubmed/26053282",
                "http://www.ncbi.nlm.nih.gov/pubmed/28585440",
                "http://www.ncbi.nlm.nih.gov/pubmed/26781569",
                "http://www.ncbi.nlm.nih.gov/pubmed/28096303",
                "http://www.ncbi.nlm.nih.gov/pubmed/23666208",
                "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                "http://www.ncbi.nlm.nih.gov/pubmed/20961960",
                "http://www.ncbi.nlm.nih.gov/pubmed/22117106"
            ],
            "id": "5ace20fa0340b9f05800000c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25501874",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 138,
                    "text": "EPAS1 involves in the hypoxic response and is suggested to be responsible for the genetic adaptation of high-altitude hypoxia in Tibetans."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25501874",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Two functional loci in the promoter of EPAS1 gene involved in high-altitude adaptation of Tibetans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22503288",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 86,
                    "text": "Recent studies have identified genes involved in high-altitude adaptation in Tibetans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26053282",
                    "endSection": "abstract",
                    "offsetInBeginSection": 383,
                    "offsetInEndSection": 469,
                    "text": "Recent studies have identified genes involved in high-altitude adaptation in Tibetans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28585440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 901,
                    "offsetInEndSection": 1060,
                    "text": "Collectively, we propose that EP300 harbors adaptive variants in Tibetans, which might contribute to high-altitude adaptation through regulating NO production."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25501874",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1042,
                    "offsetInEndSection": 1384,
                    "text": "The CC genotype at rs56721780:G>C and the insertion genotype at -742 indel were found associated with higher EPAS1 and LOX expression levels in amnion, as well as higher birth weight of Tibetan newborns, suggesting that EPAS1 gene might play important roles in the development of amnion, fetus growth and high-altitude adaptation of Tibetans."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26781569",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 76,
                    "text": "HMOX2 Functions as a Modifier Gene for High-Altitude Adaptation in Tibetans."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28585440",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 96,
                    "text": "EP300 contributes to high-altitude adaptation in Tibetans by regulating nitric oxide production."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26781569",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1249,
                    "offsetInEndSection": 1409,
                    "text": "Collectively, we propose that HMOX2 contributes to high-altitude adaptation in Tibetans by functioning as a modifier in the regulation of hemoglobin metabolism."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28096303",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Down-Regulation of EPAS1 Transcription and Genetic Adaptation of Tibetans to High-Altitude Hypoxia."
                }
            ]
        },
        {
            "body": "Which is the main protein in brown adipose tissue (BAT) active in thermogenesis?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/1763812",
                "http://www.ncbi.nlm.nih.gov/pubmed/6653675",
                "http://www.ncbi.nlm.nih.gov/pubmed/23839524",
                "http://www.ncbi.nlm.nih.gov/pubmed/28082439",
                "http://www.ncbi.nlm.nih.gov/pubmed/29224101",
                "http://www.ncbi.nlm.nih.gov/pubmed/27616452",
                "http://www.ncbi.nlm.nih.gov/pubmed/12954594",
                "http://www.ncbi.nlm.nih.gov/pubmed/23603815",
                "http://www.ncbi.nlm.nih.gov/pubmed/18938135",
                "http://www.ncbi.nlm.nih.gov/pubmed/16219868"
            ],
            "id": "5a8980d2fcd1d6a10c00000d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1763812",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 120,
                    "text": "Brown adipose tissue (BAT) is the main effector of nonshivering thermogenesis and diet-induced thermogenesis in mammals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6653675",
                    "endSection": "abstract",
                    "offsetInBeginSection": 115,
                    "offsetInEndSection": 325,
                    "text": "The main effector of diet-induced thermogenesis is brown adipose tissue (BAT), but acetylcholine (determined by bioassay) and acetylcholinesterase activity (determined histochemically) were not detected in BAT."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23839524",
                    "endSection": "abstract",
                    "offsetInBeginSection": 154,
                    "offsetInEndSection": 239,
                    "text": "Brown adipose tissue (BAT) is the main site of nonshivering thermogenesis in mammals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28082439",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 152,
                    "text": "18F-FDG PET imaging is routinely used to investigate brown adipose tissue (BAT) thermogenesis, which requires mitochondrial uncoupling protein 1 (UCP1)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29224101",
                    "endSection": "abstract",
                    "offsetInBeginSection": 515,
                    "offsetInEndSection": 627,
                    "text": "Concerning energy expenditure, the main effect of estradiol (E2) is on brown adipose tissue (BAT) thermogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27616452",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 231,
                    "text": "Brown adipose tissue (BAT) is the main site of adaptive thermogenesis and experimental studies have associated BAT activity with protection against obesity and metabolic diseases, such as type 2 diabetes mellitus and dyslipidaemia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12954594",
                    "endSection": "abstract",
                    "offsetInBeginSection": 218,
                    "offsetInEndSection": 456,
                    "text": "This study examined metabolic responses to acute and chronic beta3-AR activation in wild-type C57Bl/6 mice and congenic mice lacking functional uncoupling protein (UCP)1, the molecular effector of brown adipose tissue (BAT) thermogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23603815",
                    "endSection": "abstract",
                    "offsetInBeginSection": 123,
                    "offsetInEndSection": 334,
                    "text": "Central to these pathologies is the fat depot: white adipose tissue (WAT) stores excess calories, and brown adipose tissue (BAT) consumes fuel for thermogenesis using tissue-specific uncoupling protein 1 (UCP1)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18938135",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 140,
                    "text": "We investigated the contribution of fatty acid-binding protein 3 (FABP3) to adaptive thermogenesis in brown adipose tissue (BAT) in rodents."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16219868",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 158,
                    "text": "Acute cold exposure leads to norepinephrine release in brown adipose tissue (BAT) and activates uncoupling protein (UCP)1-mediated nonshivering thermogenesis."
                }
            ]
        },
        {
            "body": "Which method is Proseek based on?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                "http://www.ncbi.nlm.nih.gov/pubmed/28930774",
                "http://www.ncbi.nlm.nih.gov/pubmed/27383427",
                "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                "http://www.ncbi.nlm.nih.gov/pubmed/29392211",
                "http://www.ncbi.nlm.nih.gov/pubmed/27710869",
                "http://www.ncbi.nlm.nih.gov/pubmed/29050213",
                "http://www.ncbi.nlm.nih.gov/pubmed/28586402",
                "http://www.ncbi.nlm.nih.gov/pubmed/28948068",
                "http://www.ncbi.nlm.nih.gov/pubmed/28734077"
            ],
            "id": "5a9e202bde7cb99d40000002",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 44,
                    "text": "ProSeeK: a web server for MLPA probe design."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1548,
                    "offsetInEndSection": 1676,
                    "text": "ProSeeK will become a useful tool for all laboratories that are currently using MLPA in their research projects for CNV studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28930774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 738,
                    "offsetInEndSection": 948,
                    "text": "The samples were analyzed with a multiplex proximity extension assay in which 92 inflammation-related proteins were measured simultaneously (Proseek Multiplex Inflammation I; Olink Bioscience, Uppsala, Sweden)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27383427",
                    "endSection": "abstract",
                    "offsetInBeginSection": 767,
                    "offsetInEndSection": 929,
                    "text": "In addition to conventional laboratory tests, 92 inflammatory proteins were analysed with a multiplex system (Proseek Multiplex Inflammation I, Olink Bioscience)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1281,
                    "offsetInEndSection": 1489,
                    "text": "RESULTS\nSimilar quantitative expression patterns for 13 plasma antigens common to both platforms endorsed the potential efficacy of Proseek as an immune-based multiplex assay for proteomic biomarker research."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1490,
                    "offsetInEndSection": 1618,
                    "text": "Proseek found that expression of Carcinoembryonic Antigen (CEA), IL-8 and prolactin are significantly correlated with CRC stage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29392211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 366,
                    "offsetInEndSection": 542,
                    "text": "To simultaneously measure 92 inflammatory biomarkers, we used the proximity extension assay with the Proseek Multiplex Inflammation I panel (Olink Bioscience, Uppsala, Sweden)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27710869",
                    "endSection": "abstract",
                    "offsetInBeginSection": 498,
                    "offsetInEndSection": 588,
                    "text": "Samples were analyzed by Mesoscale Discovery, Myriad RBM MAP technology and Olink Proseek."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29050213",
                    "endSection": "abstract",
                    "offsetInBeginSection": 160,
                    "offsetInEndSection": 575,
                    "text": "Using highly-sensitive Proximity Extension ImmunoAssay on 92 cancer biomarkers (Proseek Multiplex, Olink), enhanced serum levels of Adrenomedullin (ADM, Pcorr= .0004), Growth differentiation factor 15 (GDF15, Pcorr= .003), and soluble Major histocompatibility complex class I-related chain A (sMICA, Pcorr= .023), all prosurvival and chemoprotective factors for myeloma cells, were detected in MM comparing to MGUS."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28586402",
                    "endSection": "abstract",
                    "offsetInBeginSection": 216,
                    "offsetInEndSection": 362,
                    "text": "A total of 92 biomarkers were measured before a standardized meal as well as 30 and 120 minutes afterwards with the Proseek Multiplex CVD III kit."
                }
            ]
        },
        {
            "body": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16110245",
                "http://www.ncbi.nlm.nih.gov/pubmed/16584839",
                "http://www.ncbi.nlm.nih.gov/pubmed/29075213",
                "http://www.ncbi.nlm.nih.gov/pubmed/19657584",
                "http://www.ncbi.nlm.nih.gov/pubmed/16436187",
                "http://www.ncbi.nlm.nih.gov/pubmed/28119174",
                "http://www.ncbi.nlm.nih.gov/pubmed/25606465",
                "http://www.ncbi.nlm.nih.gov/pubmed/16360899",
                "http://www.ncbi.nlm.nih.gov/pubmed/18845200",
                "http://www.ncbi.nlm.nih.gov/pubmed/15652876"
            ],
            "id": "5a99566e1d1251d03b00000f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16110245",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 209,
                    "text": "Monoamine oxidase A (MAOA), a mitochondrial outer membrane enzyme, degrades biogenic amines including norepinephrine, dopamine and serotonin, which have been implicated in the expression of personality traits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16584839",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 207,
                    "text": "Catechol-O-methyltransferase (COMT) and monoamine oxidase A (MAOA) are both involved in the degradation of various biogenic amines which have been hypothesized to have a relationship with personality traits."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29075213",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 134,
                    "text": "Monoamine Oxidase A (MAOA) Gene and Personality Traits from Late Adolescence through Early Adulthood: A Latent Variable Investigation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19657584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 222,
                    "text": "Monoamine oxidase A and B (MAOA and MAOB) appear to be involved in the pathogenesis of Major Depression, and vulnerability of Major Depression is associated with personality traits relating to positive and negative affect."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16436187",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 377,
                    "text": "By conferring allele-specific transcriptional activity on the monoamine oxidase A (MAOA) gene in humans, length variation of a repetitive sequence [(variable number of tandem repeat (VNTR)] in the MAOA promoter influences a constellation of personality traits related to aggressive and antisocial behavior and increases the risk of neurodevelopmental and psychiatric disorders."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19657584",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 103,
                    "text": "Negative emotionality: monoamine oxidase B gene variants modulate personality traits in healthy humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28119174",
                    "endSection": "abstract",
                    "offsetInBeginSection": 107,
                    "offsetInEndSection": 349,
                    "text": "We investigated monoamine oxidase A (MAOA: rs2064070, rs6323, rs909525) and B\u00a0(MAOB: rs1799836, rs2311013, rs2205655) genetic modulation of personality traits (Temperament and Character Inventory, TCI) as endophenotype for suicidal behaviour."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25606465",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 206,
                    "text": "Androgen receptor gene (AR), monoamine oxidase A gene (MAOA) and monoamine oxidase B gene (MAOB) have been found to have associations with behavioral traits, such as aggressiveness, and disorders in humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16360899",
                    "endSection": "abstract",
                    "offsetInBeginSection": 306,
                    "offsetInEndSection": 608,
                    "text": "In the present study, we investigated the association between personality traits and systematic combination of functional polymorphisms in three genes that regulate the metabolism of catecholamines, namely, tyrosine hydroxylase (TH), monoamine oxidase A (MAOA), and catechol-O-methyltransferase (COMT)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18845200",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 94,
                    "text": "Association between monoamine oxidase A (MAOA) and personality traits in Japanese individuals."
                }
            ]
        },
        {
            "body": "What is the function of HDAC  proteins?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22728920",
                "http://www.ncbi.nlm.nih.gov/pubmed/28337317",
                "http://www.ncbi.nlm.nih.gov/pubmed/23088873",
                "http://www.ncbi.nlm.nih.gov/pubmed/26927903",
                "http://www.ncbi.nlm.nih.gov/pubmed/11306585",
                "http://www.ncbi.nlm.nih.gov/pubmed/17786239",
                "http://www.ncbi.nlm.nih.gov/pubmed/26232305",
                "http://www.ncbi.nlm.nih.gov/pubmed/16264908",
                "http://www.ncbi.nlm.nih.gov/pubmed/19826124",
                "http://www.ncbi.nlm.nih.gov/pubmed/22621256"
            ],
            "id": "5aafc37afcf4565872000010",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22728920",
                    "endSection": "abstract",
                    "offsetInBeginSection": 101,
                    "offsetInEndSection": 288,
                    "text": "Some HDAC isoforms can also modulate the function of nonhistone proteins implicated in regulatory processes, and therefore HDACs are recognized as useful targets for therapeutic purposes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28337317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "Histone deacetylase (HDAC) proteins are epigenetic regulators that deacetylate protein substrates, leading to subsequent changes in cell function."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23088873",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 39,
                    "text": "HDAC inhibitors and chaperone function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26927903",
                    "endSection": "abstract",
                    "offsetInBeginSection": 780,
                    "offsetInEndSection": 896,
                    "text": "Rpd3, the Drosophila HDAC1 homolog, is a class I lysine deacetylase and a member of a large family of HDAC proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28337317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 147,
                    "offsetInEndSection": 340,
                    "text": "HDAC proteins are implicated in cancers, and several HDAC inhibitors have been approved by the FDA as anticancer drugs, including SAHA (suberoylanilide hydroxamic acid; Vorinostat and Zolinza)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26927903",
                    "endSection": "abstract",
                    "offsetInBeginSection": 291,
                    "offsetInEndSection": 393,
                    "text": "Histone deacetylase (HDAC) proteins have a major role in epigenetic regulation of chromatin structure."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11306585",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "The Rpd3 histone deacetylase (HDAC) functions in a large complex containing many proteins including Sin3 and Sap30."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17786239",
                    "endSection": "abstract",
                    "offsetInBeginSection": 147,
                    "offsetInEndSection": 420,
                    "text": "We show that class II histone deacetylase (HDAC) proteins, which function as transcriptional repressors of the myocyte enhancer factor 2 (MEF2) transcription factor, fail to accumulate in the soleus, a slow muscle, compared with fast muscles (e.g., white vastus lateralis)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17786239",
                    "endSection": "abstract",
                    "offsetInBeginSection": 421,
                    "offsetInEndSection": 564,
                    "text": "Accordingly, pharmacological blockade of proteasome function specifically increases expression of class II HDAC proteins in the soleus in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26232305",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 145,
                    "text": "Histone deacetylase (HDAC) proteins are promising targets for cancer treatment, with several HDAC inhibitors used clinically as anticancer drugs."
                }
            ]
        },
        {
            "body": "What is the H4S47C cleavage mapping method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/2413446",
                "http://www.ncbi.nlm.nih.gov/pubmed/25491770",
                "http://www.ncbi.nlm.nih.gov/pubmed/17033956",
                "http://www.ncbi.nlm.nih.gov/pubmed/1312500",
                "http://www.ncbi.nlm.nih.gov/pubmed/1889813",
                "http://www.ncbi.nlm.nih.gov/pubmed/8054978",
                "http://www.ncbi.nlm.nih.gov/pubmed/19378164",
                "http://www.ncbi.nlm.nih.gov/pubmed/8449495",
                "http://www.ncbi.nlm.nih.gov/pubmed/6316277",
                "http://www.ncbi.nlm.nih.gov/pubmed/26275423"
            ],
            "id": "5a885add61bb38fb24000017",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2413446",
                    "endSection": "abstract",
                    "offsetInBeginSection": 616,
                    "offsetInEndSection": 766,
                    "text": "The peptide antibody method used, called cleavage mapping, should be a convenient technique for mapping residues and ligand binding sites in proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25491770",
                    "endSection": "abstract",
                    "offsetInBeginSection": 113,
                    "offsetInEndSection": 349,
                    "text": "To identify nucleosomes with alternative structures genome-wide, we used H4S47C-anchored cleavage mapping, which revealed that 5% of budding yeast (Saccharomyces cerevisiae) nucleosome positions have asymmetric histone-DNA interactions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17033956",
                    "endSection": "abstract",
                    "offsetInBeginSection": 581,
                    "offsetInEndSection": 813,
                    "text": "A novel method, extension ligation-mediated polymerase chain reaction (ELMPCR), was used here for mapping topoisomerase-mediated DNA strand breaks and apoptotic DNA cleavage across a translocation-prone region of MLL in human cells."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1312500",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "Physical mapping of the Saccharomyces cerevisiae Ap4A phosphorylase I-encoding gene by the Achilles' cleavage method."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1889813",
                    "endSection": "abstract",
                    "offsetInBeginSection": 464,
                    "offsetInEndSection": 475,
                    "text": "GC/GGCCGC ."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25491770",
                    "endSection": "abstract",
                    "offsetInBeginSection": 708,
                    "offsetInEndSection": 939,
                    "text": "Chromatin immunoprecipitation mapping of selected nucleosome remodelers indicated that asymmetric nucleosomes are bound by the RSC chromatin remodeling complex, which is required for maintaining nucleosomes at asymmetric positions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8054978",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 163,
                    "text": "RecA-assisted restriction endonuclease (RARE) cleavage is a method to perform sequence-specific cleavage of genomic DNA, and is useful in physical mapping studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19378164",
                    "endSection": "abstract",
                    "offsetInBeginSection": 159,
                    "offsetInEndSection": 344,
                    "text": "Site-directed cleavage of DNA is a method for mapping the location of interaction of a specific site in a protein such as a linker histone within a large complex such as the nucleosome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8449495",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 281,
                    "text": "To design a strategy for more efficient long-range physical mapping of large mammalian genomes, we have developed a method for directional mapping from anchor points of randomly integrated retroviral proviruses containing sequences that provide unique cleavage sites in the genome."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6316277",
                    "endSection": "title",
                    "offsetInBeginSection": 67,
                    "offsetInEndSection": 227,
                    "text": "polypurine DNA sequence in the human alpha 2-alpha 1 globin intergenic region to S1 nuclease digestion--high resolution mapping of the clustered cleavage sites."
                }
            ]
        },
        {
            "body": "Which human gene encode for DNA polymerase \u03b8?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                "http://www.ncbi.nlm.nih.gov/pubmed/11356150",
                "http://www.ncbi.nlm.nih.gov/pubmed/27657134",
                "http://www.ncbi.nlm.nih.gov/pubmed/21883722",
                "http://www.ncbi.nlm.nih.gov/pubmed/24648516",
                "http://www.ncbi.nlm.nih.gov/pubmed/27591252",
                "http://www.ncbi.nlm.nih.gov/pubmed/28824932",
                "http://www.ncbi.nlm.nih.gov/pubmed/25643323",
                "http://www.ncbi.nlm.nih.gov/pubmed/28695890",
                "http://www.ncbi.nlm.nih.gov/pubmed/24375106"
            ],
            "id": "5aacd487fcf4565872000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "DNA polymerase theta (pol \u03b8) is an evolutionarily conserved protein encoded by the POLQ gene in mammalian genomes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 68,
                    "text": "Expression and Structural Analyses of Human DNA Polymerase \u03b8 (POLQ)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11356150",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "The human RAD30B gene has recently been shown to encode a novel DNA polymerase, DNA polymerase iota (poliota)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27657134",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "The gene encoding DNA polymerase \u03b8 (Pol\u03b8) was discovered over ten years ago as having a role in suppressing genome instability in mammalian cells."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27657134",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 63,
                    "text": "DNA Polymerase \u03b8: A Unique Multifunctional End-Joining Machine."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21883722",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "DNA polymerase \u03b8 (POLQ) is a family A polymerase that contains an intrinsic helicase domain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "abstract",
                    "offsetInBeginSection": 885,
                    "offsetInEndSection": 1152,
                    "text": "However, challenges for expression and purification are presented by the large size of pol \u03b8 (2590 residues in humans) and unusual juxtaposition of domains (a helicase-like domain and distinct DNA polymerase, separated by a region predicted to be largely disordered)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24648516",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 111,
                    "text": "The biological functions of human DNA polymerase (pol) \u03b8, an A family polymerase, have remained poorly defined."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24648516",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "A role for DNA polymerase \u03b8 in promoting replication through oxidative DNA lesion, thymine glycol, in human cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27591252",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 177,
                    "text": "DNA polymerase \u03b8 (Pol\u03b8) is a unique A-family polymerase that is essential for alternative end-joining (alt-EJ) of double-strand breaks (DSBs) and performs translesion synthesis."
                }
            ]
        },
        {
            "body": "In what percentage of skeletal muscle fibers is dystrophin expression restored after PPMO- mediated exon skipping?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18384691",
                "http://www.ncbi.nlm.nih.gov/pubmed/22146342",
                "http://www.ncbi.nlm.nih.gov/pubmed/16198206",
                "http://www.ncbi.nlm.nih.gov/pubmed/28566768",
                "http://www.ncbi.nlm.nih.gov/pubmed/21851223",
                "http://www.ncbi.nlm.nih.gov/pubmed/26634117",
                "http://www.ncbi.nlm.nih.gov/pubmed/22968479",
                "http://www.ncbi.nlm.nih.gov/pubmed/16627883",
                "http://www.ncbi.nlm.nih.gov/pubmed/21967521",
                "http://www.ncbi.nlm.nih.gov/pubmed/20580709"
            ],
            "id": "5ac0a82d19833b0d7b000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18384691",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 278,
                    "text": "BACKGROUND\nExon skipping oligonucleotides (ESOs) of 2'O-Methyl (2'OMe) and morpholino chemistry have been shown to restore dystrophin expression in muscle fibers from the mdx mouse, and are currently being tested in phase I clinical trials for Duchenne Muscular Dystrophy (DMD)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18384691",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "Nanopolymers improve delivery of exon skipping oligonucleotides and concomitant dystrophin expression in skeletal muscle of mdx mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22146342",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 287,
                    "text": "Although restoration of dystrophin expression via exon skipping in both cardiac and skeletal muscle has been successfully demonstrated in the mdx mouse, restoration of cardiac dystrophin expression in large animal models of Duchenne muscular dystrophy (DMD) has proven to be a challenge."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16198206",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 191,
                    "text": "Intraperitoneal administration of phosphorothioate antisense oligodeoxynucleotide against splicing enhancer sequence induced exon skipping in dystrophin mRNA expressed in mdx skeletal muscle."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28566768",
                    "endSection": "abstract",
                    "offsetInBeginSection": 641,
                    "offsetInEndSection": 880,
                    "text": "However, clinical trials in exon-skipping therapy did not provide satisfactory results, which may be attributed to inefficient exon skipping, low expression level of restored dystrophin and inadequate methods of muscle function evaluation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21851223",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 191,
                    "text": "Long-term systemic administration of unconjugated morpholino oligomers for therapeutic expression of dystrophin by exon skipping in skeletal muscle: implications for cardiac muscle integrity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26634117",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 203,
                    "text": "BACKGROUND\nSystemic delivery of anti-sense oligonucleotides to Duchenne muscular dystrophy (DMD) patients to induce de novo dystrophin protein expression in muscle (exon skipping) is a promising therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22146342",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1112,
                    "offsetInEndSection": 1386,
                    "text": "Percutaneous transendocardial delivery of rAAV6 expressing a modified U7 exon skipping construct is a safe, effective method for restoration of dystrophin expression and improvement of cardiac function in the GRMD canine and may be easily translatable to human DMD patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22968479",
                    "endSection": "abstract",
                    "offsetInBeginSection": 488,
                    "offsetInEndSection": 777,
                    "text": "Widespread restoration of dystrophin expression via adeno-associated virus (AAV)-mediated exon skipping has been successfully demonstrated in the mdx mouse model and in cardiac muscle after percutaneous transendocardial delivery in the golden retriever muscular dystrophy dog (GRMD) model."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16627883",
                    "endSection": "abstract",
                    "offsetInBeginSection": 123,
                    "offsetInEndSection": 328,
                    "text": "We report that intravenous (IV) infusion of an antisense oligonucleotide created an in-frame dystrophin mRNA from an out-of-frame DMD mutation (via exon skipping) which led to muscle dystrophin expression."
                }
            ]
        },
        {
            "body": "Which miRNA is associated with the circular RNA ciRS-7?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                "http://www.ncbi.nlm.nih.gov/pubmed/28296235",
                "http://www.ncbi.nlm.nih.gov/pubmed/28174233",
                "http://www.ncbi.nlm.nih.gov/pubmed/27796758",
                "http://www.ncbi.nlm.nih.gov/pubmed/27614453",
                "http://www.ncbi.nlm.nih.gov/pubmed/26649774",
                "http://www.ncbi.nlm.nih.gov/pubmed/27929395",
                "http://www.ncbi.nlm.nih.gov/pubmed/25873049",
                "http://www.ncbi.nlm.nih.gov/pubmed/29236709"
            ],
            "id": "5ac725250340b9f058000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                    "endSection": "abstract",
                    "offsetInBeginSection": 300,
                    "offsetInEndSection": 484,
                    "text": "Particularly, the recently identified circular RNA, ciRS-7, which acts as a designated miR-7 inhibitor/sponge, has conceptually changed the mechanistic understanding of miRNA networks."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 579,
                    "offsetInEndSection": 747,
                    "text": "ciRS-7 contains more than 70 selectively conserved miRNA target sites, and it is highly and widely associated with Argonaute (AGO) proteins in a miR-7-dependent manner."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 451,
                    "offsetInEndSection": 578,
                    "text": "Here we show that this circRNA acts as a miR-7 sponge; we term this circular transcript ciRS-7 (circular RNA sponge for miR-7)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28296235",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "The circular RNA ciRS-7 promotes APP and BACE1 degradation in an NF-\u03baB-dependent manner."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                    "endSection": "abstract",
                    "offsetInBeginSection": 107,
                    "offsetInEndSection": 299,
                    "text": "The identification of competing endogenous RNA and circular RNA (circRNA) as important regulators of miRNA activity underscores the increasing complexity of ncRNA-mediated regulatory networks."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28174233",
                    "endSection": "abstract",
                    "offsetInBeginSection": 77,
                    "offsetInEndSection": 161,
                    "text": "Recently, a novel circular RNA, ciRS-7, was proposed to be a potential miR-7 sponge."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28296235",
                    "endSection": "abstract",
                    "offsetInBeginSection": 349,
                    "offsetInEndSection": 500,
                    "text": "In this study, we report that the circular RNA circular RNA sponge for miR-7 (ciRS-7) has an important role in regulating BACE1 and APP protein levels."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27796758",
                    "endSection": "abstract",
                    "offsetInBeginSection": 503,
                    "offsetInEndSection": 774,
                    "text": "The best known ones so far include a particular type of circRNA namely \"circular RNA sponge for miR-7\" (ciRS-7 and CDR1as) which is the inhibitor of miR-7 microRNA-known to regulate various diseases like, cancer, neurodegenerative diseases, diabetes, and atherosclerosis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27614453",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26649774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 305,
                    "offsetInEndSection": 515,
                    "text": "Recent studies have mainly been devoted to the function of the circular RNA sponge for miR-7 (ciRS-7) and sex-determining region Y (SRY) by targeting microRNA-7 (miR-7) and microRNA-138 (miR-138), respectively."
                }
            ]
        },
        {
            "body": "Which are the two main bacterial phyla in human gut?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27900395",
                "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                "http://www.ncbi.nlm.nih.gov/pubmed/22205877",
                "http://www.ncbi.nlm.nih.gov/pubmed/26061054",
                "http://www.ncbi.nlm.nih.gov/pubmed/22025614",
                "http://www.ncbi.nlm.nih.gov/pubmed/23982459",
                "http://www.ncbi.nlm.nih.gov/pubmed/27638955",
                "http://www.ncbi.nlm.nih.gov/pubmed/25873372",
                "http://www.ncbi.nlm.nih.gov/pubmed/26271635",
                "http://www.ncbi.nlm.nih.gov/pubmed/21829462"
            ],
            "id": "5abd2ce0fcf456587200002a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27900395",
                    "endSection": "abstract",
                    "offsetInBeginSection": 147,
                    "offsetInEndSection": 304,
                    "text": "Out of thousands of bacterial species-level phylotypes inhabiting the human gut, the majority belong to two dominant phyla, the Bacteroidetes and Firmicutes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 100,
                    "text": "Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "The adult human distal gut microbial community is typically dominated by 2 bacterial phyla (divisions), the Firmicutes and the Bacteroidetes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22205877",
                    "endSection": "abstract",
                    "offsetInBeginSection": 292,
                    "offsetInEndSection": 406,
                    "text": "The Bacteroidetes, one of two dominant bacterial phyla in the adult gut, possess broad glycan-degrading abilities."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26061054",
                    "endSection": "abstract",
                    "offsetInBeginSection": 237,
                    "offsetInEndSection": 393,
                    "text": "Recent evidence suggests that obesity is influenced by specific bacterial phyla present in the human gut that have increased energy harvesting capabilities."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1517,
                    "offsetInEndSection": 1764,
                    "text": "This simplified model of the human gut microbiota illustrates niche specialization and functional redundancy within members of its major bacterial phyla, and the importance of host glycans as a nutrient foundation that ensures ecosystem stability."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22025614",
                    "endSection": "abstract",
                    "offsetInBeginSection": 801,
                    "offsetInEndSection": 1093,
                    "text": "The alternative spermidine biosynthetic pathway is present in many bacterial phyla and is the dominant spermidine route in the human gut, stomach, and oral microbiomes, and it appears to have supplanted the S-adenosylmethionine decarboxylase/spermidine synthase pathway in the gut microbiota."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23982459",
                    "endSection": "abstract",
                    "offsetInBeginSection": 334,
                    "offsetInEndSection": 577,
                    "text": "Here we reconstructed GEMs for three key species, (Bacteroides thetaiotamicron, Eubacterium rectale and Methanobrevibacter smithii) as relevant representatives of three main phyla in the human gut (Bacteroidetes, Firmicutes and Euryarchaeota)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27638955",
                    "endSection": "abstract",
                    "offsetInBeginSection": 459,
                    "offsetInEndSection": 845,
                    "text": "As results, 132 bacterial genera and some unidentified operational taxonomic units within 29 phyla in the gut bacteria were detected, with Spirochaetes (11-55%), Firmicutes (7-18%), Bacteroidetes (7-31%), and Proteobacteria (8-14%) as the main phyla, and Treponema, TG5, Dysgonomonas, Tannerella, za29, Lactococcus, Pseudomonas, and SJA-88 as the common genera in all the four termites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25873372",
                    "endSection": "abstract",
                    "offsetInBeginSection": 961,
                    "offsetInEndSection": 1208,
                    "text": "Analyses of sequenced bacterial genomes revealed that the cut cluster is present in many human gut bacteria, is predictive of choline utilization in sequenced isolates, and is widely but discontinuously distributed across multiple bacterial phyla."
                }
            ]
        },
        {
            "body": "What are 7 symptoms of yellow fever?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20300380",
                "http://www.ncbi.nlm.nih.gov/pubmed/23873723",
                "http://www.ncbi.nlm.nih.gov/pubmed/11000957",
                "http://www.ncbi.nlm.nih.gov/pubmed/6376649",
                "http://www.ncbi.nlm.nih.gov/pubmed/11463409",
                "http://www.ncbi.nlm.nih.gov/pubmed/27087559",
                "http://www.ncbi.nlm.nih.gov/pubmed/19869938",
                "http://www.ncbi.nlm.nih.gov/pubmed/19368780",
                "http://www.ncbi.nlm.nih.gov/pubmed/19930387",
                "http://www.ncbi.nlm.nih.gov/pubmed/19868347"
            ],
            "id": "5aac5469fcf4565872000005",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20300380",
                    "endSection": "abstract",
                    "offsetInBeginSection": 226,
                    "offsetInEndSection": 307,
                    "text": "Clinical symptoms and signs observed among yellow fever cases are also described."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23873723",
                    "endSection": "abstract",
                    "offsetInBeginSection": 209,
                    "offsetInEndSection": 387,
                    "text": "Yellow fever virus infection can produce a wide spectrum of symptoms, ranging from asymptomatic infection or oligosymptomatic illness to severe disease with a high fatality rate."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11000957",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "Yellow fever is an arthropod-borne disease with symptoms ranging from mild fever to acute hepatonephritis, hemorrhages and shock often fatal."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6376649",
                    "endSection": "abstract",
                    "offsetInBeginSection": 690,
                    "offsetInEndSection": 909,
                    "text": "Future users of this dengue-2 vaccine may wish to employ immunization schedules that include preliminary immunization against yellow fever and must be prepared to accept mild vaccine-related symptoms in some recipients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11463409",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1271,
                    "offsetInEndSection": 1366,
                    "text": "RNA of yellow fever virus was identical to that previously described for 17D genomic sequences."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20300380",
                    "endSection": "abstract",
                    "offsetInBeginSection": 308,
                    "offsetInEndSection": 482,
                    "text": "Humoral immune response to yellow fever, Mayaro, Venezuelan equine encephalitis, Oropouche, and dengue 2 infection was assessed by evaluating IgM and IgG specific antibodies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27087559",
                    "endSection": "abstract",
                    "offsetInBeginSection": 637,
                    "offsetInEndSection": 828,
                    "text": "Clinicians should alert to the possibility of YEL-AVD in vaccinees presenting with compatible symptoms after yellow fever vaccination, particularly in people at higher risk of adverse events."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19869938",
                    "endSection": "abstract",
                    "offsetInBeginSection": 895,
                    "offsetInEndSection": 1083,
                    "text": "If the brain was mildly injured at the time of the intraperitoneal injection, the symptoms of yellow fever encephalitis appeared 6 days later, but the virus was then absent from the blood."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19368780",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 244,
                    "text": "The neutralising antibody response after the yellow fever vaccine (YF-17D) skin test was measured in 7 egg allergic persons in whom further vaccination was abandoned because of a strong local urticarial reaction to the YF-17D vaccine test dose."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11000957",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 254,
                    "text": "The pathophysiology of severe yellow fever in humans and in monkeys susceptible to the virus is largely unknown."
                }
            ]
        },
        {
            "body": "Which test is used for the definition of colour-blindness?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                "http://www.ncbi.nlm.nih.gov/pubmed/314267",
                "http://www.ncbi.nlm.nih.gov/pubmed/1495767",
                "http://www.ncbi.nlm.nih.gov/pubmed/9893853",
                "http://www.ncbi.nlm.nih.gov/pubmed/310055",
                "http://www.ncbi.nlm.nih.gov/pubmed/4049749",
                "http://www.ncbi.nlm.nih.gov/pubmed/306798",
                "http://www.ncbi.nlm.nih.gov/pubmed/26591383",
                "http://www.ncbi.nlm.nih.gov/pubmed/16420956",
                "http://www.ncbi.nlm.nih.gov/pubmed/19493108"
            ],
            "id": "5ad6e431133db5eb7800000e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 965,
                    "offsetInEndSection": 1096,
                    "text": "To test for colour-blindness, we used a cognitive approach involving a harbour seal trained to use a concept of same and different."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1294,
                    "offsetInEndSection": 1382,
                    "text": "However, the seal responded with \"same\", providing strong evidence for colour-blindness."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                    "endSection": "title",
                    "offsetInBeginSection": 25,
                    "offsetInEndSection": 84,
                    "text": "Behavioural evidence for colour-blindness in harbour seals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/314267",
                    "endSection": "abstract",
                    "offsetInBeginSection": 159,
                    "offsetInEndSection": 352,
                    "text": "The frequency of the red-green colour-blindness in males is almost the same in both villages (2.36-2.53%), being similar to frequencies reported for other mestizo' populations in Latin America."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1495767",
                    "endSection": "abstract",
                    "offsetInBeginSection": 547,
                    "offsetInEndSection": 663,
                    "text": "In his first pedigree Horner demonstrates that colour-blindness is transmitted from the grandfather to the grandson."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9893853",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 211,
                    "text": "Alleles causing colour-blindness are present in humans at non-negligible levels, and it is not yet understood how colour-blindness is maintained, since colour-vision probably provides a selective advantage, e.g."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/314267",
                    "endSection": "abstract",
                    "offsetInBeginSection": 618,
                    "offsetInEndSection": 747,
                    "text": "These findings are consistent with the idea that in societies at the agricultural level, colour-blindness is selectively neutral."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/314267",
                    "endSection": "abstract",
                    "offsetInBeginSection": 353,
                    "offsetInEndSection": 617,
                    "text": "In one of the communities, families in which colour-blindness occurred were wealthier (P is less than 0.05) than non-colour-blind families, but there were no significant differences by colour vision class in numbers of surviving children nor mother's marriage age."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/314267",
                    "endSection": "abstract",
                    "offsetInBeginSection": 748,
                    "offsetInEndSection": 1082,
                    "text": "The association of colour-blindness with higher socio-economic status is expected given the history of European conquest in the New World, and suggests that the major cause of varying rates of the defect in Latin American populations is socio-economic heterogeneity and by inference different degrees of European-Amerindian admixture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/310055",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1024,
                    "offsetInEndSection": 1179,
                    "text": "With coloured stimuli, the difference between normal and red-green colour-blindness is more clear-cut, and red-blind can be discriminated from green-blind."
                }
            ]
        },
        {
            "body": "Of what origin is the MCF-7 cell line?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                "http://www.ncbi.nlm.nih.gov/pubmed/849449",
                "http://www.ncbi.nlm.nih.gov/pubmed/16234104",
                "http://www.ncbi.nlm.nih.gov/pubmed/20878129",
                "http://www.ncbi.nlm.nih.gov/pubmed/18316330",
                "http://www.ncbi.nlm.nih.gov/pubmed/21773964",
                "http://www.ncbi.nlm.nih.gov/pubmed/12432273",
                "http://www.ncbi.nlm.nih.gov/pubmed/11956583",
                "http://www.ncbi.nlm.nih.gov/pubmed/9378550",
                "http://www.ncbi.nlm.nih.gov/pubmed/17121229"
            ],
            "id": "5ac08fe7d0c506ce46000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1277,
                    "offsetInEndSection": 1352,
                    "text": "MCF-7/ADR and the breast cancer cell line MCF-7 are not of the same origin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/849449",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 120,
                    "text": "In a mammary gland cell line (MCF-7) of human origin, insulin stimulated the rates of RNA, DNA and protein biosynthesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 556,
                    "offsetInEndSection": 838,
                    "text": "Since the MCF-7/ADR' cell line was definitely derived from parental MCF-7 cells, we were able to directly compare these cell lines together with MCF-7/ADR using immunocytochemical, morphological, and consecutive DNA fingerprinting analyses to determine the true origin of MCF-7/ADR."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16234104",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1009,
                    "offsetInEndSection": 1121,
                    "text": "CONCLUSION\nHER2 gene has been cloned successfully and the MCF-7 cell line co-expressing HER2 and ER is obtained."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 222,
                    "offsetInEndSection": 327,
                    "text": "Many recent studies still describe MCF-7/ADR cells as originating from the breast cancer cell line MCF-7."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16234104",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 163,
                    "text": "OBJECTIVE\nTo clone human epidermal growth factor receptor (HER2) gene and establish a MCF-7 cell line with stable co-expression of HER2 and estrogen receptor (ER)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20878129",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "Knockdown of the c-Jun-N-terminal kinase expression by siRNA inhibits MCF-7 breast carcinoma cell line growth."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18316330",
                    "endSection": "abstract",
                    "offsetInBeginSection": 333,
                    "offsetInEndSection": 471,
                    "text": "We showed that the expressions of Erbin and ErbB2 were modulated by PKCdelta inhibitor, rottlerin, in the TRAIL-resistant MCF-7 cell line."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21773964",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "Glargine promotes proliferation of breast adenocarcinoma cell line MCF-7 via AKT activation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12432273",
                    "endSection": "abstract",
                    "offsetInBeginSection": 165,
                    "offsetInEndSection": 244,
                    "text": "The human breast cancer cell line MCF-7 is estrogen-receptor (ER) positive (+)."
                }
            ]
        },
        {
            "body": "Is lumican a secreted protein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22266188",
                "http://www.ncbi.nlm.nih.gov/pubmed/27126993",
                "http://www.ncbi.nlm.nih.gov/pubmed/17050378",
                "http://www.ncbi.nlm.nih.gov/pubmed/20138170",
                "http://www.ncbi.nlm.nih.gov/pubmed/12381269",
                "http://www.ncbi.nlm.nih.gov/pubmed/23480731",
                "http://www.ncbi.nlm.nih.gov/pubmed/21421073",
                "http://www.ncbi.nlm.nih.gov/pubmed/12128073",
                "http://www.ncbi.nlm.nih.gov/pubmed/17616530",
                "http://www.ncbi.nlm.nih.gov/pubmed/15966909"
            ],
            "id": "5ad255210340b9f058000018",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22266188",
                    "endSection": "abstract",
                    "offsetInBeginSection": 267,
                    "offsetInEndSection": 364,
                    "text": "Lumican-transfected PANC-1 cells secreted a 70-kDa lumican protein and had an active ERK pathway."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27126993",
                    "endSection": "abstract",
                    "offsetInBeginSection": 374,
                    "offsetInEndSection": 449,
                    "text": "Lumican is a secreted proteoglycan that regulates collagen fibril assembly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22266188",
                    "endSection": "abstract",
                    "offsetInBeginSection": 594,
                    "offsetInEndSection": 692,
                    "text": "Thus, the 70-kDa lumican secreted by PDAC cells plays important roles in cell growth and invasion."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22266188",
                    "endSection": "abstract",
                    "offsetInBeginSection": 161,
                    "offsetInEndSection": 266,
                    "text": "We used gene transfection techniques to examine the biological roles of lumican secreted from PDAC cells."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22266188",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "Secreted 70kDa lumican stimulates growth and inhibits invasion of human pancreatic cancer."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17050378",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 160,
                    "text": "Lumican, a small leucine-rich proteoglycan substituted with keratan sulfate chains is expressed and secreted by human melanoma cells and not normal melanocytes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20138170",
                    "endSection": "abstract",
                    "offsetInBeginSection": 564,
                    "offsetInEndSection": 698,
                    "text": "HEK 293 cell, stably transfected with lumican cDNA synthesized and secreted a 50 kDa lumican protein at high levels in culture medium."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27126993",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1531,
                    "offsetInEndSection": 1790,
                    "text": "CONCLUSIONS\nOur results demonstrate that activated pancreatic stellate cells within PDAC secrete lumican under the negative control of TGF-\u03b2; once secreted, the extracellular lumican enhances stellate cell adhesion and mobility in a collagen-rich environment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12381269",
                    "endSection": "abstract",
                    "offsetInBeginSection": 846,
                    "offsetInEndSection": 1014,
                    "text": "Western blot analysis with anti-lumican antibody detected a 42 kDa lumican protein secreted into the culture medium of both wild-type and C/S mutant lumican cell lines."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23480731",
                    "endSection": "abstract",
                    "offsetInBeginSection": 969,
                    "offsetInEndSection": 1130,
                    "text": "In\u00a0vitro, mechanical stretch and the proinflammatory cytokine interleukin-1\u03b2 increased lumican mRNA as well as secreted lumican protein from cardiac fibroblasts."
                }
            ]
        },
        {
            "body": "Cytochrome p450 CYP3A is induced by rifampicin  and compounds used to treat what virus?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23071008",
                "http://www.ncbi.nlm.nih.gov/pubmed/11336977",
                "http://www.ncbi.nlm.nih.gov/pubmed/21241325",
                "http://www.ncbi.nlm.nih.gov/pubmed/9413920",
                "http://www.ncbi.nlm.nih.gov/pubmed/23975654",
                "http://www.ncbi.nlm.nih.gov/pubmed/12051692",
                "http://www.ncbi.nlm.nih.gov/pubmed/27490210",
                "http://www.ncbi.nlm.nih.gov/pubmed/10628745",
                "http://www.ncbi.nlm.nih.gov/pubmed/24412072",
                "http://www.ncbi.nlm.nih.gov/pubmed/14613717"
            ],
            "id": "5ab2cc66fcf4565872000015",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23071008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 224,
                    "text": "Induction of the cytochrome P450 (CYP) family of enzymes by coadministered compounds can result in drug-drug interactions, as in the case of the coadministration of rifampicin with many CYP3A substrates, including midazolam."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11336977",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 77,
                    "text": "Induction of intestinal cytochrome P450 (CYP3A) by rifampicin in beagle dogs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21241325",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 280,
                    "text": "The influence of pretreatment with ketoconazole [cytochrome P450 3A (CYP3A) + P-glycoprotein (P-gp) inhibitor], elacridar (selective P-gp inhibitor) and rifampicin (CYP3A + P-gp inducer) on oral morphine pharmacokinetics and pharmacodynamics was investigated in experimental dogs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9413920",
                    "endSection": "abstract",
                    "offsetInBeginSection": 3,
                    "offsetInEndSection": 158,
                    "text": "The effect of rifampicin on cytochrome P450 isoforms in the CYP1A and CYP3A subfamilies has been studied in 72-h cultured precision-cut human liver slices."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23975654",
                    "endSection": "abstract",
                    "offsetInBeginSection": 222,
                    "offsetInEndSection": 696,
                    "text": "Clinical studies in healthy subjects were performed to evaluate potential pharmacokinetic interactions between vortioxetine (Lu AA21004) and co-administered agents, including fluconazole (cytochrome P450 [CYP] 2C9, CYP2C19 and CYP3A inhibitor), ketoconazole (CYP3A and P-glycoprotein inhibitor), rifampicin (CYP inducer), bupropion (CYP2D6 inhibitor and CYP2B6 substrate), ethinyl estradiol/levonorgestrel (CYP3A substrates) and omeprazole (CYP2C19 substrate and inhibitor)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23071008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 804,
                    "offsetInEndSection": 993,
                    "text": "The E(max) and EC(50) values in two separate lots of hepatocytes for CYP3A induction by rifampicin in a 96-well format were similar when discrete probe was compared with the probe cocktail."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12051692",
                    "endSection": "abstract",
                    "offsetInBeginSection": 394,
                    "offsetInEndSection": 513,
                    "text": "Phenobarbital induced CYP2B and rifampicin induced CYP3A, respectively, in addition to NADPH-cytochrome P450 reductase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27490210",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 341,
                    "text": "In this study with crucian carp (Carassius auratus gibelio), the effect on enrofloxacin (EF) and its metabolite ciprofloxacin (CF) and on the activity of cytochrome P450 1A (CYP1A) and cytochrome P450 3A (CYP3A) was estimated following the oral administration of rifampicin (RIF) (12mg/kg) and \u03b2-naphthoflavone (BNF) (12mg/kg), respectively."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10628745",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 134,
                    "text": "Transcription of genes encoding cytochrome P450 3A (CYP3A) monooxygenases is induced by a variety of xenobiotics and natural steroids."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11336977",
                    "endSection": "abstract",
                    "offsetInBeginSection": 199,
                    "offsetInEndSection": 409,
                    "text": "The inducible effect of Rif on intestinal cytochrome P450, especially CYP3A enzyme, was investigated by measuring microsomal testosterone 6beta-hydroxylation (6beta-OHT) activity, immunoblot and ELISA analysis."
                }
            ]
        },
        {
            "body": "Which human chromosome is the product of fusion?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/3325883",
                "http://www.ncbi.nlm.nih.gov/pubmed/15815621",
                "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                "http://www.ncbi.nlm.nih.gov/pubmed/28259884",
                "http://www.ncbi.nlm.nih.gov/pubmed/10637483",
                "http://www.ncbi.nlm.nih.gov/pubmed/19332641",
                "http://www.ncbi.nlm.nih.gov/pubmed/28333343",
                "http://www.ncbi.nlm.nih.gov/pubmed/20132013",
                "http://www.ncbi.nlm.nih.gov/pubmed/12836614",
                "http://www.ncbi.nlm.nih.gov/pubmed/11196135"
            ],
            "id": "5ace238e0340b9f05800000d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3325883",
                    "endSection": "abstract",
                    "offsetInBeginSection": 372,
                    "offsetInEndSection": 592,
                    "text": "The results also demonstrate that the product of the activated met gene is a fusion protein and that the amino terminal end of this fusion protein, which is encoded by human chromosome 1, exhibits homology to laminin B1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15815621",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 144,
                    "text": "Human chromosome 2 is unique to the human lineage in being the product of a head-to-head fusion of two intermediate-sized ancestral chromosomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "Human chromosome 2 is a product of a telomere fusion of two ancestral chromosomes and loss/degeneration of one of the two original centromeres."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28259884",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 128,
                    "text": "The Dicentric Chromosome dic(20;22) Is a Recurrent Abnormality in Myelodysplastic Syndromes and Is a Product of Telomere Fusion."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10637483",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1138,
                    "offsetInEndSection": 1246,
                    "text": "Our data indicate that the CALM/AF10 fusion product on the der(10) chromosome is critical to leukemogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19332641",
                    "endSection": "abstract",
                    "offsetInBeginSection": 415,
                    "offsetInEndSection": 644,
                    "text": "The recombinant chromosome that harbors the beta/delta fusion gene in elephants is structurally similar to the \"anti-Lepore\" duplication mutant of humans (the reciprocal exchange product of the hemoglobin Lepore deletion mutant)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 123,
                    "text": "Chromosome-Specific Centromere Sequences Provide an Estimate of the Ancestral Chromosome 2 Fusion Event in Hominin Genomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28333343",
                    "endSection": "abstract",
                    "offsetInBeginSection": 632,
                    "offsetInEndSection": 961,
                    "text": "We investigate the most recent product of a chromosome fusion event fixed in the human lineage, human chromosome 2, whose stability was acquired by the suppression of one centromere, resulting in a unique difference in chromosome number between humans (46 chromosomes) and our most closely related ape relatives (48 chromosomes)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3325883",
                    "endSection": "abstract",
                    "offsetInBeginSection": 178,
                    "offsetInEndSection": 371,
                    "text": "These analyses reveal that the met kinase domain (located on human chromosome 7) possesses unique features that distinguish met from other members of the src family of protein tyrosine kinases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                    "endSection": "abstract",
                    "offsetInBeginSection": 842,
                    "offsetInEndSection": 1239,
                    "text": "By doing so, one is able to provide evidence for the presence of both active and degenerate centromeric satellite profiles on chromosome 2 in these archaic genomes, supporting the hypothesis that the chromosomal fusion event took place prior to our last common ancestor with Denisovan and Neandertal hominins and presenting a genomic reference for predicting karyotype in ancient genomic datasets."
                }
            ]
        },
        {
            "body": "Where is the EpCam protein mainly located?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26054340",
                "http://www.ncbi.nlm.nih.gov/pubmed/23026194",
                "http://www.ncbi.nlm.nih.gov/pubmed/23484855",
                "http://www.ncbi.nlm.nih.gov/pubmed/20974811",
                "http://www.ncbi.nlm.nih.gov/pubmed/25893293",
                "http://www.ncbi.nlm.nih.gov/pubmed/19925656",
                "http://www.ncbi.nlm.nih.gov/pubmed/26613680",
                "http://www.ncbi.nlm.nih.gov/pubmed/24980949",
                "http://www.ncbi.nlm.nih.gov/pubmed/29245156",
                "http://www.ncbi.nlm.nih.gov/pubmed/26356670"
            ],
            "id": "5ac09a7b19833b0d7b000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26054340",
                    "endSection": "abstract",
                    "offsetInBeginSection": 112,
                    "offsetInEndSection": 235,
                    "text": "Basolaterally located cld7 is enriched in glycolipid-enriched membrane domains (GEM), where it associates with EpCAM (EpC)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26054340",
                    "endSection": "abstract",
                    "offsetInBeginSection": 358,
                    "offsetInEndSection": 479,
                    "text": "Thus, we asked whether cld7 serines or palmitoylation affect cld7 location and protein, particularly EpCAM, associations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26054340",
                    "endSection": "abstract",
                    "offsetInBeginSection": 482,
                    "offsetInEndSection": 656,
                    "text": "RESULTS\nHEK cells were transfected with EpCAM and wild type cld7 or cld7, where serine phopsphorylation or the palmitoylation sites (AA184, AA186) (cld7(mPalm)) were mutated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26054340",
                    "endSection": "abstract",
                    "offsetInBeginSection": 838,
                    "offsetInEndSection": 1106,
                    "text": "This has consequences on migration and invasiveness as palmitoylated cld7 facilitates integrin and EpCAM recruitment, associates with cytoskeletal linker proteins and cooperates with MMP14, CD147 and TACE, which support motility, matrix degradation and EpCAM cleavage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23026194",
                    "endSection": "abstract",
                    "offsetInBeginSection": 324,
                    "offsetInEndSection": 477,
                    "text": "Of interest, 3' exons deletions of the EPCAM gene, which is located upstream of MSH2 in chromosome 2, are associated with MSH2 promoter hypermethylation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23026194",
                    "endSection": "abstract",
                    "offsetInBeginSection": 478,
                    "offsetInEndSection": 563,
                    "text": "EPCAM protein, expressed in epithelial tissues, is encoded by the EPCAM/TACSTD1 gene."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23484855",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 80,
                    "text": "EpCAM is an endoderm-specific Wnt derepressor that licenses hepatic development."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26054340",
                    "endSection": "abstract",
                    "offsetInBeginSection": 657,
                    "offsetInEndSection": 785,
                    "text": "Exchange of individual serine phosphorylation sites did not significantly affect the GEM localization and the EpCAM association."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20974811",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "Epithelial cell adhesion molecule (EpCAM) is best known as a tumor-associated protein highly expressed in carcinomas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25893293",
                    "endSection": "abstract",
                    "offsetInBeginSection": 605,
                    "offsetInEndSection": 739,
                    "text": "In hepatocytes, EpCAM is silenced by polycomb repressive complex 2 (PRC2) and ZNF198/LSD1/Co-REST/HDAC1 chromatin-modifying complexes."
                }
            ]
        },
        {
            "body": "What is the drug target for Eliquis (Apixaban)?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28008269",
                "http://www.ncbi.nlm.nih.gov/pubmed/23649961",
                "http://www.ncbi.nlm.nih.gov/pubmed/26095540",
                "http://www.ncbi.nlm.nih.gov/pubmed/23821689",
                "http://www.ncbi.nlm.nih.gov/pubmed/24391389",
                "http://www.ncbi.nlm.nih.gov/pubmed/26417627",
                "http://www.ncbi.nlm.nih.gov/pubmed/24672216",
                "http://www.ncbi.nlm.nih.gov/pubmed/26369819",
                "http://www.ncbi.nlm.nih.gov/pubmed/24624626",
                "http://www.ncbi.nlm.nih.gov/pubmed/22292869"
            ],
            "id": "5abbe429fcf456587200001c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28008269",
                    "endSection": "abstract",
                    "offsetInBeginSection": 692,
                    "offsetInEndSection": 814,
                    "text": "The drugs were dabigatran etexilate mesylate (Pradaxa), rivaroxaban (Xarelto), apixaban (Eliquis), and edoxaban (Savaysa)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23649961",
                    "endSection": "abstract",
                    "offsetInBeginSection": 245,
                    "offsetInEndSection": 458,
                    "text": "The new oral anticoagulants (NOAC) include dabigatran etexilate (Pradaxa\u00ae), a direct thrombin inhibitor, and rivaroxaban (Xarelto\u00ae), Apixaban (Eliquis) and Edoxaban (Lixiana\u00ae), which are direct anti-Xa inhibitors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26095540",
                    "endSection": "abstract",
                    "offsetInBeginSection": 216,
                    "offsetInEndSection": 482,
                    "text": "They include the oral direct thrombin inhibitor dabigatran etexilate (Pradaxa, Boehringer Ingelheim) and the oral direct FXa inhibitors rivaroxaban (Xarelto, Bayer HealthCare), apixaban (Eliquis, Bristol-Myers Squibb), and edoxaban (Lixiana/Savaysa, Daiichi-Sankyo)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23821689",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 201,
                    "text": "The new oral anticoagulants dabigatran etexilate (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis) have predictable pharmacokinetic and pharmacodynamic profiles and are alternatives to warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24391389",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1291,
                    "offsetInEndSection": 1527,
                    "text": "Conflicting evidence exists regarding the ability of aPCCs to reverse the prolonged bleeding times caused by the anticoagulant agents dabigatran etexilate (Pradaxa), rivaroxaban (Xarelto), apixaban (Eliquis), and fondaparinux (Arixtra)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26417627",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 66,
                    "text": "Apixaban (Eliquis) in deep vein thrombosis and pulmonary embolism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24672216",
                    "endSection": "abstract",
                    "offsetInBeginSection": 577,
                    "offsetInEndSection": 680,
                    "text": "Dabigatran (Pradaxa) and apixaban (Eliquis) have demonstrated improved efficacy compared with warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26369819",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1763,
                    "offsetInEndSection": 1941,
                    "text": "Apixaban (Eliquis), rivaroxaban (Xarelto), and edoxaban (Savaysa) are the new Xa inhibitors that have been recently approved by the U.S. FDA and are in current clinical practice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24624626",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 332,
                    "text": "The new direct oral anticoagulants directly targeting thrombin (factor IIa) or factor-Xa, are currently used for the treatment of deep venous thrombosis and pulmonary embolism (rivaroxaban, Xarelto) or for the prevention of systemic embolism in non-valvular atrial fibrillation (rivaroxaban; dabigatran, Pradaxa; Apixaban, Eliquis)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22292869",
                    "endSection": "abstract",
                    "offsetInBeginSection": 208,
                    "offsetInEndSection": 326,
                    "text": "Apixaban, a direct Factor Xa inhibitor, is orally dosed, target selective and has few known drug or food interactions."
                }
            ]
        },
        {
            "body": "What in vivo tau tracers are being used?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25239654",
                "http://www.ncbi.nlm.nih.gov/pubmed/29564387",
                "http://www.ncbi.nlm.nih.gov/pubmed/24833492",
                "http://www.ncbi.nlm.nih.gov/pubmed/28914736",
                "http://www.ncbi.nlm.nih.gov/pubmed/17080730",
                "http://www.ncbi.nlm.nih.gov/pubmed/28587897",
                "http://www.ncbi.nlm.nih.gov/pubmed/25572087",
                "http://www.ncbi.nlm.nih.gov/pubmed/27683159",
                "http://www.ncbi.nlm.nih.gov/pubmed/28106992",
                "http://www.ncbi.nlm.nih.gov/pubmed/28314821"
            ],
            "id": "5a7d5580faa1ab7d2e00001a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25239654",
                    "endSection": "abstract",
                    "offsetInBeginSection": 348,
                    "offsetInEndSection": 496,
                    "text": "Recently, several tau PET tracers including T807, THK-5117, and PBB3 have been developed and succeeded in imaging neurofibrillary pathology in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29564387",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1153,
                    "offsetInEndSection": 1381,
                    "text": "Tracers are now being developed for evaluation of tau protein, which is associated with decreased cognitive function and neurodegenerative changes in AD, and is implicated in the pathogenesis of other neurodegenerative diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24833492",
                    "endSection": "abstract",
                    "offsetInBeginSection": 526,
                    "offsetInEndSection": 658,
                    "text": "Selective PET radiotracers for amyloid-\u03b2 are already available, and potential tau tracers are emerging as new-generation biomarkers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28914736",
                    "endSection": "abstract",
                    "offsetInBeginSection": 714,
                    "offsetInEndSection": 887,
                    "text": "Although diagnostic accuracy remains deceiving in non-Alzheimer's disease tauopathies, positron emission tomography tau tracers could be used to monitor disease progression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17080730",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1354,
                    "offsetInEndSection": 1550,
                    "text": "The possibility of in vivo detection of tau-positive amyloid lesions has been demonstrated by intravenous administration of potential tracers into tau transgenic mice and subsequent brain imaging."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28587897",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 191,
                    "text": "The recent development of tau-specific positron emission tomography (PET) tracers enables in vivo quantification of regional tau pathology, one of the key lesions in Alzheimer's disease (AD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25239654",
                    "endSection": "abstract",
                    "offsetInBeginSection": 497,
                    "offsetInEndSection": 692,
                    "text": "For use of tau PET as a biomarker of tau pathology in Alzheimer's disease, PET tracers should have high affinity to PHF-tau and high selectivity for tau over amyloid-\u03b2 and other protein deposits."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25572087",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 77,
                    "text": "Cortical laminar binding of PET amyloid and tau tracers in Alzheimer disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27683159",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 258,
                    "text": "BACKGROUND\nThe recent development of tau-specific positron emission tomography (PET) tracers has allowed in vivo quantification of regional tau deposition and offers the opportunity to monitor the progression of tau pathology along with cognitive impairment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29564387",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1493,
                    "offsetInEndSection": 1718,
                    "text": "Development of tau tracers comprises in-depth characterisation of existing radiotracers, clinical validation, a better understanding of uptake patterns, test-retest/dosimetry data, and neuropathological correlations with PET."
                }
            ]
        },
        {
            "body": "What is the Formalin test used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/9431444",
                "http://www.ncbi.nlm.nih.gov/pubmed/9147033",
                "http://www.ncbi.nlm.nih.gov/pubmed/6493793",
                "http://www.ncbi.nlm.nih.gov/pubmed/9231869",
                "http://www.ncbi.nlm.nih.gov/pubmed/8731171",
                "http://www.ncbi.nlm.nih.gov/pubmed/19168051",
                "http://www.ncbi.nlm.nih.gov/pubmed/20832171",
                "http://www.ncbi.nlm.nih.gov/pubmed/1484716",
                "http://www.ncbi.nlm.nih.gov/pubmed/2438584",
                "http://www.ncbi.nlm.nih.gov/pubmed/6087789"
            ],
            "id": "5abbfd97fcf456587200001d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9431444",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 145,
                    "text": "The formalin test for nociception, predominantly used with rodents, is characterized by continuous pain due to tissue injury induced by formalin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9147033",
                    "endSection": "abstract",
                    "offsetInBeginSection": 764,
                    "offsetInEndSection": 877,
                    "text": "It is concluded that baclofen antinociception in the formalin test is mediated through GABAB receptor activation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6493793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 62,
                    "text": "The formalin test has been used in monkeys for assessing pain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9231869",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 72,
                    "text": "The formalin test is a valuable tool widely used in animal pain studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8731171",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 164,
                    "text": "While the formalin test is a widely used behavioral model of tonic chemogenic pain, little is known about the responses of primary afferent nociceptors to formalin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19168051",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 135,
                    "text": "The formalin test is used as a primary behavioural screen for assaying the antinociceptive activity of compounds in laboratory rodents."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20832171",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 197,
                    "text": "Although the formalin test is a widely used model of persistent pain, the primary afferent fiber types that underlie the cellular and behavioral responses to formalin injection are largely unknown."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9431444",
                    "endSection": "abstract",
                    "offsetInBeginSection": 146,
                    "offsetInEndSection": 357,
                    "text": "In addition to the pain generated by formalin itself, the classical formalin test for nociception comprises a number of additional strong stressful events such as restraint and injury caused by needle insertion."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9147033",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 95,
                    "text": "Involvement of GABAB receptors in the antinociception induced by baclofen in the formalin test."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1484716",
                    "endSection": "abstract",
                    "offsetInBeginSection": 110,
                    "offsetInEndSection": 318,
                    "text": "The formalin test, which is based on these observations, is now widely used as a model of pain produced by tissue injury, but the neural mechanisms of pain and analgesia in this test have not been identified."
                }
            ]
        },
        {
            "body": "What drug treatment can cause a spinal epidural hematoma?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21799620",
                "http://www.ncbi.nlm.nih.gov/pubmed/28614233",
                "http://www.ncbi.nlm.nih.gov/pubmed/29696120",
                "http://www.ncbi.nlm.nih.gov/pubmed/15202871",
                "http://www.ncbi.nlm.nih.gov/pubmed/9471143",
                "http://www.ncbi.nlm.nih.gov/pubmed/8886740",
                "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                "http://www.ncbi.nlm.nih.gov/pubmed/21082060",
                "http://www.ncbi.nlm.nih.gov/pubmed/8447556",
                "http://www.ncbi.nlm.nih.gov/pubmed/12592554"
            ],
            "id": "5ab90a79fcf456587200001b",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21799620",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "Drug interaction as cause of spontaneously resolving epidural spinal hematoma on warfarin therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28614233",
                    "endSection": "abstract",
                    "offsetInBeginSection": 96,
                    "offsetInEndSection": 222,
                    "text": "Even though spinal epidural hematoma after caudal epidural injection is rare but it can cause serious neurologic complication."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29696120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "Introduction\nSpontaneous spinal epidural hematoma (SSEH) is a rare condition that can potentially cause paraplegia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15202871",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 83,
                    "text": "Spinal epidural hematoma (SEH) is an uncommon cause of acute cauda equina syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9471143",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "Spontaneous spinal epidural hematoma (SSEH) is an uncommon cause of acute nontraumatic myelopathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8886740",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "Epidural hematoma is a rare cause of spinal cord compression, which usually provokes severe neurological deficits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                    "endSection": "abstract",
                    "offsetInBeginSection": 277,
                    "offsetInEndSection": 370,
                    "text": "Spontaneous spinal epidural hematoma is an uncommon phenomenon and may be of uncertain cause."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21082060",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1079,
                    "offsetInEndSection": 1161,
                    "text": "Surgical treatment is an effective option to resolve the spinal epidural hematoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8447556",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 129,
                    "text": "PURPOSE\nAlthough intracranial hemorrhage remains a leading cause of death in hemophilia, spinal epidural hematoma is seen rarely."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12592554",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "Chronic spontaneous spinal epidural hematoma -- a rare cause of cervical myelopathy."
                }
            ]
        },
        {
            "body": "List diseases caused by protein glutamine expanded repeats",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19429504",
                "http://www.ncbi.nlm.nih.gov/pubmed/10502825",
                "http://www.ncbi.nlm.nih.gov/pubmed/26517966",
                "http://www.ncbi.nlm.nih.gov/pubmed/21610160",
                "http://www.ncbi.nlm.nih.gov/pubmed/25320121",
                "http://www.ncbi.nlm.nih.gov/pubmed/18216249",
                "http://www.ncbi.nlm.nih.gov/pubmed/10098399",
                "http://www.ncbi.nlm.nih.gov/pubmed/8202492",
                "http://www.ncbi.nlm.nih.gov/pubmed/9932422",
                "http://www.ncbi.nlm.nih.gov/pubmed/9852144"
            ],
            "id": "5ac2776195d0062724000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19429504",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 184,
                    "text": "Huntington's Disease (HD) is a rare neurodegenerative disease caused by mutation of the huntingtin gene that results in a protein with an expanded stretch of glutamine repeats (polyQ)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10502825",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "Huntington disease (HD) is a genetically dominant condition caused by expanded CAG repeats coding for glutamine in the HD gene product huntingtin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26517966",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "BACKGROUND\nPolyglutamine (polyQ) disorders are caused by expanded CAG (Glutamine) repeats in neurons in the brain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21610160",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "Expanded glutamine repeats of the ataxin-2 (ATXN2) protein cause spinocerebellar ataxia type 2 (SCA2), a rare neurodegenerative disorder."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25320121",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 189,
                    "text": "Polyglutamine diseases, including spinocerebellar ataxia type 3 (SCA3), are caused by CAG repeat expansions that encode abnormally long glutamine repeats in the respective disease proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18216249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 159,
                    "text": "Polyglutamine diseases are inherited neurodegenerative disorders caused by expansion of CAG repeats encoding a glutamine tract in the disease-causing proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10098399",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 120,
                    "text": "Eight severe inherited neurodegenerative diseases are caused by expansion of glutamine repeats in the affected proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8202492",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "Four inherited neurodegenerative diseases are linked to abnormally expanded repeats of glutamine residues in the affected proteins."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9932422",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "Pathogenesis of neurodegenerative diseases associated with expanded glutamine repeats: new answers, new questions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9852144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 155,
                    "text": "The inherited neurodegenerative diseases caused by an expanded glutamine repeat share the pathologic feature of intranuclear aggregates or inclusions (NI)."
                }
            ]
        },
        {
            "body": "What is the nucleotide composition of the Lamin Associated Domains (LADs)?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                "http://www.ncbi.nlm.nih.gov/pubmed/26654219",
                "http://www.ncbi.nlm.nih.gov/pubmed/23934658",
                "http://www.ncbi.nlm.nih.gov/pubmed/26883443",
                "http://www.ncbi.nlm.nih.gov/pubmed/28424353",
                "http://www.ncbi.nlm.nih.gov/pubmed/25602132",
                "http://www.ncbi.nlm.nih.gov/pubmed/23964094",
                "http://www.ncbi.nlm.nih.gov/pubmed/25784758",
                "http://www.ncbi.nlm.nih.gov/pubmed/15636422",
                "http://www.ncbi.nlm.nih.gov/pubmed/24717229"
            ],
            "id": "5a86e6fafaa1ab7d2e000036",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 856,
                    "offsetInEndSection": 1006,
                    "text": "De novo formation of adipogenic lamin A/C LADs occurs nonrandomly on GADs, which consist of megabase-size intergenic and repressive chromatin domains."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 143,
                    "offsetInEndSection": 378,
                    "text": "Here, we provide evidence for prepatterning of differentiation-driven formation of lamin A/C LADs by domains of histone H2B modified on serine 112 by the nutrient sensor O-linked N-acetylglucosamine (H2BS112GlcNAc), which we term GADs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1007,
                    "offsetInEndSection": 1159,
                    "text": "Accordingly, whereas predifferentiation lamin A/C LADs are gene-rich, post-differentiation LADs harbor repressive features reminiscent of lamin B1 LADs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1378,
                    "offsetInEndSection": 1586,
                    "text": "Our results unveil an epigenetic prepatterning of adipogenic LADs by GADs, suggesting a coupling of developmentally regulated lamin A/C-genome interactions to a metabolically sensitive chromatin modification."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26654219",
                    "endSection": "abstract",
                    "offsetInBeginSection": 250,
                    "offsetInEndSection": 424,
                    "text": "We reveal that the autophagy protein LC3/Atg8 directly interacts with the nuclear lamina protein LMNB1 (lamin B1), and binds to LMN/lamin-associated chromatin domains (LADs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 727,
                    "offsetInEndSection": 855,
                    "text": "Lamin A/C LADs are found both in active and repressive chromatin contexts that can be influenced by cell differentiation status."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23934658",
                    "endSection": "abstract",
                    "offsetInBeginSection": 602,
                    "offsetInEndSection": 855,
                    "text": "Mesas form at lamin B1-associated domains (LADs) in replicative senescence and oncogene-induced senescence and overlap DNA hypomethylation regions in cancer, suggesting that pre-malignant senescent chromatin changes foreshadow epigenetic cancer changes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 142,
                    "text": "Dynamic interactions of nuclear lamins with chromatin through lamin-associated domains (LADs) contribute to spatial arrangement of the genome."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "Prepatterning of differentiation-driven nuclear lamin A/C-associated chromatin domains by GlcNAcylated histone H2B."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1160,
                    "offsetInEndSection": 1377,
                    "text": "Release of lamin A/C from genes directly involved in glycolysis concurs with their transcriptional up-regulation after adipogenic induction, and with downstream elevations in H2BS112GlcNAc levels and O-GlcNAc cycling."
                }
            ]
        },
        {
            "body": "What is the clathrin triskelia structure?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27410749",
                "http://www.ncbi.nlm.nih.gov/pubmed/27574975",
                "http://www.ncbi.nlm.nih.gov/pubmed/7738035",
                "http://www.ncbi.nlm.nih.gov/pubmed/11460887",
                "http://www.ncbi.nlm.nih.gov/pubmed/11795487",
                "http://www.ncbi.nlm.nih.gov/pubmed/11943181",
                "http://www.ncbi.nlm.nih.gov/pubmed/10926122",
                "http://www.ncbi.nlm.nih.gov/pubmed/1587861",
                "http://www.ncbi.nlm.nih.gov/pubmed/10630373",
                "http://www.ncbi.nlm.nih.gov/pubmed/15858577"
            ],
            "id": "5ad4dd93133db5eb78000008",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27410749",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "The assembly of clathrin triskelia into polyhedral cages during endocytosis is regulated by adaptor proteins (APs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27574975",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 155,
                    "text": "The clathrin heavy chain N-terminal domain interacts with endocytic adapter proteins via clathrin binding motifs to assemble clathrin triskelia into cages."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7738035",
                    "endSection": "abstract",
                    "offsetInBeginSection": 573,
                    "offsetInEndSection": 727,
                    "text": "The 16-kDa C-terminal region of AP-3 can bind to clathrin cages, but cannot bind to clathrin triskelia or assemble clathrin triskelia into clathrin cages."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11460887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 116,
                    "offsetInEndSection": 235,
                    "text": "Binding of clathrin assembly protein to clathrin triskelia induces their assembly into clathrin-coated vesicles (CCVs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11795487",
                    "endSection": "abstract",
                    "offsetInBeginSection": 283,
                    "offsetInEndSection": 402,
                    "text": "Binding of clathrin assembly protein to clathrin triskelia induces their assembly into clathrin-coated vesicles (CCVs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11943181",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 75,
                    "text": "Clathrin light chains (CLCs) are regulatory subunits of clathrin triskelia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10926122",
                    "endSection": "abstract",
                    "offsetInBeginSection": 629,
                    "offsetInEndSection": 767,
                    "text": "However, 33 kD N-terminal domain of CALM could not bind pre-assembled clathrin cages, but assemble clathrin triskelia into clathrin cages."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7738035",
                    "endSection": "abstract",
                    "offsetInBeginSection": 420,
                    "offsetInEndSection": 572,
                    "text": "The 42-kDa central region of AP-3 can bind to both clathrin triskelia and to clathrin cages, but cannot assemble clathrin triskelia into clathrin cages."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7738035",
                    "endSection": "abstract",
                    "offsetInBeginSection": 228,
                    "offsetInEndSection": 419,
                    "text": "The 58-kDa C-terminal region of AP-3 is able to bind to clathrin triskelia and assemble them into a homogeneous population of clathrin cages and will also bind to preassembled clathrin cages."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1587861",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 87,
                    "text": "Recognition sites for clathrin-associated proteins AP-2 and AP-3 on clathrin triskelia."
                }
            ]
        },
        {
            "body": "What is myelin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25682762",
                "http://www.ncbi.nlm.nih.gov/pubmed/26776480",
                "http://www.ncbi.nlm.nih.gov/pubmed/7650750",
                "http://www.ncbi.nlm.nih.gov/pubmed/16712958",
                "http://www.ncbi.nlm.nih.gov/pubmed/10854769",
                "http://www.ncbi.nlm.nih.gov/pubmed/8590221",
                "http://www.ncbi.nlm.nih.gov/pubmed/21343408",
                "http://www.ncbi.nlm.nih.gov/pubmed/9097074",
                "http://www.ncbi.nlm.nih.gov/pubmed/7683887",
                "http://www.ncbi.nlm.nih.gov/pubmed/6184122"
            ],
            "id": "5abcf108fcf4565872000025",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25682762",
                    "endSection": "abstract",
                    "offsetInBeginSection": 812,
                    "offsetInEndSection": 903,
                    "text": "The myelin sheath is generated by myelin membrane fusion inside an oligodendrocyte process."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26776480",
                    "endSection": "abstract",
                    "offsetInBeginSection": 841,
                    "offsetInEndSection": 980,
                    "text": "Chondrichthyans central nervous system (CNS) myelin composition is also very similar to peripheral nervous system (PNS) myelin composition."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25682762",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 130,
                    "text": "CNS myelin sheath is stochastically built by homotypic fusion of myelin membranes within the bounds of an oligodendrocyte process."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26776480",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 158,
                    "text": "Myelin is probably one of the most fascinating and innovative biological acquisition: a glia plasma membrane tightly wrapped around an axon and insulating it."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25682762",
                    "endSection": "abstract",
                    "offsetInBeginSection": 235,
                    "offsetInEndSection": 359,
                    "text": "It is pertinent to ask how myelin is built because oligodendrocyte plasma membrane and myelin are compositionally different."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7650750",
                    "endSection": "abstract",
                    "offsetInBeginSection": 131,
                    "offsetInEndSection": 279,
                    "text": "The emphasis is on CNS myelin of adult mammals although both central nervous system (CNS) and peripheral nervous system (PNS) myelin are considered."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16712958",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "Antibodies directed against myelin components have been described in multiple sclerosis (MS)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10854769",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 124,
                    "text": "Myelin-associated oligodendrocytic basic protein is a member of the proteins constituting the central nervous system myelin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25682762",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "Myelin - the multilayer membrane that envelops axons - is a facilitator of rapid nerve conduction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7650750",
                    "endSection": "abstract",
                    "offsetInBeginSection": 440,
                    "offsetInEndSection": 569,
                    "text": "Special attention is paid to myelin swelling phenomena because these indicate ways in which the myelin multilayer can break down."
                }
            ]
        },
        {
            "body": "Is Brucella abortus the organism that causes brucillosis known to cause spontaneous abortions in humans?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16368972",
                "http://www.ncbi.nlm.nih.gov/pubmed/18390151",
                "http://www.ncbi.nlm.nih.gov/pubmed/16739129",
                "http://www.ncbi.nlm.nih.gov/pubmed/28167945",
                "http://www.ncbi.nlm.nih.gov/pubmed/26578650",
                "http://www.ncbi.nlm.nih.gov/pubmed/24609497",
                "http://www.ncbi.nlm.nih.gov/pubmed/10564509",
                "http://www.ncbi.nlm.nih.gov/pubmed/21829705",
                "http://www.ncbi.nlm.nih.gov/pubmed/19824392",
                "http://www.ncbi.nlm.nih.gov/pubmed/27800616"
            ],
            "id": "5aa6800ad6d6b54f79000011",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16368972",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 132,
                    "text": "Brucella abortus is a facultative, intracellular zoonotic pathogen which can cause undulant fever in humans and abortions in cattle."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18390151",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "Brucella abortus is a bacterium which causes abortions and infertility in cattle and undulant fever in humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16739129",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 125,
                    "text": "Brucella abortus is the etiologic agent of bovine brucellosis and causes a chronic disease in humans known as undulant fever."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28167945",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 186,
                    "text": "Brucella abortus is a Gram-negative, facultative intracellular bacterium that causes brucellosis, a worldwide zoonotic disease leading to undulant fever in humans and abortion in cattle."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26578650",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 186,
                    "text": "Brucella abortus is a Gram-negative intracellular bacterial pathogen that causes a zoonosis of worldwide occurrence, leading to undulant fever in humans and abortion in domestic animals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24609497",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 194,
                    "text": "Brucella abortus is a gram-negative, facultative intracellular pathogen that causes brucellosis, a chronic zoonotic disease resulting in abortion in pregnant cattle and undulant fever in humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16368972",
                    "endSection": "abstract",
                    "offsetInBeginSection": 133,
                    "offsetInEndSection": 246,
                    "text": "A 14-kDa protein of B. abortus was previously identified to be immunogenic in animals infected with Brucella spp."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10564509",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 166,
                    "text": "Brucella abortus is a facultative intracellular pathogen that causes abortion and infertility in domestic animals and a severe debilitating febrile illness in humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21829705",
                    "endSection": "abstract",
                    "offsetInBeginSection": 273,
                    "offsetInEndSection": 486,
                    "text": "In this study, we addressed the role of type I IFN signaling during Brucella abortus infection, a facultative intracellular bacterial pathogen that causes abortion in domestic animals and undulant fever in humans."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16368972",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 80,
                    "text": "Role in virulence of a Brucella abortus protein exhibiting lectin-like activity."
                }
            ]
        },
        {
            "body": "What percentage of Homo sapiens DNA is of Neanderthal origin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/7942855",
                "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                "http://www.ncbi.nlm.nih.gov/pubmed/10788336",
                "http://www.ncbi.nlm.nih.gov/pubmed/21404232",
                "http://www.ncbi.nlm.nih.gov/pubmed/18768141",
                "http://www.ncbi.nlm.nih.gov/pubmed/6791506",
                "http://www.ncbi.nlm.nih.gov/pubmed/28348941",
                "http://www.ncbi.nlm.nih.gov/pubmed/19781697",
                "http://www.ncbi.nlm.nih.gov/pubmed/21445243",
                "http://www.ncbi.nlm.nih.gov/pubmed/25481629"
            ],
            "id": "5ace1a590340b9f05800000b",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7942855",
                    "endSection": "abstract",
                    "offsetInBeginSection": 470,
                    "offsetInEndSection": 670,
                    "text": "Although ancient, none of these haplogroups is old enough to be compatible with a Neanderthal origin, suggesting that Homo sapiens sapiens displaced H. s. neanderthaliensis, rather than mixed with it."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 246,
                    "text": "The retrieval of Neanderthal (Homo neanderthalsensis) mitochondrial DNA is thought to be among the most significant ancient DNA contributions to date, allowing conflicting hypotheses on modern human (Homo sapiens) evolution to be tested directly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10788336",
                    "endSection": "abstract",
                    "offsetInBeginSection": 146,
                    "offsetInEndSection": 565,
                    "text": "When hybridized with genomic DNA of either human or Neanderthal origin, DNA extracted from two Neanderthal finds-the Os parietale, from Warendorf-Neuwarendorf, Germany, and a clavicula, from Krapina, Croatia-was shown to yield hybridization signals that differ by at least a factor of two compared to the signals obtained with the use of fossil DNA of an early Homo sapiens from the Vogelherd cave (Stetten I), Germany."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21404232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1290,
                    "offsetInEndSection": 1427,
                    "text": "Based on the results, it is suggested that the Homo sapiens non-supranuchal fossa and Neanderthal suprainiac fossa are convergent traits."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21404232",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 89,
                    "text": "Are Homo sapiens nonsupranuchal fossa and Neanderthal suprainiac fossa convergent traits?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21404232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 500,
                    "offsetInEndSection": 740,
                    "text": "In this article, the hypothesis that the Homo sapiens non-supranuchal fossa and the Neanderthal suprainiac fossa both formed to maintain the optimal shape of the occipital plane (to minimize strain on the posterior cranial vault) is tested."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18768141",
                    "endSection": "abstract",
                    "offsetInBeginSection": 138,
                    "offsetInEndSection": 329,
                    "text": "To study how the Neanderthal private alleles may have spread over the genes of Homo sapiens, we propose a deterministic model based on recursive equations and ordinary differential equations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21404232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 243,
                    "offsetInEndSection": 499,
                    "text": "However, while anatomical differences between Neanderthal suprainiac fossa and the depression in the inion region of the occipital bone of fossil and recent Homo sapiens have been discussed in detail, the etiology of these structures has not been resolved."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21404232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 85,
                    "offsetInEndSection": 242,
                    "text": "This was a result of a detailed analysis of the internal bone composition in the area of the suprainiac depression on Neanderthal and Homo sapiens specimens."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18768141",
                    "endSection": "abstract",
                    "offsetInBeginSection": 998,
                    "offsetInEndSection": 1164,
                    "text": "We find that the power to reject ancient admixture might be particularly low if the population size of Homo sapiens was comparable to the Neanderthal population size."
                }
            ]
        },
        {
            "body": "What is Dupuytren's contracture?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18847012",
                "http://www.ncbi.nlm.nih.gov/pubmed/3744141",
                "http://www.ncbi.nlm.nih.gov/pubmed/24024053",
                "http://www.ncbi.nlm.nih.gov/pubmed/3225413",
                "http://www.ncbi.nlm.nih.gov/pubmed/1345125",
                "http://www.ncbi.nlm.nih.gov/pubmed/22448555",
                "http://www.ncbi.nlm.nih.gov/pubmed/26152183",
                "http://www.ncbi.nlm.nih.gov/pubmed/22872850",
                "http://www.ncbi.nlm.nih.gov/pubmed/20676061",
                "http://www.ncbi.nlm.nih.gov/pubmed/190684"
            ],
            "id": "5abcf66afcf4565872000026",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18847012",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 168,
                    "text": "Dupuytren's contracture is a connective tissue disorder characterized by contractile palmar aponeurosis leading to shortening and progressive digital flexion deformity."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3744141",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 48,
                    "text": "[Dupuytren's contracture as an accident sequela."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24024053",
                    "endSection": "abstract",
                    "offsetInBeginSection": 346,
                    "offsetInEndSection": 421,
                    "text": "Dupuytren's contracture is a common disease, especially in Northern Europe."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3225413",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 102,
                    "text": "Microvascular occlusion has been implicated as a possible causative factor of Dupuytren's contracture."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3744141",
                    "endSection": "title",
                    "offsetInBeginSection": 49,
                    "offsetInEndSection": 129,
                    "text": "Can progression of Dupuytren's contracture be recognized as an accident sequela?"
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24024053",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 72,
                    "text": "Dupuytren's Contracture Cosegregation with Limb-Girdle Muscle Dystrophy."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1345125",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 69,
                    "text": "Vibration white finger and Dupuytren's contracture: are they related?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22448555",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 89,
                    "text": "Dupuytren's contracture forms nodules and fibril bundles causing the fingers to contract."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26152183",
                    "endSection": "abstract",
                    "offsetInBeginSection": 694,
                    "offsetInEndSection": 785,
                    "text": "CONCLUSIONS\nDupuytren's contracture is not a known side effect of BRAF inhibitor treatment."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22448555",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 26,
                    "text": "[Dupuytren's contracture]."
                }
            ]
        },
        {
            "body": "What phenotype is associated with the V60L mutation in the human MC1R gene?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                "http://www.ncbi.nlm.nih.gov/pubmed/19725989",
                "http://www.ncbi.nlm.nih.gov/pubmed/18717860",
                "http://www.ncbi.nlm.nih.gov/pubmed/18803811",
                "http://www.ncbi.nlm.nih.gov/pubmed/22259655",
                "http://www.ncbi.nlm.nih.gov/pubmed/12006619",
                "http://www.ncbi.nlm.nih.gov/pubmed/18637132",
                "http://www.ncbi.nlm.nih.gov/pubmed/19924138",
                "http://www.ncbi.nlm.nih.gov/pubmed/16567973",
                "http://www.ncbi.nlm.nih.gov/pubmed/21737053"
            ],
            "id": "5ace2d600340b9f05800000e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1145,
                    "offsetInEndSection": 1393,
                    "text": "RESULTS\nCarrying any one of the four most frequent MC1R variants (V60L, V92M, R151C, R160W) in CDKN2A mutation carriers was associated with a statistically significantly increased risk for melanoma across all continents (1.24 \u00d7 10(-6) \u2264 P \u2264 .0007)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 700,
                    "offsetInEndSection": 1019,
                    "text": "In this family-based study, we assessed the associations of the four most frequent MC1R variants (V60L, V92M, R151C, and R160W) and the number of variants (1, \u22652 variants), alone or jointly with the host phenotypes (hair color, propensity to sunburn, and number of nevi), with melanoma risk in CDKN2A mutation carriers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19725989",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1080,
                    "offsetInEndSection": 1191,
                    "text": "Common recurrent variants of the MC1R gene (V60L, R151C, R163Q and R160W) may predispose to malignant melanoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18717860",
                    "endSection": "abstract",
                    "offsetInBeginSection": 428,
                    "offsetInEndSection": 654,
                    "text": "The genotypic findings of six MC1R gene variants (V60L, D84E, R150C, R160W, R163Q, and T314T) in 116 healthy individuals from a population-based cohort with at least three generations of Canary Islands' ancestry are evaluated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2017,
                    "offsetInEndSection": 2163,
                    "text": "CONCLUSION\nResults show that MC1R variants, hair color, and number of nevi were jointly associated with melanoma risk in CDKN2A mutation carriers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18803811",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1702,
                    "offsetInEndSection": 1957,
                    "text": "Most frequently found variants of the MC1R gene were T314T, V60L, V92M, R151C, R160W and R163Q with frequencies slightly higher in the group of patients and their relatives than in the group of controls, but the difference was statistically insignificant."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22259655",
                    "endSection": "abstract",
                    "offsetInBeginSection": 918,
                    "offsetInEndSection": 1016,
                    "text": "In MC1R polymorphic fibroblasts (R163Q, R151C and V60L) both effects are significantly alleviated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 134,
                    "offsetInEndSection": 348,
                    "text": "Penetrance of CDKN2A mutations is modified by pigmentation characteristics, nevus phenotypes, and some variants of the melanocortin-1 receptor gene (MC1R), which is known to have a role in the pigmentation process."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 113,
                    "text": "Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12006619",
                    "endSection": "abstract",
                    "offsetInBeginSection": 366,
                    "offsetInEndSection": 527,
                    "text": "The human MC1R gene is highly polymorphic and certain allelic variants of the gene are associated with red hair phenotype, melanoma and non-melanoma skin cancer."
                }
            ]
        },
        {
            "body": "List proteins with HEAT repeats",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26793205",
                "http://www.ncbi.nlm.nih.gov/pubmed/23570942",
                "http://www.ncbi.nlm.nih.gov/pubmed/14970380",
                "http://www.ncbi.nlm.nih.gov/pubmed/10361086",
                "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                "http://www.ncbi.nlm.nih.gov/pubmed/10378263",
                "http://www.ncbi.nlm.nih.gov/pubmed/9673349",
                "http://www.ncbi.nlm.nih.gov/pubmed/12379151",
                "http://www.ncbi.nlm.nih.gov/pubmed/19777061",
                "http://www.ncbi.nlm.nih.gov/pubmed/21708948"
            ],
            "id": "5abd44b1fcf4565872000030",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26793205",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1113,
                    "offsetInEndSection": 1274,
                    "text": "Such as Armadillo (ARM), Ankyrin (ANK), HEAT, Kelch-like repeats, Tetratricopeptide (TPR), Leucine rich repeats (LRR), WD40, and Pentatricopeptide repeats (PPR)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23570942",
                    "endSection": "abstract",
                    "offsetInBeginSection": 663,
                    "offsetInEndSection": 675,
                    "text": "moderators)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14970380",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "The Noc proteins involved in ribosome synthesis and export contain divergent HEAT repeats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10361086",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 227,
                    "text": "The recent elucidation of protein structures based upon repeating amino acid motifs, including the armadillo motif, the HEAT motif and tetratricopeptide repeats, reveals that they belong to the class of helical repeat proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 155,
                    "offsetInEndSection": 438,
                    "text": "Using sensitive sequence analysis techniques we detected HEAT repeats in various chromosome-associated proteins, including four families of proteins associated with condensins and cohesins, which are nuclear complexes that contain structural maintenance of chromosome (SMC) proteins."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "HEAT repeats associated with condensins, cohesins, and other complexes involved in chromosome-related functions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10378263",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 151,
                    "text": "The recently determined crystal structure of the PR65/A subunit of protein phosphatase 2A reveals the architecture of proteins containing HEAT repeats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9673349",
                    "endSection": "abstract",
                    "offsetInBeginSection": 478,
                    "offsetInEndSection": 652,
                    "text": "The protein contains a conserved positively charged tail and several HEAT repeats, designated after four functionally characterized proteins in which the repeat was detected."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1266,
                    "offsetInEndSection": 1498,
                    "text": "HEAT repeats also were found in dis1-TOG family and cofactor D family microtubule-associated proteins, which, owing to their roles in microtubule dynamics, perform functions related to mitotic progression and chromosome segregation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12379151",
                    "endSection": "abstract",
                    "offsetInBeginSection": 253,
                    "offsetInEndSection": 346,
                    "text": "Huntingtin is moderately conserved, with 10 HEAT repeats reported in its amino-terminal half."
                }
            ]
        },
        {
            "body": "What is the aim of  perfoming a \"cycloheximide chase assay\"?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16925598",
                "http://www.ncbi.nlm.nih.gov/pubmed/23432726",
                "http://www.ncbi.nlm.nih.gov/pubmed/21518760",
                "http://www.ncbi.nlm.nih.gov/pubmed/27283735",
                "http://www.ncbi.nlm.nih.gov/pubmed/23962426",
                "http://www.ncbi.nlm.nih.gov/pubmed/27987332",
                "http://www.ncbi.nlm.nih.gov/pubmed/16081639",
                "http://www.ncbi.nlm.nih.gov/pubmed/19151744",
                "http://www.ncbi.nlm.nih.gov/pubmed/29082276",
                "http://www.ncbi.nlm.nih.gov/pubmed/28880013"
            ],
            "id": "5ac08478d0c506ce46000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16925598",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1244,
                    "offsetInEndSection": 1361,
                    "text": "Finally, we show that Renilla luciferase may serve as a reporter of protein stability in a cycloheximide chase assay."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23432726",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1086,
                    "offsetInEndSection": 1256,
                    "text": "Finally, a cycloheximide chase assay indicated that coexpression of Chk11-365 decelerated the degradation of ectopically expressed RALT, but not that of the S250A mutant."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21518760",
                    "endSection": "abstract",
                    "offsetInBeginSection": 859,
                    "offsetInEndSection": 1015,
                    "text": "Cycloheximide chase assay showed a decrease in the half-life of KLF8 protein when PARP-1 expression was suppressed or KLF8-PARP-1 interaction was disrupted."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27283735",
                    "endSection": "abstract",
                    "offsetInBeginSection": 776,
                    "offsetInEndSection": 875,
                    "text": "Curcumin increased the rate of Tat protein degradation as shown by cycloheximide (CHX) chase assay."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23962426",
                    "endSection": "abstract",
                    "offsetInBeginSection": 880,
                    "offsetInEndSection": 1014,
                    "text": "The cycloheximide chase assay revealed that an S410L mutation in the Kelch domain significantly decreased the intracellular stability."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27987332",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1249,
                    "offsetInEndSection": 1386,
                    "text": "In addition, cycloheximide chase assay revealed that the half-life of VE-cadherin protein was dramatically reduced by Cullin 3 depletion."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16081639",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1878,
                    "offsetInEndSection": 2205,
                    "text": "Cycloheximide chase experiments with metalloprotease, proteasome, and lysosome inhibitors indicated that the enhanced stability of mature GHR conferred by JAK2 is not related to effects on constitutive receptor metalloproteolysis but rather is a result of reduced constitutive endosomal/lysosomal degradation of the mature GHR."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151744",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1649,
                    "offsetInEndSection": 1802,
                    "text": "Furthermore, the cycloheximide chase assay indicated that the degradation of Bcl-2 protein was extended in the BAG-1 p50 and p46 transfected MCF-7 cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151744",
                    "endSection": "abstract",
                    "offsetInBeginSection": 730,
                    "offsetInEndSection": 841,
                    "text": "The mechanism by which BAG-1 affected the function of Bcl-2 was exploredby using the cycloheximide chase assay."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29082276",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 63,
                    "text": "Analysis of Protein Stability by the Cycloheximide Chase Assay."
                }
            ]
        },
        {
            "body": "What is an exosome?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19111177",
                "http://www.ncbi.nlm.nih.gov/pubmed/16087368",
                "http://www.ncbi.nlm.nih.gov/pubmed/26725667",
                "http://www.ncbi.nlm.nih.gov/pubmed/27756426",
                "http://www.ncbi.nlm.nih.gov/pubmed/21618876",
                "http://www.ncbi.nlm.nih.gov/pubmed/21713679",
                "http://www.ncbi.nlm.nih.gov/pubmed/17174896",
                "http://www.ncbi.nlm.nih.gov/pubmed/26341056",
                "http://www.ncbi.nlm.nih.gov/pubmed/26601950",
                "http://www.ncbi.nlm.nih.gov/pubmed/25267620"
            ],
            "id": "5ac0a36f19833b0d7b000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19111177",
                    "endSection": "abstract",
                    "offsetInBeginSection": 112,
                    "offsetInEndSection": 223,
                    "text": "RNA exosomes are multisubunit complexes composed of at least nine distinct proteins that form the exosome core."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16087368",
                    "endSection": "abstract",
                    "offsetInBeginSection": 840,
                    "offsetInEndSection": 1074,
                    "text": "The Exosome Display technology is very versatile since soluble, membrane-bound, trans-membrane or multimeric antigens that are not naturally found on exosomes can now be efficiently expressed at their surface in a native conformation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16087368",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "Exosome Display is a novel methodology enabling the manipulation of exosome protein content."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26725667",
                    "endSection": "abstract",
                    "offsetInBeginSection": 689,
                    "offsetInEndSection": 841,
                    "text": "We selected lactadherin as an exosome tropic protein and developed it as a fusion protein with Gaussia luciferase to label exosomes for in vivo imaging."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16087368",
                    "endSection": "abstract",
                    "offsetInBeginSection": 383,
                    "offsetInEndSection": 571,
                    "text": "Exosome Display of soluble antigens and extracellular domains of membrane proteins that are not naturally found on exosomes occurs upon fusion of proteins with the Lactadherin C1C2 domain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16087368",
                    "endSection": "abstract",
                    "offsetInBeginSection": 572,
                    "offsetInEndSection": 723,
                    "text": "Exosome Display of native full-length membrane proteins can also be achieved by non-restricted expression or sampling of membrane proteins on exosomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27756426",
                    "endSection": "abstract",
                    "offsetInBeginSection": 151,
                    "offsetInEndSection": 187,
                    "text": "Exosome is an important part of TME."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21618876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 619,
                    "offsetInEndSection": 704,
                    "text": "These cofactors presumably direct the exosome to specific cytoplasmic RNA substrates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21713679",
                    "endSection": "abstract",
                    "offsetInBeginSection": 622,
                    "offsetInEndSection": 707,
                    "text": "These cofactors presumably direct the exosome to specific cytoplasmic RNA substrates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17174896",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "The RNA exosome is a multisubunit 3' to 5' exoribonuclease complex that participates in degradation and processing of cellular RNA."
                }
            ]
        },
        {
            "body": "Are human enhancers or promoters evolving faster?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21282711",
                "http://www.ncbi.nlm.nih.gov/pubmed/23479409",
                "http://www.ncbi.nlm.nih.gov/pubmed/23652427",
                "http://www.ncbi.nlm.nih.gov/pubmed/10843693",
                "http://www.ncbi.nlm.nih.gov/pubmed/24429298",
                "http://www.ncbi.nlm.nih.gov/pubmed/2104960",
                "http://www.ncbi.nlm.nih.gov/pubmed/28116828",
                "http://www.ncbi.nlm.nih.gov/pubmed/28288115",
                "http://www.ncbi.nlm.nih.gov/pubmed/1668145",
                "http://www.ncbi.nlm.nih.gov/pubmed/8356050"
            ],
            "id": "5ac3699f0340b9f058000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21282711",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1215,
                    "offsetInEndSection": 1328,
                    "text": "Promoters were primarily evolving under purifying selection but with certain categories of genes evolving faster."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23479409",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 86,
                    "text": "Porcine CD4 promoters and enhancers can direct foreign gene expression in human cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23479409",
                    "endSection": "abstract",
                    "offsetInBeginSection": 603,
                    "offsetInEndSection": 734,
                    "text": "The results indicated the porcine CD4 promoters and enhancers could effectively direct expression of a foreign gene in human cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23652427",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1112,
                    "offsetInEndSection": 1259,
                    "text": "I propose that these newly inserted segments may play a role in genome evolution by potentially functioning as novel exons, promoters or enhancers."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10843693",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "Regulation of germline promoters by the two human Ig heavy chain 3' alpha enhancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21282711",
                    "endSection": "abstract",
                    "offsetInBeginSection": 363,
                    "offsetInEndSection": 407,
                    "text": "dysgalactiae is strictly an animal pathogen."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24429298",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1112,
                    "offsetInEndSection": 1236,
                    "text": "These hominid-specific lincRNAs are more tissue specific, enriched for testis, and faster evolving within the human lineage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21282711",
                    "endSection": "abstract",
                    "offsetInBeginSection": 267,
                    "offsetInEndSection": 362,
                    "text": "equisimilis is both a human commensal organism and a human pathogen, and S. dysgalactiae subsp."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2104960",
                    "endSection": "abstract",
                    "offsetInBeginSection": 135,
                    "offsetInEndSection": 282,
                    "text": "3), for which binding sites are widely distributed in the promoters and enhancers of the globin gene family, and of other erythroid-specific genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21282711",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1436,
                    "offsetInEndSection": 1675,
                    "text": "Overall, these results suggest that adaptation to changing environments and new hosts in the SD species group has involved the acquisition of key virulence genes along with selection of orthologous protein-coding loci and operon promoters."
                }
            ]
        },
        {
            "body": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23953907",
                "http://www.ncbi.nlm.nih.gov/pubmed/24205696",
                "http://www.ncbi.nlm.nih.gov/pubmed/28198201",
                "http://www.ncbi.nlm.nih.gov/pubmed/12643318",
                "http://www.ncbi.nlm.nih.gov/pubmed/2363124",
                "http://www.ncbi.nlm.nih.gov/pubmed/23455714",
                "http://www.ncbi.nlm.nih.gov/pubmed/27626268",
                "http://www.ncbi.nlm.nih.gov/pubmed/24275169",
                "http://www.ncbi.nlm.nih.gov/pubmed/14727932",
                "http://www.ncbi.nlm.nih.gov/pubmed/3896792"
            ],
            "id": "5ac0f7b919833b0d7b000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23953907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 301,
                    "offsetInEndSection": 576,
                    "text": "Specific antidotes for the reversal of the anticoagulant effect of these drugs, such as monoclonal antibodies against the direct thrombin inhibitor dabigatran or recombinant Xa-analog in the case of factor Xa inhibitors, are still being investigated in early clinical trials."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24205696",
                    "endSection": "abstract",
                    "offsetInBeginSection": 90,
                    "offsetInEndSection": 337,
                    "text": "In addition to established agents such as warfarin, unfractionated heparin and low-molecular-weight heparins, a variety of new anticoagulant drugs has been introduced for clinical use, including direct thrombin inhibitors and factor Xa inhibitors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28198201",
                    "endSection": "abstract",
                    "offsetInBeginSection": 215,
                    "offsetInEndSection": 409,
                    "text": "Now, a specific antidote for the direct thrombin inhibitor, dabigatran has been approved for use, and antidotes for factor Xa inhibitors (rivaroxaban, apixaban and edoxaban) are being developed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12643318",
                    "endSection": "abstract",
                    "offsetInBeginSection": 286,
                    "offsetInEndSection": 691,
                    "text": "The in vitro anticoagulant profile of DX-9065a, a synthetic direct factor Xa inhibitor, was studied using activated clotting time assay, thrombelastography, and global clotting tests, such as prothrombin time (PT), activated partial thromboplastin time (aPTT), diluted aPTT, Heptest, Heptest-HI, dilute Russell's viper venom time (dRVVT), thrombin time, ecarin clotting time, and amidolytic anti-Xa assay."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2363124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 138,
                    "text": "The anticoagulant effect of selected synthetic inhibitors of thrombin and factor Xa was studied in vitro in commonly used clotting assays."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23455714",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 161,
                    "text": "Inhibitors of coagulation factor Xa (fXa) have emerged as a new class of antithrombotics but lack effective antidotes for patients experiencing serious bleeding."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27626268",
                    "endSection": "abstract",
                    "offsetInBeginSection": 716,
                    "offsetInEndSection": 949,
                    "text": "This is followed by analysing the present-day results of clinical trials aimed at working out pharmaceutical agents (andexanet alpha, idarucizumab, aripazine) being antidotes to direct thrombin inhibitor and the factor Xa inhibitors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24275169",
                    "endSection": "abstract",
                    "offsetInBeginSection": 254,
                    "offsetInEndSection": 450,
                    "text": "Major advances have been made in targeting downstream clotting factors in the coagulation cascade, resulting in two major new classes of drugs: direct thrombin inhibitors and factor Xa inhibitors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14727932",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1274,
                    "offsetInEndSection": 1716,
                    "text": "These include inhibitors of initiation of coagulation (tissue factor pathway inhibitor, nematode anticoagulant peptide and active-site blocked factor VIIa), inhibitors of propagation of coagulation (active-site blocked factor IXa, antibodies against factor IX/IXa, fondaparinux sodium, direct factor Xa inhibitors, protein C derivatives and soluble thrombomodulin), and thrombin inhibitors (hirudin, bivalirudin, argatroban and ximelagatran)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23953907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1060,
                    "offsetInEndSection": 1253,
                    "text": "Activated prothrombin complex concentrate seems promising for the reversal of dabigatran, while non-activated prothrombin complex concentrates have potential for the reversal of anti-factor Xa."
                }
            ]
        },
        {
            "body": "Which genes are associated with Epidermolysis Bullosa Simplex?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/7537032",
                "http://www.ncbi.nlm.nih.gov/pubmed/27766310",
                "http://www.ncbi.nlm.nih.gov/pubmed/21674528",
                "http://www.ncbi.nlm.nih.gov/pubmed/3355199",
                "http://www.ncbi.nlm.nih.gov/pubmed/20624679",
                "http://www.ncbi.nlm.nih.gov/pubmed/7899187",
                "http://www.ncbi.nlm.nih.gov/pubmed/2420118",
                "http://www.ncbi.nlm.nih.gov/pubmed/12655565",
                "http://www.ncbi.nlm.nih.gov/pubmed/12184667",
                "http://www.ncbi.nlm.nih.gov/pubmed/19945613"
            ],
            "id": "5ace34eb0340b9f058000010",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7537032",
                    "endSection": "abstract",
                    "offsetInBeginSection": 267,
                    "offsetInEndSection": 392,
                    "text": "The simplex forms of epidermolysis bullosa are caused by mutations in the genes for the basal epidermal keratins, K5 and K14."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27766310",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "Epidermolysis bullosa simplex with muscular dystrophy associated with PLEC deletion mutation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21674528",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 173,
                    "text": "Epidermolysis bullosa associated with muscular dystrophy is a rare, autosomal recessive form of epidermolysis bullosa simplex caused by mutations in the plectin gene, PLEC1."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3355199",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "Epidermolysis bullosa simplex associated with muscular dystrophy with recessive inheritance."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20624679",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 152,
                    "text": "Congenital muscular dystrophy, myasthenic symptoms and epidermolysis bullosa simplex (EBS) associated with mutations in the PLEC1 gene encoding plectin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7899187",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 77,
                    "text": "Epidermolysis bullosa simplex associated with muscular dystrophy: a new case."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7537032",
                    "endSection": "abstract",
                    "offsetInBeginSection": 809,
                    "offsetInEndSection": 1075,
                    "text": "Junctional epidermolysis bullosa is caused by mutations in the genes encoding different chains of the novel laminin isoform, nicein/kalinin, also known as laminin 5, which is associated with the anchoring filament-hemidesmosome complex of the basement membrane zone."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2420118",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "Epidermolysis bullosa simplex localisata associated with anodontia, hair and nail disorders: a new syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12655565",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 132,
                    "text": "Epidermolysis bullosa simplex is a group of blistering skin disorders caused by defects in one of the keratin genes, KRT5 and KRT14."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12184667",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 30,
                    "text": "Epidermolysis bullosa simplex."
                }
            ]
        },
        {
            "body": "What biologic process in the body is associated with Mast cells?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26840764",
                "http://www.ncbi.nlm.nih.gov/pubmed/10359893",
                "http://www.ncbi.nlm.nih.gov/pubmed/22706316",
                "http://www.ncbi.nlm.nih.gov/pubmed/8353280",
                "http://www.ncbi.nlm.nih.gov/pubmed/30188629",
                "http://www.ncbi.nlm.nih.gov/pubmed/18028996",
                "http://www.ncbi.nlm.nih.gov/pubmed/21185371",
                "http://www.ncbi.nlm.nih.gov/pubmed/1608656",
                "http://www.ncbi.nlm.nih.gov/pubmed/7726638",
                "http://www.ncbi.nlm.nih.gov/pubmed/8629992"
            ],
            "id": "5aac543bfcf4565872000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26840764",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 277,
                    "text": "Mast cell degranulation is the typical anaphylaxis process of mast cells associated with the release of cytokines, eicosanoids and their secretory granules, which play very important roles in the allergic inflammatory response of the human body upon anaphylactogen stimulation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10359893",
                    "endSection": "abstract",
                    "offsetInBeginSection": 335,
                    "offsetInEndSection": 501,
                    "text": "OBJECTIVE\nWe sought to determine the ability of HgCl2 to degranulate murine mast cells and promote cytokine secretion and whether this was an active biologic process."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22706316",
                    "endSection": "abstract",
                    "offsetInBeginSection": 328,
                    "offsetInEndSection": 454,
                    "text": "Lipid body accumulation in mast cells is associated with enhanced levels of leukotriene-synthesizing enzymes (LTC4S and 5-LO)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22706316",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1076,
                    "offsetInEndSection": 1299,
                    "text": "Lipid body accumulation in mast cells is mechanistically distinct from the process in adipocytes; for example, it is independent of PPAR\u03b3 up-regulation and does not involve significant accumulation of conjugated glycerides."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8353280",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1037,
                    "offsetInEndSection": 1475,
                    "text": "The prolonged biologic half-life of IL-3 was reproducibly associated with a threefold to fivefold increase in splenic mast-cell precursors over levels observed in mice treated with IL-3 alone; increases in the numbers of mature mucosal-type mast cells in the spleen, but not in the jejunum or lung; increases in IL-3-dependent colony-forming unit-cell in the spleen; and an apparent redistribution of mast cells away from the bone marrow."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/30188629",
                    "endSection": "abstract",
                    "offsetInBeginSection": 139,
                    "offsetInEndSection": 342,
                    "text": "This may be associated with mast cells, which are found in all body tissues of an organism, secrete a wide range of biologically active substances and are important in the regulation of repair processes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18028996",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 101,
                    "text": "Human mast cells release oncostatin M on contact with activated T cells: possible biologic relevance."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21185371",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1088,
                    "offsetInEndSection": 1286,
                    "text": "Understanding selective release of mediators could explain how mast cells participate in numerous diverse biologic processes, and how they exert both immunostimulatory and immunosuppressive actions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22706316",
                    "endSection": "abstract",
                    "offsetInBeginSection": 110,
                    "offsetInEndSection": 248,
                    "text": "Here, we test the hypothesis that insulin may regulate lipid body content in mast cells and hence, modify their proinflammatory potential."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10359893",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1473,
                    "offsetInEndSection": 1614,
                    "text": "These findings are consistent with recognition of HgCl2 as a biologically important environmentally derived immunotoxic agent for mast cells."
                }
            ]
        },
        {
            "body": "What are the 3 types of ultraviolet (UV) solar radiation?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17204418",
                "http://www.ncbi.nlm.nih.gov/pubmed/20519675",
                "http://www.ncbi.nlm.nih.gov/pubmed/21253661",
                "http://www.ncbi.nlm.nih.gov/pubmed/19360745",
                "http://www.ncbi.nlm.nih.gov/pubmed/23250626",
                "http://www.ncbi.nlm.nih.gov/pubmed/9704331",
                "http://www.ncbi.nlm.nih.gov/pubmed/22163847",
                "http://www.ncbi.nlm.nih.gov/pubmed/23113025",
                "http://www.ncbi.nlm.nih.gov/pubmed/12575720",
                "http://www.ncbi.nlm.nih.gov/pubmed/9346474"
            ],
            "id": "5aae6a86fcf456587200000e",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17204418",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 259,
                    "text": "Sunlight, skin cancer and vitamin D: What are the conclusions of recent findings that protection against solar ultraviolet (UV) radiation causes 25-hydroxyvitamin D deficiency in solid organ-transplant recipients, xeroderma pigmentosum, and other risk groups?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17204418",
                    "endSection": "abstract",
                    "offsetInBeginSection": 126,
                    "offsetInEndSection": 415,
                    "text": "We have shown that patients that have to protect themselves against solar UV radiation for medical reasons, including patients with xeroderma pigmentosum (XP), basal cell nevus syndrome (BCNS), lupus erythematodes (LE) or transplant recipients, are at risk to develop vitamin D deficiency."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20519675",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 149,
                    "text": "Ultraviolet (UV) radiation is an important environmental factor for plant communities; however, plant responses to solar UV are not fully understood."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21253661",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 97,
                    "text": "Ultraviolet radiation (UV) is a minor fraction of the solar spectrum reaching the ground surface."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19360745",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 162,
                    "text": "Epidemiological and experimental evidence has supported the notion that solar ultraviolet (UV) radiation is the leading cause of skin cell damage and skin cancer."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23250626",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 147,
                    "text": "Multiple roles for UV RESISTANCE LOCUS8 in regulating gene expression and metabolite accumulation in Arabidopsis under solar ultraviolet radiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9704331",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 232,
                    "text": "BACKGROUND\nTo test the effectiveness of commercially available ultraviolet (UV)-protective eye drops (8-hydroxy-1-methylchinolinium methylsulphate) which are recommended for protection against both solar and artificial UV radiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22163847",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 139,
                    "text": "Solar ultraviolet (UV) radiation is widely known as a genotoxic environmental agent that affects Earth ecosystems and the human population."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23113025",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "BACKGROUND\nIn general, measurements of solar ultraviolet (UV) radiation are related to horizontal surfaces."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17204418",
                    "endSection": "abstract",
                    "offsetInBeginSection": 416,
                    "offsetInEndSection": 610,
                    "text": "We conclude that 25-hydroxyvitamin D serum levels as a measure of vitamin D status have to be analyzed in patients that have to protect themselves against solar UV radiation for medical reasons."
                }
            ]
        },
        {
            "body": "Please list 10 conditions which play a role in causing atrial fibrillation.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12693508",
                "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                "http://www.ncbi.nlm.nih.gov/pubmed/16105015",
                "http://www.ncbi.nlm.nih.gov/pubmed/20685575",
                "http://www.ncbi.nlm.nih.gov/pubmed/27957098",
                "http://www.ncbi.nlm.nih.gov/pubmed/10569341",
                "http://www.ncbi.nlm.nih.gov/pubmed/9486937",
                "http://www.ncbi.nlm.nih.gov/pubmed/18496132",
                "http://www.ncbi.nlm.nih.gov/pubmed/26872434",
                "http://www.ncbi.nlm.nih.gov/pubmed/14574041"
            ],
            "id": "5aaef38dfcf456587200000f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12693508",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 314,
                    "text": "5-Hydroxytryptamine, a recent addition to the list of hormonal triggers for atrial fibrillation (AF), may play a pivotal role in the induction of AF related not only to cardiac surgery but also to acute coronary syndromes, valvular heart disease, cardiomyopathies, alcoholism, aging, and conducting tissue disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 288,
                    "offsetInEndSection": 453,
                    "text": "Of the long list of various cardiac conditions associated with an increased risk of cardioembolic strokes, non-valvular atrial fibrillation is the most common cause."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16105015",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 62,
                    "text": "Bachmann's bundle: does it play a role in atrial fibrillation?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20685575",
                    "endSection": "abstract",
                    "offsetInBeginSection": 328,
                    "offsetInEndSection": 560,
                    "text": "Increased activity of the enzyme calmodulin kinase II (CaMKII) and, specifically, enhanced CaMKII phosphorylation of ryanodine receptors appear to play a critical role in the induction and perhaps maintenance of atrial fibrillation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27957098",
                    "endSection": "abstract",
                    "offsetInBeginSection": 67,
                    "offsetInEndSection": 176,
                    "text": "It has a role to play in atrial fibrosis and remodeling which tends to propagate further atrial fibrillation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 963,
                    "offsetInEndSection": 1161,
                    "text": "Apart from atrial fibrillation, there is relatively limited evidence for the role of antithrombotic therapy for other cardiac conditions associated with cardioembolism and how long one should treat."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10569341",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 402,
                    "text": "In patients without left atrial spontaneous echo contrast, 78% had some embolic sources other than left atrial thrombus or spontaneous echo contrast, suggesting that these embolic sources play an important role in patients with nonvalvular atrial fibrillation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9486937",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1344,
                    "offsetInEndSection": 1447,
                    "text": "It is concluded that the mild class I effect of metoprolol does not play a role in atrial fibrillation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12693508",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 89,
                    "text": "5-hydroxytryptamine and atrial fibrillation: how significant is this piece in the puzzle?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18496132",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 177,
                    "text": "OBJECTIVES\nThe renin-angiotensin system may play a role in the pathogenesis of atrial fibrillation, and renin-angiotensin system blockers reduce the risk of atrial fibrillation."
                }
            ]
        },
        {
            "body": "Is p53 a transcription factor?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25755280",
                "http://www.ncbi.nlm.nih.gov/pubmed/22983008",
                "http://www.ncbi.nlm.nih.gov/pubmed/17383232",
                "http://www.ncbi.nlm.nih.gov/pubmed/9618472",
                "http://www.ncbi.nlm.nih.gov/pubmed/10446138",
                "http://www.ncbi.nlm.nih.gov/pubmed/20679336",
                "http://www.ncbi.nlm.nih.gov/pubmed/20805247",
                "http://www.ncbi.nlm.nih.gov/pubmed/15969767",
                "http://www.ncbi.nlm.nih.gov/pubmed/9215863",
                "http://www.ncbi.nlm.nih.gov/pubmed/9344880"
            ],
            "id": "5ac0817cd0c506ce46000001",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25755280",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "PATZ1 Is a DNA Damage-Responsive Transcription Factor That Inhibits p53 Function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25755280",
                    "endSection": "abstract",
                    "offsetInBeginSection": 148,
                    "offsetInEndSection": 332,
                    "text": "Here we report that the BTB/POZ domain transcription factor PATZ1 (MAZR), previously known for its transcriptional suppressor functions in T lymphocytes, is a crucial regulator of p53."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22983008",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 69,
                    "text": "The transcription factor CREBZF is a novel positive regulator of p53."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17383232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "The tumor suppressor p53 is a transcription factor that is frequently inactivated in human tumors."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9618472",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "Non-p53 p53RE binding protein, a human transcription factor functionally analogous to P53."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25755280",
                    "endSection": "abstract",
                    "offsetInBeginSection": 779,
                    "offsetInEndSection": 923,
                    "text": "Significantly, treatment with the DNA damage-inducing drug doxorubicin results in the loss of the PATZ1 transcription factor as p53 accumulates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25755280",
                    "endSection": "abstract",
                    "offsetInBeginSection": 924,
                    "offsetInEndSection": 1008,
                    "text": "We find that PATZ1 binds to p53 and inhibits p53-dependent transcription activation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10446138",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 121,
                    "text": "The adenovirus oncoprotein E1a stimulates binding of transcription factor ETF to transcriptionally activate the p53 gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9618472",
                    "endSection": "abstract",
                    "offsetInBeginSection": 119,
                    "offsetInEndSection": 327,
                    "text": "We describe the identification of a transcription factor that is functionally similar to p53 and contains the same DNA binding and transcription activities specific for the p53 responsive DNA element (p53RE)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20679336",
                    "endSection": "abstract",
                    "offsetInBeginSection": 419,
                    "offsetInEndSection": 486,
                    "text": "Indeed p53 is the most well studied mammalian transcription factor."
                }
            ]
        },
        {
            "body": "Is Cystatin D a biomarker?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22795897",
                "http://www.ncbi.nlm.nih.gov/pubmed/21377848",
                "http://www.ncbi.nlm.nih.gov/pubmed/21918259",
                "http://www.ncbi.nlm.nih.gov/pubmed/29087712",
                "http://www.ncbi.nlm.nih.gov/pubmed/28178353",
                "http://www.ncbi.nlm.nih.gov/pubmed/21151566",
                "http://www.ncbi.nlm.nih.gov/pubmed/22350134",
                "http://www.ncbi.nlm.nih.gov/pubmed/26364852",
                "http://www.ncbi.nlm.nih.gov/pubmed/19623638",
                "http://www.ncbi.nlm.nih.gov/pubmed/28282874"
            ],
            "id": "5a9d9ab94e03427e73000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22795897",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 80,
                    "text": "Cystatin C, a cysteine protease inhibitor, is a novel biomarker of renal damage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21377848",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 80,
                    "text": "Cystatin C, a cysteine protease inhibitor, is a novel biomarker of renal damage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21918259",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 165,
                    "text": "Cystatin C (cysC) is an endogenous cysteine peptidase (proteinase) inhibitor that has been intensively investigated as a biomarker of kidney function for many years."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29087712",
                    "endSection": "abstract",
                    "offsetInBeginSection": 653,
                    "offsetInEndSection": 881,
                    "text": "Because cathepsin D is a biomarker in aggressive forms of breast cancer and linked to poor prognosis, the effects of cathepsin D inhibition by 1 and 3 on the downstream cellular substrates cystatin C and PAI-1 were investigated."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28178353",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 56,
                    "text": "Cystatin F is a biomarker of prion pathogenesis in mice."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21151566",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 68,
                    "text": "Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22795897",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "Urinary cystatin C as a biomarker for diabetic nephropathy and its immunohistochemical localization in kidney in Zucker diabetic fatty (ZDF) rats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21151566",
                    "endSection": "abstract",
                    "offsetInBeginSection": 382,
                    "offsetInEndSection": 576,
                    "text": "The cysteine protease inhibitor cystatin C has recently gained interest as a candidate diagnostic biomarker for ALS, but further studies are required to fully characterize its biomarker utility."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21377848",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 134,
                    "text": "Urinary cystatin C as a biomarker for acute kidney injury and its immunohistochemical localization in kidney in the CDDP-treated rats."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22350134",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 60,
                    "text": "Cystatin C is not a good candidate biomarker for HNF1A-MODY."
                }
            ]
        },
        {
            "body": "What causes leishmaniasis?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27785103",
                "http://www.ncbi.nlm.nih.gov/pubmed/22802694",
                "http://www.ncbi.nlm.nih.gov/pubmed/11475954",
                "http://www.ncbi.nlm.nih.gov/pubmed/2670376",
                "http://www.ncbi.nlm.nih.gov/pubmed/21040662",
                "http://www.ncbi.nlm.nih.gov/pubmed/24707415",
                "http://www.ncbi.nlm.nih.gov/pubmed/25988048",
                "http://www.ncbi.nlm.nih.gov/pubmed/23219435",
                "http://www.ncbi.nlm.nih.gov/pubmed/6247584",
                "http://www.ncbi.nlm.nih.gov/pubmed/17361837"
            ],
            "id": "5abcf0b0fcf4565872000024",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27785103",
                    "endSection": "abstract",
                    "offsetInBeginSection": 187,
                    "offsetInEndSection": 239,
                    "text": "Visceral leishmaniasis is more frequently described."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22802694",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 132,
                    "text": "Leishmaniasis is an important vector-borne disease, and it is classified as one of the most important tropical fly-borne infections."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22802694",
                    "endSection": "abstract",
                    "offsetInBeginSection": 230,
                    "offsetInEndSection": 332,
                    "text": "Visceral leishmaniasis, which is also called kala-azar, is a very serious infection that can be fatal."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27785103",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 124,
                    "text": "Leishmaniasis - human immunodeficiency virus (HIV) coinfection can manifest itself as tegumentary or visceral leishmaniasis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22802694",
                    "endSection": "abstract",
                    "offsetInBeginSection": 547,
                    "offsetInEndSection": 676,
                    "text": "Paromomycin is a relatively new antibiotic drug that has been used for the treatment of visceral leishmaniasis for several years."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11475954",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 63,
                    "text": "Leishmaniasis is a sandfly-borne disease caused by a protozoan."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27785103",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1039,
                    "offsetInEndSection": 1128,
                    "text": "Drugs available to treat leishmaniasis are more restricted and cause severe side effects."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2670376",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 14,
                    "text": "Leishmaniasis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21040662",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 129,
                    "text": "Mucosal leishmaniasis is uncommon outside Central and South America, where it is commonly caused by Leishmania (L.) braziliensis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24707415",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 145,
                    "text": "Leishmaniasis is a tropical infection caused by the protozoan, belonging to the group of Leishmania which causes Old World and New World disease."
                }
            ]
        },
        {
            "body": "Please list 7 classes of drugs that interact with Warfarin.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/9707357",
                "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                "http://www.ncbi.nlm.nih.gov/pubmed/21359645",
                "http://www.ncbi.nlm.nih.gov/pubmed/20191029",
                "http://www.ncbi.nlm.nih.gov/pubmed/6347619",
                "http://www.ncbi.nlm.nih.gov/pubmed/15585436",
                "http://www.ncbi.nlm.nih.gov/pubmed/8357000",
                "http://www.ncbi.nlm.nih.gov/pubmed/27416928",
                "http://www.ncbi.nlm.nih.gov/pubmed/22198820",
                "http://www.ncbi.nlm.nih.gov/pubmed/7944078"
            ],
            "id": "5abce6acfcf4565872000022",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9707357",
                    "endSection": "abstract",
                    "offsetInBeginSection": 485,
                    "offsetInEndSection": 634,
                    "text": "Of 35 patients reviewed, 7 had a predisposing condition such as peptic ulcer and 19 received drugs or folk medicines that can interact with warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1744,
                    "offsetInEndSection": 2026,
                    "text": "CONCLUSION\nThis assessment of official US product labeling for 50 drugs, biologics, and drug classes known to interact with warfarin, comprising 73 distinct agents, found that 15% failed to mention the interaction, even though the interaction was mentioned in the warfarin labeling."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21359645",
                    "endSection": "abstract",
                    "offsetInBeginSection": 982,
                    "offsetInEndSection": 1376,
                    "text": "As the list of drugs and supplements that interact with warfarin is continuously expanding, and the knowledge on drug interactions with the novel oral anticoagulants is still in its infancy, clinicians need to be vigilant when initiating any of these agents or when any changes in the patient's medication profile occur and perform a close screening for potential drug and dietary interactions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20191029",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 151,
                    "text": "Nonsteroidal anti-inflammatory drugs (NSAIDs) are known to interact with the oral anticoagulant warfarin and can cause a serious bleeding complication."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                    "endSection": "abstract",
                    "offsetInBeginSection": 399,
                    "offsetInEndSection": 754,
                    "text": "METHODS\nWe examined the official labeling information approved by the US Food and Drug Administration for the 50 drugs, biologics, and drug classes that were commonly identified by 3 drug information compendia--Clinical Pharmacology, ePocrates(\u00ae), and Micromedex(\u00ae)--and the warfarin US prescribing information (PI) as having an interaction with warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6347619",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 87,
                    "text": "Drugs may interact with warfarin through pharmacodynamic or pharmacokinetic mechanisms."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15585436",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1698,
                    "offsetInEndSection": 1893,
                    "text": "The high percentage of patients taking drugs that may increase INR or bleeding risk is a reminder that bleeding events are a likely adverse outcome of combining drugs that interact with warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8357000",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 266,
                    "text": "Phenylbutazone has been clearly demonstrated to interact pharmacokinetically and clinically with warfarin, although several other nonsteroidal antiinflammatory drugs (NSAIDs) also have the potential to interact with warfarin to cause alterations in prothrombin time."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15585436",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1574,
                    "offsetInEndSection": 1697,
                    "text": "CONCLUSION\nMany patients receiving warfarin therapy are treated with concomitant drugs that may interact with the warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                    "endSection": "abstract",
                    "offsetInBeginSection": 207,
                    "offsetInEndSection": 396,
                    "text": "OBJECTIVE\nThe aim of this study was to assess the information regarding warfarin interactions that is included in the official labeling of prescription products that interact with warfarin."
                }
            ]
        },
        {
            "body": "What part of the body is affected by mesotheliomia?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17119338",
                "http://www.ncbi.nlm.nih.gov/pubmed/22879850",
                "http://www.ncbi.nlm.nih.gov/pubmed/24520350",
                "http://www.ncbi.nlm.nih.gov/pubmed/19280864",
                "http://www.ncbi.nlm.nih.gov/pubmed/21963254",
                "http://www.ncbi.nlm.nih.gov/pubmed/16051171",
                "http://www.ncbi.nlm.nih.gov/pubmed/1402972",
                "http://www.ncbi.nlm.nih.gov/pubmed/17957509",
                "http://www.ncbi.nlm.nih.gov/pubmed/22688599",
                "http://www.ncbi.nlm.nih.gov/pubmed/11984226"
            ],
            "id": "5a74eaa50384be955100000b",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17119338",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 11,
                    "text": "Misoplegia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22879850",
                    "endSection": "abstract",
                    "offsetInBeginSection": 628,
                    "offsetInEndSection": 764,
                    "text": "Symptoms vary from person to person, and may come and go, depend on what part of the body is affected, can be mild, moderate, or severe."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24520350",
                    "endSection": "abstract",
                    "offsetInBeginSection": 220,
                    "offsetInEndSection": 485,
                    "text": "In isolated focal dystonia, whole putaminal binding of dopamine D2-like receptor radioligands is quantitatively decreased, but it has not been known whether selected parts of the putamen are differentially affected depending upon the body part affected by dystonia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19280864",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 100,
                    "text": "Dystonia is a common movement disorder characterised by abnormal postures of the affected body part."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17119338",
                    "endSection": "abstract",
                    "offsetInBeginSection": 161,
                    "offsetInEndSection": 282,
                    "text": "Afflicted patients show dislike, amounting to hatred of the affected part, often accompanied by verbal or physical abuse."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21963254",
                    "endSection": "abstract",
                    "offsetInBeginSection": 139,
                    "offsetInEndSection": 261,
                    "text": "Another site often affected by inflammatory pseudotumors is the orbit, although they can be found in any part of the body."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16051171",
                    "endSection": "abstract",
                    "offsetInBeginSection": 240,
                    "offsetInEndSection": 410,
                    "text": "Here, we demonstrate that an intrinsic primary quality of a tactile object, for example its size, is directly affected by the perceived size of the body part touching it."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22879850",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "Systemic lupus erythematosus (SLE) is a chronic, multifaceted autoimmune inflammatory disease that can affect any part of the body."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24520350",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1439,
                    "offsetInEndSection": 1602,
                    "text": "We conclude that in isolated focal dystonia, dopamine D2-like receptors are distributed differently in the putamen depending on the body part manifesting dystonia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24520350",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 219,
                    "text": "The putamen has a somatotopic organization of neurons identified by correspondence of firing rates with selected body part movements, as well as by complex, but organized, differential cortical projections onto putamen."
                }
            ]
        },
        {
            "body": "What is BORSA?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                "http://www.ncbi.nlm.nih.gov/pubmed/17108271",
                "http://www.ncbi.nlm.nih.gov/pubmed/23554199",
                "http://www.ncbi.nlm.nih.gov/pubmed/16224179",
                "http://www.ncbi.nlm.nih.gov/pubmed/1563385",
                "http://www.ncbi.nlm.nih.gov/pubmed/2069374",
                "http://www.ncbi.nlm.nih.gov/pubmed/10834971",
                "http://www.ncbi.nlm.nih.gov/pubmed/20880412",
                "http://www.ncbi.nlm.nih.gov/pubmed/1900315",
                "http://www.ncbi.nlm.nih.gov/pubmed/19116360"
            ],
            "id": "5aae6499fcf456587200000c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 586,
                    "offsetInEndSection": 692,
                    "text": "BORSA cannot be classified as either truly methicillin-resistant or truly methicillin-susceptible strains."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 159,
                    "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype of methicillin resistance."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) - a more common problem than expected?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 800,
                    "offsetInEndSection": 920,
                    "text": "BORSA strains are commonly isolated from humans and animals, and are found both in hospitals and in a community setting."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 921,
                    "offsetInEndSection": 1123,
                    "text": "The epidemiology and clinical presentation of BORSA infections seem to be similar to those for MRSA; these infections are usually more severe than those caused by methicillin-sensitive S. aureus (MSSA)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17108271",
                    "endSection": "abstract",
                    "offsetInBeginSection": 881,
                    "offsetInEndSection": 1054,
                    "text": "A Gln(629)-->Pro substitution was common to all ST25 BORSA, but most could be distinguished from one another by additional unique substitutions in the transpeptidase domain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23554199",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1218,
                    "offsetInEndSection": 1410,
                    "text": "Retrospective typing of an MRSA outbreak showed that it is possible to differentiate unrelated MSSA, MRSA, and borderline resistant S. aureus (BORSA) strains isolated from health care workers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1228,
                    "offsetInEndSection": 1440,
                    "text": "The available evidence suggests that BORSA represent a frequently neglected problem, and their emergence in new environments implies that they need to be monitored and accurately distinguished from MSSA and MRSA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 160,
                    "offsetInEndSection": 455,
                    "text": "BORSA strains show low, borderline resistance to penicillinase-resistant penicillins (PRPs), with oxacillin MICs typically equal to 1-8\u2009\u00b5g\u2009ml-1, and in contrast to methicillin-resistant S. aureus (MRSA), do not have an altered penicillin-binding protein, PBP2a, encoded by the mecA or mecC gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1124,
                    "offsetInEndSection": 1227,
                    "text": "Treatment of severe infections caused by BORSA may be ineffective, even with larger doses of oxacillin."
                }
            ]
        },
        {
            "body": "Which gene is responsible for proper speech development?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26980647",
                "http://www.ncbi.nlm.nih.gov/pubmed/24563287",
                "http://www.ncbi.nlm.nih.gov/pubmed/10204849",
                "http://www.ncbi.nlm.nih.gov/pubmed/22644823",
                "http://www.ncbi.nlm.nih.gov/pubmed/9081276",
                "http://www.ncbi.nlm.nih.gov/pubmed/25269856",
                "http://www.ncbi.nlm.nih.gov/pubmed/7362428",
                "http://www.ncbi.nlm.nih.gov/pubmed/20571508",
                "http://www.ncbi.nlm.nih.gov/pubmed/3343880",
                "http://www.ncbi.nlm.nih.gov/pubmed/16497722"
            ],
            "id": "5ace12be0340b9f058000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26980647",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 89,
                    "text": "The FOXP2 gene is important for the development of proper speech motor control in humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24563287",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 204,
                    "text": "Plant growth and development require proper cell wall organization but little is known about the transcription factors responsible for the regulation of gene expression involved in cell wall organization."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10204849",
                    "endSection": "abstract",
                    "offsetInBeginSection": 454,
                    "offsetInEndSection": 660,
                    "text": "Since we know of two more patients with velocardiofacial syndrome and HSCR, we hypothesise that a gene responsible for proper development of the enteric nervous system may be included in the 22q11.2 region."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22644823",
                    "endSection": "abstract",
                    "offsetInBeginSection": 351,
                    "offsetInEndSection": 470,
                    "text": "Therefore early diagnosis and treatment with rehabilitation of hearing loss is important for proper speech development."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9081276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1286,
                    "offsetInEndSection": 1464,
                    "text": "Nine children had congenital deafness which was detected early in life and showed no improvement after proper hearing aid fitting and audioverbal training for speech development."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25269856",
                    "endSection": "abstract",
                    "offsetInBeginSection": 259,
                    "offsetInEndSection": 414,
                    "text": "An adequate amount of functional FOXP2 protein is thought to be critical for the proper development of the neural circuitry underlying speech and language."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7362428",
                    "endSection": "abstract",
                    "offsetInBeginSection": 837,
                    "offsetInEndSection": 1059,
                    "text": "The data indicate that children with speech and langauge disorders are highly at risk for the development of significant psychiatric problems, which suggests the need for proper screening and multimodal treatment planning."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20571508",
                    "endSection": "abstract",
                    "offsetInBeginSection": 282,
                    "offsetInEndSection": 381,
                    "text": "These findings suggest the possibility that FOXP1 may also contribute to proper speech development."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3343880",
                    "endSection": "abstract",
                    "offsetInBeginSection": 399,
                    "offsetInEndSection": 504,
                    "text": "To date, other factors which might be responsible for the development of normal speech have been ignored."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16497722",
                    "endSection": "abstract",
                    "offsetInBeginSection": 265,
                    "offsetInEndSection": 423,
                    "text": "We have identified the Xq22 gene SRPX2 as being responsible for rolandic seizures (RSs) associated with oral and speech dyspraxia and mental retardation (MR)."
                }
            ]
        },
        {
            "body": "What is PNPPP?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                "http://www.ncbi.nlm.nih.gov/pubmed/21747892"
            ],
            "id": "5a9da59c4e03427e73000005",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 919,
                    "offsetInEndSection": 1050,
                    "text": "PdeM is a monomer of 29.3 kDa, which exhibits optimum activity at 25\u00b0C and pH 8.5, but low affinity for bis(pNPP) as well as pNPPP."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 167,
                    "text": "Effect of genetic and environmental factors on protein biomarkers for common non-communicable disease and use of personally normalized plasma protein profiles (PNPPP)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 520,
                    "offsetInEndSection": 722,
                    "text": "CONCLUSION\nPNPPP efficiently controls for non-disease-related variance, allowing both for efficient discovery of novel biomarkers and for covariate-independent linear cut-offs suitable for clinical use."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 196,
                    "text": "OBJECTIVE\nTo study the impact of genetic and lifestyle factors on protein biomarkers and develop personally normalized plasma protein profiles (PNPPP) controlling for non-disease-related variance."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1827,
                    "offsetInEndSection": 1913,
                    "text": "PdeM, thus, is a novel representative of new subclass of class III phosphodiesterases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 79,
                    "text": "Phosphoesterases are involved in the degradation of organophosphorus compounds."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "Identification and characterization of a novel phosphodiesterase from the metagenome of an Indian coalbed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 428,
                    "offsetInEndSection": 727,
                    "text": "Bioinformatic analysis showed that PdeM sequence possessed the characteristic signature motifs of the class III phosphodiesterases and phylogenetic study of PdeM enabled us to identify three distinct subclasses (A, B, and C) within class III phosphodiesterases, PdeM clustering in new subclass IIIB."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 213,
                    "offsetInEndSection": 427,
                    "text": "In our search to find novel phosphodiesterases using metagenomic approach, we cloned a gene encoding a putative phosphodiesterase (PdeM) from the metagenome of the formation water collected from an Indian coal bed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                    "endSection": "abstract",
                    "offsetInBeginSection": 165,
                    "offsetInEndSection": 531,
                    "text": "In the + MP transgenic plants, as compared with non-transgenic and - MP plants, higher hydrolytic activities were found on the following substrates: bis-(nitrophenyl)-phosphate (BPNPP, phosphodiesterase), p-nitrophenyl-(phenyl)-phosphate (PNPPP, nucleotidephosphodiesterase) and thymidine-3'-monophosphate p-nitrophenyl ester (T3MPP; 3'nucleotide phosphodiesterase.)"
                }
            ]
        },
        {
            "body": "What is Mendelian randomization?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23934314",
                "http://www.ncbi.nlm.nih.gov/pubmed/30221016",
                "http://www.ncbi.nlm.nih.gov/pubmed/26050253",
                "http://www.ncbi.nlm.nih.gov/pubmed/25322353",
                "http://www.ncbi.nlm.nih.gov/pubmed/27411906",
                "http://www.ncbi.nlm.nih.gov/pubmed/17715159",
                "http://www.ncbi.nlm.nih.gov/pubmed/19674341",
                "http://www.ncbi.nlm.nih.gov/pubmed/26775119",
                "http://www.ncbi.nlm.nih.gov/pubmed/27749700",
                "http://www.ncbi.nlm.nih.gov/pubmed/23199790"
            ],
            "id": "5a9da37e4e03427e73000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23934314",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 193,
                    "text": "Mendelian randomization, which is instrumental variable analysis using genetic variants as instruments, is an increasingly popular method of making causal inferences from observational studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/30221016",
                    "endSection": "abstract",
                    "offsetInBeginSection": 340,
                    "offsetInEndSection": 553,
                    "text": "Mendelian randomization (MR), which uses genetic variants as the instrumental variables, is an application of the instrumental variable method to biomedical research fields, and has become popular in recent years."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26050253",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 124,
                    "text": "BACKGROUND\nThe number of Mendelian randomization analyses including large numbers of genetic variants is rapidly increasing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25322353",
                    "endSection": "abstract",
                    "offsetInBeginSection": 352,
                    "offsetInEndSection": 484,
                    "text": "A solution is to conduct a Mendelian randomization analysis, which uses genetic variation as a surrogate marker for the risk factor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27411906",
                    "endSection": "abstract",
                    "offsetInBeginSection": 416,
                    "offsetInEndSection": 550,
                    "text": "Mendelian randomization analysis uses these genetic variants to test whether a particular risk factor is causal for a disease outcome."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17715159",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "Mendelian randomization as an instrumental variable approach to causal inference."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23934314",
                    "endSection": "abstract",
                    "offsetInBeginSection": 194,
                    "offsetInEndSection": 311,
                    "text": "In order to design efficient Mendelian randomization studies, it is essential to calculate the sample sizes required."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19674341",
                    "endSection": "abstract",
                    "offsetInBeginSection": 523,
                    "offsetInEndSection": 620,
                    "text": "Mendelian randomization uses genetic variants as proxies for environmental exposures of interest."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26050253",
                    "endSection": "abstract",
                    "offsetInBeginSection": 426,
                    "offsetInEndSection": 601,
                    "text": "METHODS\nWe view Mendelian randomization with multiple instruments as a meta-analysis, and show that bias caused by pleiotropy can be regarded as analogous to small study bias."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26775119",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 180,
                    "text": "Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population."
                }
            ]
        }
    ]
}